Genbank References: capsid (p24)

Authors	Title	Citation	E-value	# in Gb	#Pts	ART	Source	Cloning	StudyType
Novitsky (2016)	Timing constraints of in vivo gag mutations during primary HIV-1 subtype C infection	PLoS ONE 4 (11), E7727 (2009)	3.83e-164	2521	42	Naive	Plasma; PBMC	SGS	Acute infection

Download sequences

Accession	IsolateName	Country	Coll Date	Clone	MolType	Source	Note	FirstAA	LastAA	MutList
GQ275570	C_095_12	Botswana			genomic DNA	patient C sampled 095 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275571	C_095_13	Botswana			genomic DNA	patient C sampled 095 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275572	C_095_14	Botswana			genomic DNA	patient C sampled 095 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S,228P
GQ275573	C_095_15	Botswana			genomic DNA	patient C sampled 095 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275574	C_095_17	Botswana			genomic DNA	patient C sampled 095 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275575	C_095_18	Botswana			genomic DNA	patient C sampled 095 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275576	C_095_19	Botswana			genomic DNA	patient C sampled 095 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275577	C_095_20	Botswana			genomic DNA	patient C sampled 095 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275578	C_095_21	Botswana			genomic DNA	patient C sampled 095 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275579	C_095_22	Botswana			genomic DNA	patient C sampled 095 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275580	C_095_23	Botswana			genomic DNA	patient C sampled 095 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275581	C_095_24	Botswana			genomic DNA	patient C sampled 095 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275582	C_095_25	Botswana			genomic DNA	patient C sampled 095 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275583	C_109_01	Botswana			genomic DNA	patient C sampled 109 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275584	C_109_02	Botswana			genomic DNA	patient C sampled 109 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275585	C_109_03	Botswana			genomic DNA	patient C sampled 109 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275586	C_109_04	Botswana			genomic DNA	patient C sampled 109 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275587	C_109_05	Botswana			genomic DNA	patient C sampled 109 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275588	C_109_06	Botswana			genomic DNA	patient C sampled 109 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S,216P
GQ275589	C_109_07	Botswana			genomic DNA	patient C sampled 109 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275590	C_109_08	Botswana			genomic DNA	patient C sampled 109 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,94A,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275591	C_109_10	Botswana			genomic DNA	patient C sampled 109 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275592	C_109_11	Botswana			genomic DNA	patient C sampled 109 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275593	C_109_12	Botswana			genomic DNA	patient C sampled 109 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,210S
GQ275594	C_109_14	Botswana			genomic DNA	patient C sampled 109 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275595	C_109_15	Botswana			genomic DNA	patient C sampled 109 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275596	C_109_16	Botswana			genomic DNA	patient C sampled 109 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275597	C_109_17	Botswana			genomic DNA	patient C sampled 109 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275598	C_109_18	Botswana			genomic DNA	patient C sampled 109 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275599	C_201_01	Botswana			genomic DNA	patient C sampled 201 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,210S
GQ275600	C_201_01R	Botswana			genomic RNA	patient C sampled 201 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,210S
GQ275601	C_201_02	Botswana			genomic DNA	patient C sampled 201 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,210S
GQ275602	C_201_02R	Botswana			genomic RNA	patient C sampled 201 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275603	C_201_03	Botswana			genomic DNA	patient C sampled 201 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,210S
GQ275604	C_201_03R	Botswana			genomic RNA	patient C sampled 201 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,210S
GQ275605	C_201_04	Botswana			genomic DNA	patient C sampled 201 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,210S
GQ275606	C_201_04R	Botswana			genomic RNA	patient C sampled 201 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275607	C_201_05	Botswana			genomic DNA	patient C sampled 201 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,210S
GQ275608	C_201_05R	Botswana			genomic RNA	patient C sampled 201 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,210S
GQ275609	C_201_06	Botswana			genomic DNA	patient C sampled 201 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275610	C_201_06R	Botswana			genomic RNA	patient C sampled 201 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,210S
GQ275611	C_201_07	Botswana			genomic DNA	patient C sampled 201 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,206E,208G,210S
GQ275612	C_201_07R	Botswana			genomic RNA	patient C sampled 201 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,210S
GQ275613	C_201_08R	Botswana			genomic RNA	patient C sampled 201 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,210S
GQ275614	C_201_09	Botswana			genomic DNA	patient C sampled 201 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275615	C_201_10	Botswana			genomic DNA	patient C sampled 201 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,210S
GQ275616	C_201_10R	Botswana			genomic RNA	patient C sampled 201 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275617	C_201_11	Botswana			genomic DNA	patient C sampled 201 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275618	C_201_11R	Botswana			genomic RNA	patient C sampled 201 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,210S
GQ275619	C_201_12	Botswana			genomic DNA	patient C sampled 201 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,210S
GQ275620	C_201_12R	Botswana			genomic RNA	patient C sampled 201 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275621	C_201_13	Botswana			genomic DNA	patient C sampled 201 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275622	C_201_13R	Botswana			genomic RNA	patient C sampled 201 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275623	C_201_14	Botswana			genomic DNA	patient C sampled 201 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,210S
GQ275624	C_201_14R	Botswana			genomic RNA	patient C sampled 201 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,210S
GQ275625	C_201_15	Botswana			genomic DNA	patient C sampled 201 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,46R,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275626	C_201_15R	Botswana			genomic RNA	patient C sampled 201 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275627	C_201_16	Botswana			genomic DNA	patient C sampled 201 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,210S
GQ275628	C_201_16R	Botswana			genomic RNA	patient C sampled 201 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275629	C_201_17R	Botswana			genomic RNA	patient C sampled 201 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275630	C_201_18R	Botswana			genomic RNA	patient C sampled 201 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,210S
GQ275631	C_201_19R	Botswana			genomic RNA	patient C sampled 201 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275632	C_201_20R	Botswana			genomic RNA	patient C sampled 201 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275633	C_201_21R	Botswana			genomic RNA	patient C sampled 201 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275634	C_201_22R	Botswana			genomic RNA	patient C sampled 201 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275635	C_201_24R	Botswana			genomic RNA	patient C sampled 201 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275636	C_292_01	Botswana			genomic DNA	patient C sampled 292 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,101E,110N,111F,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275637	C_292_02	Botswana			genomic DNA	patient C sampled 292 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275638	C_292_03	Botswana			genomic DNA	patient C sampled 292 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,210S
GQ275639	C_292_04	Botswana			genomic DNA	patient C sampled 292 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275640	C_292_05	Botswana			genomic DNA	patient C sampled 292 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275641	C_292_06	Botswana			genomic DNA	patient C sampled 292 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275642	C_292_07	Botswana			genomic DNA	patient C sampled 292 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,210S
GQ275643	C_292_08	Botswana			genomic DNA	patient C sampled 292 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275644	C_325_01R	Botswana			genomic RNA	patient C sampled 325 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275645	C_325_02R	Botswana			genomic RNA	patient C sampled 325 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275646	C_325_03R	Botswana			genomic RNA	patient C sampled 325 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,210S
GQ275647	C_325_04R	Botswana			genomic RNA	patient C sampled 325 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275648	C_325_05R	Botswana			genomic RNA	patient C sampled 325 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275649	C_325_06R	Botswana			genomic RNA	patient C sampled 325 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275650	C_325_07R	Botswana			genomic RNA	patient C sampled 325 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275651	C_325_08R	Botswana			genomic RNA	patient C sampled 325 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275652	C_325_09R	Botswana			genomic RNA	patient C sampled 325 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275653	C_445_01	Botswana			genomic DNA	patient C sampled 445 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275654	C_445_02	Botswana			genomic DNA	patient C sampled 445 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275655	C_445_03	Botswana			genomic DNA	patient C sampled 445 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,210S
GQ275656	C_445_04	Botswana			genomic DNA	patient C sampled 445 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275657	C_445_05	Botswana			genomic DNA	patient C sampled 445 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275658	C_445_06	Botswana			genomic DNA	patient C sampled 445 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,210S
GQ275659	C_445_07	Botswana			genomic DNA	patient C sampled 445 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275660	C_445_08	Botswana			genomic DNA	patient C sampled 445 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275661	C_445_09	Botswana			genomic DNA	patient C sampled 445 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275662	C_445_10	Botswana			genomic DNA	patient C sampled 445 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275663	C_445_12	Botswana			genomic DNA	patient C sampled 445 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,210S
GQ275664	C_445_13	Botswana			genomic DNA	patient C sampled 445 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275665	C_445_14	Botswana			genomic DNA	patient C sampled 445 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275666	C_445_15	Botswana			genomic DNA	patient C sampled 445 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275667	C_445_18	Botswana			genomic DNA	patient C sampled 445 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ275668	D_006_01	Botswana			genomic DNA	patient D sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275669	D_006_01R	Botswana			genomic RNA	patient D sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275670	D_006_02	Botswana			genomic DNA	patient D sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275671	D_006_03	Botswana			genomic DNA	patient D sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275672	D_006_03R	Botswana			genomic RNA	patient D sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275673	D_006_04	Botswana			genomic DNA	patient D sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275674	D_006_04R	Botswana			genomic RNA	patient D sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275675	D_006_05	Botswana			genomic DNA	patient D sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275676	D_006_05R	Botswana			genomic RNA	patient D sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,83L,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275677	D_006_06	Botswana			genomic DNA	patient D sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275678	D_006_06R	Botswana			genomic RNA	patient D sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275679	D_006_07	Botswana			genomic DNA	patient D sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,83L,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275680	D_006_07R	Botswana			genomic RNA	patient D sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275681	D_006_08	Botswana			genomic DNA	patient D sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275682	D_006_08R	Botswana			genomic RNA	patient D sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275683	D_006_09	Botswana			genomic DNA	patient D sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275684	D_006_09R	Botswana			genomic RNA	patient D sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275685	D_006_10	Botswana			genomic DNA	patient D sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275686	D_006_10R	Botswana			genomic RNA	patient D sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275687	D_006_11	Botswana			genomic DNA	patient D sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275688	D_006_11R	Botswana			genomic RNA	patient D sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,83L,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275689	D_006_12	Botswana			genomic DNA	patient D sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275690	D_006_12R	Botswana			genomic RNA	patient D sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275691	D_006_13R	Botswana			genomic RNA	patient D sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,83L,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275692	D_006_14R	Botswana			genomic RNA	patient D sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275693	D_006_15R	Botswana			genomic RNA	patient D sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275694	D_006_18R	Botswana			genomic RNA	patient D sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275695	D_006_19R	Botswana			genomic RNA	patient D sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275696	D_006_20R	Botswana			genomic RNA	patient D sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275697	D_103_02	Botswana			genomic DNA	patient D sampled 103 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275698	D_103_03	Botswana			genomic DNA	patient D sampled 103 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,83L,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275699	D_103_04	Botswana			genomic DNA	patient D sampled 103 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,83L,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275700	D_103_05	Botswana			genomic DNA	patient D sampled 103 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,83L,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275701	D_103_06	Botswana			genomic DNA	patient D sampled 103 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,83L,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275702	D_103_08	Botswana			genomic DNA	patient D sampled 103 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,83L,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275703	D_103_09	Botswana			genomic DNA	patient D sampled 103 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,83L,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275704	D_148_01	Botswana			genomic DNA	patient D sampled 148 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,83L,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275705	D_148_03	Botswana			genomic DNA	patient D sampled 148 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,83L,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275706	D_148_04	Botswana			genomic DNA	patient D sampled 148 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,83L,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275707	D_148_07	Botswana			genomic DNA	patient D sampled 148 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,10T,15M,41T,50S,54S,58A,75D,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275708	D_148_08	Botswana			genomic DNA	patient D sampled 148 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,10T,15M,41T,50S,54S,58A,75D,83L,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275709	D_148_09	Botswana			genomic DNA	patient D sampled 148 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,83L,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275710	D_148_10	Botswana			genomic DNA	patient D sampled 148 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275711	D_177_01	Botswana			genomic DNA	patient D sampled 177 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275712	D_177_02	Botswana			genomic DNA	patient D sampled 177 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,83L,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275713	D_177_03	Botswana			genomic DNA	patient D sampled 177 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15M,41T,50S,54S,58A,75D,83L,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275714	D_177_04	Botswana			genomic DNA	patient D sampled 177 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275715	D_177_05	Botswana			genomic DNA	patient D sampled 177 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,83L,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275716	D_177_06	Botswana			genomic DNA	patient D sampled 177 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,83L,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275717	D_177_07	Botswana			genomic DNA	patient D sampled 177 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275718	D_177_08	Botswana			genomic DNA	patient D sampled 177 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,83L,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275719	D_177_09	Botswana			genomic DNA	patient D sampled 177 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15M,41T,50S,54S,58A,75D,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275720	D_301_01	Botswana			genomic DNA	patient D sampled 301 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,10T,15M,41T,50S,54S,58A,75D,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275721	D_301_03	Botswana			genomic DNA	patient D sampled 301 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275722	D_301_04	Botswana			genomic DNA	patient D sampled 301 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275723	D_301_05	Botswana			genomic DNA	patient D sampled 301 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275724	D_301_07	Botswana			genomic DNA	patient D sampled 301 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,83L,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275725	D_301_08	Botswana			genomic DNA	patient D sampled 301 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,91A,116A,120S,128D,135V,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ275726	D_301_09	Botswana			genomic DNA	patient D sampled 301 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275727	D_301_10	Botswana			genomic DNA	patient D sampled 301 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,83L,91A,116P,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275728	D_301_11	Botswana			genomic DNA	patient D sampled 301 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,83L,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275729	D_301_12	Botswana			genomic DNA	patient D sampled 301 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15M,41T,50S,54S,58A,75D,83L,91V,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275730	D_301_13	Botswana			genomic DNA	patient D sampled 301 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15M,41T,50S,54S,58A,75D,83L,91V,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275731	D_393_01	Botswana			genomic DNA	patient D sampled 393 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275734	D_393_01R	Botswana			genomic RNA	patient D sampled 393 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,10T,15M,41T,50S,54C,58A,75D,83L,91V,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275732	D_393_02	Botswana			genomic DNA	patient D sampled 393 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15M,41T,50S,54S,58A,75D,83L,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275735	D_393_02R	Botswana			genomic RNA	patient D sampled 393 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15M,41T,50S,54S,58A,75D,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275733	D_393_03	Botswana			genomic DNA	patient D sampled 393 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54S,58A,75D,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275736	D_393_03R	Botswana			genomic RNA	patient D sampled 393 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15M,41T,50S,54S,58A,75D,83L,91V,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275737	D_393_04R	Botswana			genomic RNA	patient D sampled 393 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15M,41T,50S,54S,58A,75D,91V,116A,120S,128D,135V,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ275738	D_393_05R	Botswana			genomic RNA	patient D sampled 393 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15M,41T,50S,54S,58A,75D,91V,116A,120S,128D,135V,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ275739	D_393_06R	Botswana			genomic RNA	patient D sampled 393 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15M,41T,50S,54S,58A,75D,91V,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275740	D_393_08R	Botswana			genomic RNA	patient D sampled 393 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15M,41T,50S,54S,56S,58A,75D,83L,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275741	D_393_09R	Botswana			genomic RNA	patient D sampled 393 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15M,41T,50S,54C,58A,75D,83L,91A,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275742	D_483_01R	Botswana			genomic RNA	patient D sampled 483 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15M,41T,50S,54S,58A,75D,91V,116A,120S,128D,135V,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ275743	D_483_02R	Botswana			genomic RNA	patient D sampled 483 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15M,41T,50S,54S,58A,83L,91V,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275744	D_483_03R	Botswana			genomic RNA	patient D sampled 483 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15M,41T,50S,54C,58A,75D,91V,116A,120S,128D,135V,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ275745	D_483_04R	Botswana			genomic RNA	patient D sampled 483 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15M,41T,50S,54S,58A,75D,91V,116A,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275746	D_483_05R	Botswana			genomic RNA	patient D sampled 483 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15M,41T,50S,54S,58A,75D,91V,116T,120S,128D,135V,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ275747	D_483_06R	Botswana			genomic RNA	patient D sampled 483 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15M,41T,50S,54S,58A,83L,91V,116T,120S,128D,135V,148V,154K,160S,169F,177S,178T,187D,203R,208G,225S
GQ275748	D_483_08R	Botswana			genomic RNA	patient D sampled 483 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15M,41T,50S,54S,58A,75D,83L,91V,116A,120S,128D,135V,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ275749	D_483_09R	Botswana			genomic RNA	patient D sampled 483 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15M,41T,50S,54C,58A,75D,91V,116A,120S,128D,135V,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ275750	E_030_01	Botswana			genomic DNA	patient E sampled 030 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,209T,225S
GQ275751	E_030_02	Botswana			genomic DNA	patient E sampled 030 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275752	E_030_03	Botswana			genomic DNA	patient E sampled 030 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275753	E_030_04	Botswana			genomic DNA	patient E sampled 030 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275754	E_030_05	Botswana			genomic DNA	patient E sampled 030 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275755	E_030_06	Botswana			genomic DNA	patient E sampled 030 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,9H,19P,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,166A,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275756	E_030_07	Botswana			genomic DNA	patient E sampled 030 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275757	E_030_08	Botswana			genomic DNA	patient E sampled 030 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275758	E_030_09	Botswana			genomic DNA	patient E sampled 030 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275759	E_030_10	Botswana			genomic DNA	patient E sampled 030 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275760	E_030_11	Botswana			genomic DNA	patient E sampled 030 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275761	E_030_12	Botswana			genomic DNA	patient E sampled 030 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275762	E_030_13	Botswana			genomic DNA	patient E sampled 030 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275763	E_030_14	Botswana			genomic DNA	patient E sampled 030 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275764	E_030_15	Botswana			genomic DNA	patient E sampled 030 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275765	E_030_16	Botswana			genomic DNA	patient E sampled 030 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275766	E_030_17	Botswana			genomic DNA	patient E sampled 030 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275767	E_030_18	Botswana			genomic DNA	patient E sampled 030 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275768	E_030_19	Botswana			genomic DNA	patient E sampled 030 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275769	E_030_20	Botswana			genomic DNA	patient E sampled 030 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275770	E_030_21	Botswana			genomic DNA	patient E sampled 030 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275771	E_030_22	Botswana			genomic DNA	patient E sampled 030 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275772	E_030_23	Botswana			genomic DNA	patient E sampled 030 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275773	E_030_24	Botswana			genomic DNA	patient E sampled 030 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275774	E_059_01	Botswana			genomic DNA	patient E sampled 059 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275775	E_059_04	Botswana			genomic DNA	patient E sampled 059 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275776	E_059_05	Botswana			genomic DNA	patient E sampled 059 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275777	E_059_06	Botswana			genomic DNA	patient E sampled 059 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275778	E_059_15	Botswana			genomic DNA	patient E sampled 059 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275779	E_059_16	Botswana			genomic DNA	patient E sampled 059 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275780	E_059_17	Botswana			genomic DNA	patient E sampled 059 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275781	E_059_18	Botswana			genomic DNA	patient E sampled 059 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275782	E_059_19	Botswana			genomic DNA	patient E sampled 059 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275783	E_059_20	Botswana			genomic DNA	patient E sampled 059 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275784	E_150_01	Botswana			genomic DNA	patient E sampled 150 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275785	E_150_02	Botswana			genomic DNA	patient E sampled 150 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275786	E_150_03	Botswana			genomic DNA	patient E sampled 150 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275787	E_150_04	Botswana			genomic DNA	patient E sampled 150 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275788	E_150_05	Botswana			genomic DNA	patient E sampled 150 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275789	E_150_06	Botswana			genomic DNA	patient E sampled 150 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275790	E_150_07	Botswana			genomic DNA	patient E sampled 150 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275791	E_150_08	Botswana			genomic DNA	patient E sampled 150 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275792	E_150_10	Botswana			genomic DNA	patient E sampled 150 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,157~,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275793	E_243_01R	Botswana			genomic RNA	patient E sampled 243 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,71D,83L,91A,94A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275794	E_243_02R	Botswana			genomic RNA	patient E sampled 243 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275795	E_243_03R	Botswana			genomic RNA	patient E sampled 243 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275796	E_243_04R	Botswana			genomic RNA	patient E sampled 243 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275797	E_243_05R	Botswana			genomic RNA	patient E sampled 243 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275798	E_243_06R	Botswana			genomic RNA	patient E sampled 243 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96L,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275799	E_274_01	Botswana			genomic DNA	patient E sampled 274 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,207R,208G,225S
GQ275800	E_274_02	Botswana			genomic DNA	patient E sampled 274 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275801	E_274_03	Botswana			genomic DNA	patient E sampled 274 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275802	E_274_04	Botswana			genomic DNA	patient E sampled 274 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275803	E_274_05	Botswana			genomic DNA	patient E sampled 274 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275804	E_274_06	Botswana			genomic DNA	patient E sampled 274 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275805	E_274_07	Botswana			genomic DNA	patient E sampled 274 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275806	E_274_08	Botswana			genomic DNA	patient E sampled 274 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275807	E_274_09	Botswana			genomic DNA	patient E sampled 274 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275808	E_274_10	Botswana			genomic DNA	patient E sampled 274 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275809	E_305_01	Botswana			genomic DNA	patient E sampled 305 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275810	E_305_02	Botswana			genomic DNA	patient E sampled 305 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275811	E_305_03	Botswana			genomic DNA	patient E sampled 305 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275812	E_305_04	Botswana			genomic DNA	patient E sampled 305 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275813	E_305_05	Botswana			genomic DNA	patient E sampled 305 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275814	E_305_06	Botswana			genomic DNA	patient E sampled 305 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,133*,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275815	E_305_07	Botswana			genomic DNA	patient E sampled 305 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275816	E_305_08	Botswana			genomic DNA	patient E sampled 305 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275817	E_305_09	Botswana			genomic DNA	patient E sampled 305 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275818	E_305_10	Botswana			genomic DNA	patient E sampled 305 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275819	E_339_01	Botswana			genomic DNA	patient E sampled 339 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275820	E_339_02	Botswana			genomic DNA	patient E sampled 339 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275821	E_339_03	Botswana			genomic DNA	patient E sampled 339 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275822	E_339_05	Botswana			genomic DNA	patient E sampled 339 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275823	E_339_06	Botswana			genomic DNA	patient E sampled 339 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275824	E_339_07	Botswana			genomic DNA	patient E sampled 339 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275825	E_339_09	Botswana			genomic DNA	patient E sampled 339 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275826	E_339_10	Botswana			genomic DNA	patient E sampled 339 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275827	E_404_01	Botswana			genomic DNA	patient E sampled 404 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275828	E_404_02	Botswana			genomic DNA	patient E sampled 404 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275829	E_404_03	Botswana			genomic DNA	patient E sampled 404 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275830	E_404_04	Botswana			genomic DNA	patient E sampled 404 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275831	E_404_04R	Botswana			genomic RNA	patient E sampled 404 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275832	E_404_05	Botswana			genomic DNA	patient E sampled 404 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275833	E_404_05R	Botswana			genomic RNA	patient E sampled 404 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275834	E_404_06	Botswana			genomic DNA	patient E sampled 404 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275835	E_404_07	Botswana			genomic DNA	patient E sampled 404 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275836	E_404_09	Botswana			genomic DNA	patient E sampled 404 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275837	E_404_09R	Botswana			genomic RNA	patient E sampled 404 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275838	E_404_10	Botswana			genomic DNA	patient E sampled 404 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275839	E_404_10R	Botswana			genomic RNA	patient E sampled 404 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275840	E_404_12R	Botswana			genomic RNA	patient E sampled 404 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275841	E_404_13R	Botswana			genomic RNA	patient E sampled 404 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275842	E_404_14R	Botswana			genomic RNA	patient E sampled 404 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275843	E_404_15R	Botswana			genomic RNA	patient E sampled 404 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275844	E_404_16R	Botswana			genomic RNA	patient E sampled 404 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275845	E_404_17R	Botswana			genomic RNA	patient E sampled 404 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275846	E_404_18R	Botswana			genomic RNA	patient E sampled 404 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275847	E_404_19R	Botswana			genomic RNA	patient E sampled 404 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,218Y,225S
GQ275848	E_404_20R	Botswana			genomic RNA	patient E sampled 404 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,31G,33N,41T,71D,83L,91A,96I,116A,123A,128D,148V,154K,169F,178T,180D,187D,199R,200N,203R,208G,225S
GQ275849	F_007_01R	Botswana			genomic RNA	patient F sampled 007 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	15	231	15L,16T,27I,41T,50T,71D,83L,91V,116A,120S,124V,128D,136M,148V,154K,169F,170R,178T,180D,187D,203R,204G,207Q,208G,210S,225S
GQ275850	F_007_02R	Botswana			genomic RNA	patient F sampled 007 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	15	231	15L,16T,27I,41T,50T,71D,83L,91V,116A,120S,124V,128D,136M,148V,154K,169F,170R,178T,180D,187D,203R,204G,207Q,208G,210S,225S
GQ275851	F_007_03R	Botswana			genomic RNA	patient F sampled 007 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	15	231	15L,16T,27I,41T,50T,71D,83L,91V,116A,120S,124V,128D,136M,148V,154K,169F,170R,178T,180D,187D,203R,204G,207Q,208G,210S,225S
GQ275852	F_007_04R	Botswana			genomic RNA	patient F sampled 007 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,16T,27I,41T,50T,71D,83L,91V,116A,120S,124V,128D,136M,148V,154K,169F,170R,178T,180D,187D,203R,204G,207Q,208G,210S,225S
GQ275853	F_007_05R	Botswana			genomic RNA	patient F sampled 007 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,16T,27I,41T,50T,71D,83L,91V,116A,120S,124V,128D,136M,146R,148V,154K,169F,170R,178T,180D,187D,203R,204G,207Q,208G,210S,225S
GQ275854	F_007_06R	Botswana			genomic RNA	patient F sampled 007 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,16T,27I,41T,50T,71D,83L,91V,116A,120S,124V,128D,136M,148V,154K,169F,170R,178T,180D,187D,203R,204G,207Q,208G,210S,225S
GQ275855	F_007_07R	Botswana			genomic RNA	patient F sampled 007 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,16T,27I,41T,50T,71D,83L,91V,116A,120S,124V,128D,136M,148V,154K,169F,170R,178T,180D,187D,203R,204G,207Q,208G,210S,225S
GQ275856	F_070_08	Botswana			genomic DNA	patient F sampled 070 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,16T,27I,41T,50T,71D,83L,91V,116A,120S,124V,128D,136M,148V,154K,169F,170R,178T,180D,187D,203R,204G,207Q,208G,210S,225S
GQ275857	F_098_03	Botswana			genomic DNA	patient F sampled 098 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,16T,27I,41T,50T,71D,83L,91V,116A,120S,124V,128D,136M,148V,154K,169F,170R,178T,180D,187D,203R,204G,207Q,208G,210S,225S
GQ275858	F_098_04	Botswana			genomic DNA	patient F sampled 098 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,16T,27I,41T,50T,71D,83L,91V,116A,120S,124V,128D,136M,148V,154K,169F,170R,178T,180D,187D,203R,204G,207Q,208G,210S,225S
GQ275859	F_098_05	Botswana			genomic DNA	patient F sampled 098 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,16T,27I,41T,50T,71D,83L,91V,116A,120S,124V,128D,136M,148V,154K,169F,170R,178T,180D,187D,203R,204G,207Q,208G,210S,225S
GQ275860	F_098_06	Botswana			genomic DNA	patient F sampled 098 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,16T,27I,41T,50T,71D,83L,91V,116A,120S,124V,128D,136M,148V,154K,169F,170R,178T,180D,187D,203R,204G,207Q,208G,210S,225S
GQ275861	F_098_07	Botswana			genomic DNA	patient F sampled 098 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,16T,27I,41T,50T,51G,71D,83L,91V,116A,120S,124V,128D,136M,148V,154K,169F,170R,178T,180D,187D,203R,204G,207Q,208G,210S,225S
GQ275862	F_098_08	Botswana			genomic DNA	patient F sampled 098 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,16T,27I,41T,50P,71D,83L,91V,116A,120S,124V,128D,136M,148V,154K,169F,170R,178T,180D,187D,203R,204G,207Q,208G,210S,225S
GQ275863	F_098_09	Botswana			genomic DNA	patient F sampled 098 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,16T,27I,41T,50T,71D,83L,91V,116A,120S,124V,128D,136M,148V,154K,169F,170R,178T,180D,187D,203R,204G,207Q,208G,210S,225S
GQ275864	F_098_10	Botswana			genomic DNA	patient F sampled 098 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,16T,27I,41T,50T,71D,83L,91V,116A,120S,124V,128D,136M,148V,154K,169F,170R,178T,180D,187D,203R,204G,207Q,208G,210S,225S
GQ275865	F_203_02	Botswana			genomic DNA	patient F sampled 203 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,16T,27I,41T,50T,71D,83L,91V,116A,120S,124V,128D,136M,148V,154K,169F,170R,178T,180D,187D,203R,204G,207Q,208G,210S,225S
GQ275866	F_203_03	Botswana			genomic DNA	patient F sampled 203 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,16T,27I,41T,50T,71D,83L,91V,112S,116A,120S,124V,128D,136M,148V,154K,169F,170R,178T,180D,187D,203R,204G,207Q,208G,210S,225S
GQ275867	F_203_04	Botswana			genomic DNA	patient F sampled 203 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,16T,27I,41T,50T,71D,83L,91V,110N,116A,120S,124V,128D,136M,148V,154K,169F,170R,178T,180D,187D,203R,204G,207Q,208G,210S,225S
GQ275868	F_203_06	Botswana			genomic DNA	patient F sampled 203 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,16T,27I,41T,50T,71D,83L,91V,116A,120S,124V,128D,136M,148V,154K,169F,170R,178T,180D,187D,203R,204G,207Q,208G,210S,225S
GQ275869	F_203_08	Botswana			genomic DNA	patient F sampled 203 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,16T,27I,41T,50T,71D,83L,91V,116A,120S,124V,128D,136M,148V,154K,169F,170R,178T,180D,187D,203R,204G,207Q,208G,210S,225S
GQ275870	F_203_09	Botswana			genomic DNA	patient F sampled 203 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,16T,27I,41T,50T,71D,83L,91V,110N,116A,120S,124V,128D,136M,148V,154K,169F,170R,178T,180D,187D,203R,204G,207Q,208G,210S,225S
GQ275871	F_261_01	Botswana			genomic DNA	patient F sampled 261 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,16T,27I,41T,50T,71D,83L,91V,116A,120S,124V,128D,136M,148V,154K,169F,170R,178T,180D,187D,203R,204G,207Q,208G,210S,225S
GQ275872	F_261_02	Botswana			genomic DNA	patient F sampled 261 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,16T,27I,41T,50T,71D,83L,91V,116A,120S,124V,128D,136M,148V,154K,169F,178T,180D,187D,203R,204G,207Q,208G,210S,225S
GQ275873	F_261_03	Botswana			genomic DNA	patient F sampled 261 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,16T,27I,41T,50T,71D,83L,91V,110N,116A,120S,124V,128D,136M,148V,154K,169F,170R,178T,180D,187D,203R,204G,207Q,208G,210S,225S
GQ275874	F_261_05	Botswana			genomic DNA	patient F sampled 261 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,16T,27I,41T,50K,71D,83L,91V,110N,116A,120S,124V,128D,136M,148V,154K,169F,178T,180D,187D,203R,204G,207Q,208G,210S,225S
GQ275875	F_261_06	Botswana			genomic DNA	patient F sampled 261 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,16T,27I,41T,50T,71D,83L,91V,112A,116A,120S,124V,128D,136M,148V,154K,169F,178T,180D,187D,203R,204G,207Q,208G,210S,225S
GQ275876	F_261_07	Botswana			genomic DNA	patient F sampled 261 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,16T,27I,36I,41T,50T,71D,83L,91V,110N,116A,120S,124V,128D,136M,148V,154K,169F,178T,180D,187D,203R,204G,207Q,208G,210S,225S
GQ275877	F_261_08	Botswana			genomic DNA	patient F sampled 261 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,16T,27I,41T,50T,71D,83L,91V,110N,116A,120S,124V,128D,136M,148V,154K,169F,170R,178T,180D,187D,203R,204G,207Q,208G,210S,225S
GQ275878	F_323_01	Botswana			genomic DNA	patient F sampled 323 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,16T,27I,41T,50T,71D,83L,91V,110N,116A,120S,124V,128D,136M,148V,154K,169F,178T,180D,187D,203R,204G,207Q,208G,210S,225S
GQ275879	F_323_02	Botswana			genomic DNA	patient F sampled 323 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,16T,27I,41T,50T,71D,83L,91V,110N,116A,120S,124V,128D,136M,148V,154K,169F,178T,180D,187D,203R,204G,207Q,208G,210S,225S
GQ275880	F_323_03	Botswana			genomic DNA	patient F sampled 323 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,16T,27I,41T,50T,71D,83L,91V,110N,116A,120G,124V,128D,136M,148V,154K,169F,178T,180D,187D,203R,204G,207Q,208G,210S,225S
GQ275881	F_323_04	Botswana			genomic DNA	patient F sampled 323 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,16T,27I,41T,50T,71D,83L,91V,110N,116A,120S,124V,128D,136M,148V,154K,169F,178T,180D,187D,203R,204G,207Q,208G,210S,225S
GQ275885	F_447_01R	Botswana			genomic RNA	patient F sampled 447 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	15	231	15L,16T,27I,41T,50T,71D,83L,91V,110N,116A,120G,124V,128D,136M,148V,154K,169F,178T,180D,187D,203R,204G,207Q,208G,210S,225S
GQ275886	F_447_02R	Botswana			genomic RNA	patient F sampled 447 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	15	231	15L,16T,27I,41T,50T,71D,83L,91V,110N,116A,120G,124V,128D,136M,148V,154K,169F,178T,180D,187D,203R,204G,207Q,208G,210S,225S
GQ275882	F_447_03R	Botswana			genomic RNA	patient F sampled 447 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,16T,27I,41T,50T,71D,83L,91V,110N,116A,120G,124V,128D,136M,148V,154K,169F,178T,180D,187D,203R,204G,207Q,208G,210S,225S
GQ275887	F_447_05R	Botswana			genomic RNA	patient F sampled 447 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	15	231	15L,16T,27I,41T,50T,71D,83L,91V,110N,116A,120G,124V,128D,136M,148V,154K,169F,178T,180D,187D,203R,204G,207Q,208G,210S,225S
GQ275888	F_447_06R	Botswana			genomic RNA	patient F sampled 447 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	15	231	15L,16T,27I,41T,50T,71D,83L,91V,110N,116A,120G,124V,128D,136M,148V,154K,169F,178T,180D,187D,203R,204G,207Q,208G,210S,225S
GQ275883	F_447_07R	Botswana			genomic RNA	patient F sampled 447 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,16T,27I,41T,50T,71D,83L,91V,110N,116A,120G,124V,128D,136M,148V,154K,169F,178T,180D,187D,203R,204G,207Q,208G,210S,225S
GQ275889	F_447_08R	Botswana			genomic RNA	patient F sampled 447 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,16T,27I,41T,50T,71D,83L,91V,110N,116A,120G,124V,128D,136M,148V,154K,169F,178T,180D,187D,203R,204G,207Q,208G,210S,225S
GQ275884	F_447_09R	Botswana			genomic RNA	patient F sampled 447 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,16T,27I,41T,50T,71D,83L,91V,110N,116A,120G,124V,128D,136M,148V,154K,169F,178T,180D,187D,203R,204G,207Q,208G,210S,225S
GQ275890	F_447_10R	Botswana			genomic RNA	patient F sampled 447 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	15	231	15L,16T,27I,41T,50T,71D,83L,91V,110N,116A,120G,124V,128D,136M,148V,154K,169F,178T,180D,187D,203R,204G,207Q,208G,210S,225S
GQ275891	F_447_11R	Botswana			genomic RNA	patient F sampled 447 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	15	231	15L,16T,27I,41T,50T,71D,83L,91V,110N,116A,120G,124V,128D,136M,148V,154K,169F,178T,180D,187D,203R,204G,207Q,208G,210S,225S
GQ275892	F_447_12R	Botswana			genomic RNA	patient F sampled 447 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	15	231	15L,16T,27I,41T,50T,71D,83L,91V,110N,116A,120G,124V,128D,136M,148V,154K,169F,178T,180D,187D,203R,204G,207Q,208G,210S,225S
GQ275893	F_447_13R	Botswana			genomic RNA	patient F sampled 447 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	15	231	15L,16T,27I,41T,50T,71D,83L,91V,110N,116A,120G,124V,128D,136M,148V,154K,169F,178T,180D,187D,203R,204G,207Q,208G,210S,225S
GQ275894	G_004_01	Botswana			genomic DNA	patient G sampled 004 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275895	G_004_02	Botswana			genomic DNA	patient G sampled 004 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275896	G_004_03	Botswana			genomic DNA	patient G sampled 004 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275897	G_004_04	Botswana			genomic DNA	patient G sampled 004 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275898	G_004_05	Botswana			genomic DNA	patient G sampled 004 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275899	G_004_06	Botswana			genomic DNA	patient G sampled 004 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275900	G_004_07	Botswana			genomic DNA	patient G sampled 004 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275901	G_004_08	Botswana			genomic DNA	patient G sampled 004 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,158N,169F,178T,180D,187D,203R,208G,225S
GQ275902	G_004_09	Botswana			genomic DNA	patient G sampled 004 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,129F,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275903	G_004_10	Botswana			genomic DNA	patient G sampled 004 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275904	G_095_01	Botswana			genomic DNA	patient G sampled 095 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275905	G_095_02	Botswana			genomic DNA	patient G sampled 095 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275906	G_095_03	Botswana			genomic DNA	patient G sampled 095 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275907	G_095_05	Botswana			genomic DNA	patient G sampled 095 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275908	G_095_06	Botswana			genomic DNA	patient G sampled 095 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275909	G_095_07	Botswana			genomic DNA	patient G sampled 095 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275910	G_095_08	Botswana			genomic DNA	patient G sampled 095 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275911	G_095_09	Botswana			genomic DNA	patient G sampled 095 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275912	G_095_10	Botswana			genomic DNA	patient G sampled 095 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275913	G_197_01	Botswana			genomic DNA	patient G sampled 197 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275914	G_197_01R	Botswana			genomic RNA	patient G sampled 197 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275915	G_197_02R	Botswana			genomic RNA	patient G sampled 197 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275916	G_197_03	Botswana			genomic DNA	patient G sampled 197 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275917	G_197_03R	Botswana			genomic RNA	patient G sampled 197 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275918	G_197_04R	Botswana			genomic RNA	patient G sampled 197 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275919	G_197_05R	Botswana			genomic RNA	patient G sampled 197 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275920	G_197_06	Botswana			genomic DNA	patient G sampled 197 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275921	G_197_06R	Botswana			genomic RNA	patient G sampled 197 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275922	G_197_07	Botswana			genomic DNA	patient G sampled 197 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275923	G_197_07R	Botswana			genomic RNA	patient G sampled 197 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275924	G_197_08R	Botswana			genomic RNA	patient G sampled 197 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169S,178T,180D,187D,203R,208G,225S
GQ275925	G_197_09	Botswana			genomic DNA	patient G sampled 197 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275926	G_197_10	Botswana			genomic DNA	patient G sampled 197 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275927	G_197_10R	Botswana			genomic RNA	patient G sampled 197 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275928	G_197_11R	Botswana			genomic RNA	patient G sampled 197 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275929	G_197_12R	Botswana			genomic RNA	patient G sampled 197 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275930	G_197_13R	Botswana			genomic RNA	patient G sampled 197 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275931	G_197_14R	Botswana			genomic RNA	patient G sampled 197 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275932	G_197_15R	Botswana			genomic RNA	patient G sampled 197 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275933	G_197_16R	Botswana			genomic RNA	patient G sampled 197 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275934	G_295_02	Botswana			genomic DNA	patient G sampled 295 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275935	G_295_03	Botswana			genomic DNA	patient G sampled 295 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275936	G_295_05	Botswana			genomic DNA	patient G sampled 295 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275937	G_295_06	Botswana			genomic DNA	patient G sampled 295 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275938	G_295_07	Botswana			genomic DNA	patient G sampled 295 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275939	G_295_08	Botswana			genomic DNA	patient G sampled 295 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275940	G_345_02	Botswana			genomic DNA	patient G sampled 345 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275941	G_345_02R	Botswana			genomic RNA	patient G sampled 345 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275942	G_345_03R	Botswana			genomic RNA	patient G sampled 345 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275943	G_345_04	Botswana			genomic DNA	patient G sampled 345 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275944	G_345_05	Botswana			genomic DNA	patient G sampled 345 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275945	G_345_05R	Botswana			genomic RNA	patient G sampled 345 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275946	G_345_06R	Botswana			genomic RNA	patient G sampled 345 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275947	G_345_07	Botswana			genomic DNA	patient G sampled 345 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275948	G_345_07R	Botswana			genomic RNA	patient G sampled 345 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275949	G_345_08R	Botswana			genomic RNA	patient G sampled 345 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275950	G_345_09	Botswana			genomic DNA	patient G sampled 345 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275951	G_345_09R	Botswana			genomic RNA	patient G sampled 345 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275952	G_345_10	Botswana			genomic DNA	patient G sampled 345 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275953	G_345_10R	Botswana			genomic RNA	patient G sampled 345 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275954	G_345_11	Botswana			genomic DNA	patient G sampled 345 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275955	G_345_11R	Botswana			genomic RNA	patient G sampled 345 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275956	G_345_12R	Botswana			genomic RNA	patient G sampled 345 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275957	G_345_13R	Botswana			genomic RNA	patient G sampled 345 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275958	G_345_14R	Botswana			genomic RNA	patient G sampled 345 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275959	G_345_15R	Botswana			genomic RNA	patient G sampled 345 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275960	G_345_17R	Botswana			genomic RNA	patient G sampled 345 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275961	G_345_18R	Botswana			genomic RNA	patient G sampled 345 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,206E,208G,225S
GQ275962	G_345_19R	Botswana			genomic RNA	patient G sampled 345 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275963	G_345_20R	Botswana			genomic RNA	patient G sampled 345 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14N,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275964	H_016_01	Botswana			genomic DNA	patient H sampled 016 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,60E,71D,83T,86I,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ275965	H_016_02	Botswana			genomic DNA	patient H sampled 016 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ275966	H_016_03	Botswana			genomic DNA	patient H sampled 016 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ275967	H_016_04	Botswana			genomic DNA	patient H sampled 016 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ275968	H_016_05	Botswana			genomic DNA	patient H sampled 016 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ275969	H_016_06	Botswana			genomic DNA	patient H sampled 016 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ275970	H_016_07	Botswana			genomic DNA	patient H sampled 016 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ275971	H_016_08	Botswana			genomic DNA	patient H sampled 016 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ275972	H_016_09	Botswana			genomic DNA	patient H sampled 016 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ275973	H_055_01	Botswana			genomic DNA	patient H sampled 055 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ275974	H_055_02	Botswana			genomic DNA	patient H sampled 055 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ275975	H_055_03	Botswana			genomic DNA	patient H sampled 055 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ275976	H_055_04	Botswana			genomic DNA	patient H sampled 055 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ275977	H_055_05	Botswana			genomic DNA	patient H sampled 055 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ275978	H_055_06	Botswana			genomic DNA	patient H sampled 055 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ275979	H_055_07	Botswana			genomic DNA	patient H sampled 055 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ275980	H_055_08	Botswana			genomic DNA	patient H sampled 055 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ275981	H_055_09	Botswana			genomic DNA	patient H sampled 055 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ275982	H_055_10	Botswana			genomic DNA	patient H sampled 055 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ275983	H_055_11	Botswana			genomic DNA	patient H sampled 055 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ275984	H_055_12	Botswana			genomic DNA	patient H sampled 055 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ275985	H_055_13	Botswana			genomic DNA	patient H sampled 055 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ275986	H_055_14	Botswana			genomic DNA	patient H sampled 055 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ275987	H_055_15	Botswana			genomic DNA	patient H sampled 055 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ275988	H_055_16	Botswana			genomic DNA	patient H sampled 055 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ275989	H_055_17	Botswana			genomic DNA	patient H sampled 055 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ275990	H_055_18	Botswana			genomic DNA	patient H sampled 055 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ275991	H_055_19	Botswana			genomic DNA	patient H sampled 055 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ275992	H_055_20	Botswana			genomic DNA	patient H sampled 055 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ275993	H_098_01	Botswana			genomic DNA	patient H sampled 098 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ275994	H_098_02	Botswana			genomic DNA	patient H sampled 098 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ275995	H_098_03	Botswana			genomic DNA	patient H sampled 098 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,17L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ275996	H_098_04	Botswana			genomic DNA	patient H sampled 098 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ275997	H_098_05	Botswana			genomic DNA	patient H sampled 098 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ275998	H_098_06	Botswana			genomic DNA	patient H sampled 098 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ275999	H_098_07	Botswana			genomic DNA	patient H sampled 098 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276000	H_098_08	Botswana			genomic DNA	patient H sampled 098 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276001	H_098_09	Botswana			genomic DNA	patient H sampled 098 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276002	H_098_10	Botswana			genomic DNA	patient H sampled 098 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276003	H_098_12	Botswana			genomic DNA	patient H sampled 098 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276004	H_098_13	Botswana			genomic DNA	patient H sampled 098 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276005	H_098_14	Botswana			genomic DNA	patient H sampled 098 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276006	H_098_15	Botswana			genomic DNA	patient H sampled 098 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276007	H_098_16	Botswana			genomic DNA	patient H sampled 098 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276008	H_098_17	Botswana			genomic DNA	patient H sampled 098 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276009	H_098_18	Botswana			genomic DNA	patient H sampled 098 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276010	H_098_19	Botswana			genomic DNA	patient H sampled 098 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276011	H_098_20	Botswana			genomic DNA	patient H sampled 098 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276012	H_202_01	Botswana			genomic DNA	patient H sampled 202 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276013	H_202_02	Botswana			genomic DNA	patient H sampled 202 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276014	H_202_04	Botswana			genomic DNA	patient H sampled 202 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276015	H_202_05	Botswana			genomic DNA	patient H sampled 202 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276016	H_202_06	Botswana			genomic DNA	patient H sampled 202 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276017	H_202_09	Botswana			genomic DNA	patient H sampled 202 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,93Q,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276018	H_202_10	Botswana			genomic DNA	patient H sampled 202 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276019	H_202_11	Botswana			genomic DNA	patient H sampled 202 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276020	H_202_12	Botswana			genomic DNA	patient H sampled 202 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276021	H_202_13	Botswana			genomic DNA	patient H sampled 202 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276022	H_202_15	Botswana			genomic DNA	patient H sampled 202 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276023	H_202_16	Botswana			genomic DNA	patient H sampled 202 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276024	H_202_17	Botswana			genomic DNA	patient H sampled 202 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276025	H_202_18	Botswana			genomic DNA	patient H sampled 202 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276026	H_202_19	Botswana			genomic DNA	patient H sampled 202 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276027	H_202_20	Botswana			genomic DNA	patient H sampled 202 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276028	H_202_21	Botswana			genomic DNA	patient H sampled 202 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276029	H_202_22	Botswana			genomic DNA	patient H sampled 202 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276030	H_202_23	Botswana			genomic DNA	patient H sampled 202 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276031	H_271_01	Botswana			genomic DNA	patient H sampled 271 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276032	H_271_02	Botswana			genomic DNA	patient H sampled 271 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276033	H_271_03	Botswana			genomic DNA	patient H sampled 271 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276034	H_271_05	Botswana			genomic DNA	patient H sampled 271 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276035	H_271_06	Botswana			genomic DNA	patient H sampled 271 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276036	H_271_08	Botswana			genomic DNA	patient H sampled 271 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276037	H_271_09	Botswana			genomic DNA	patient H sampled 271 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276038	H_347_03	Botswana			genomic DNA	patient H sampled 347 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120G,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276039	H_347_04	Botswana			genomic DNA	patient H sampled 347 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276040	H_347_06	Botswana			genomic DNA	patient H sampled 347 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276041	H_347_07	Botswana			genomic DNA	patient H sampled 347 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276042	H_347_08	Botswana			genomic DNA	patient H sampled 347 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276043	H_347_09	Botswana			genomic DNA	patient H sampled 347 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276044	H_347_12	Botswana			genomic DNA	patient H sampled 347 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276045	H_347_13	Botswana			genomic DNA	patient H sampled 347 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276046	H_347_18	Botswana			genomic DNA	patient H sampled 347 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276047	H_347_19	Botswana			genomic DNA	patient H sampled 347 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91A,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276048	H_347_22	Botswana			genomic DNA	patient H sampled 347 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276049	H_347_23	Botswana			genomic DNA	patient H sampled 347 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91V,92V,116N,120S,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276050	H_347_27	Botswana			genomic DNA	patient H sampled 347 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91A,92V,116N,120G,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276051	H_347_31	Botswana			genomic DNA	patient H sampled 347 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83T,91A,92V,116N,120G,124V,128D,148V,169F,178T,183H,203R,208G,225S
GQ276052	NA_169_01	Botswana			genomic DNA	patient NA sampled 169 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,118I,120S,128D,148V,154K,169F,178T,187D,199R,200N,208G,225S
GQ276053	NA_169_02	Botswana			genomic DNA	patient NA sampled 169 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,118I,120S,128D,148V,154K,169F,178T,187D,199R,200N,208G,225S
GQ276054	NA_169_03	Botswana			genomic DNA	patient NA sampled 169 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,118I,120S,128D,148V,154K,169F,178T,187D,199R,200N,208G,225S
GQ276055	NA_169_04	Botswana			genomic DNA	patient NA sampled 169 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,118I,120S,128D,148V,154K,169F,178T,187D,199R,200N,208G,225S
GQ276056	NA_169_05	Botswana			genomic DNA	patient NA sampled 169 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,118I,120S,128D,148V,154K,169F,178T,187D,199R,200N,208G,225S
GQ276057	NA_169_06	Botswana			genomic DNA	patient NA sampled 169 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,118I,120S,128D,148V,154K,169F,178T,187D,199R,200N,208G,225S
GQ276058	NA_169_07	Botswana			genomic DNA	patient NA sampled 169 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,118I,120S,128D,148V,154K,169F,178T,187D,199R,200N,208G,225S
GQ276059	NA_169_09	Botswana			genomic DNA	patient NA sampled 169 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,118I,120S,128D,148V,154K,169F,178T,187D,199R,200N,208G,225S
GQ276060	NA_169_10	Botswana			genomic DNA	patient NA sampled 169 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,118I,120S,128D,148V,154K,169F,178T,187D,199R,200N,208G,225S
GQ276061	NA_231_01	Botswana			genomic DNA	patient NA sampled 231 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31D,41T,71D,83L,91V,116A,118I,120S,128D,148V,154K,169F,178T,187D,199R,200N,208G,225S
GQ276062	NA_231_02	Botswana			genomic DNA	patient NA sampled 231 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,118I,120S,128D,148V,154K,169F,178T,187D,199R,200N,208G,225S
GQ276063	NA_231_03	Botswana			genomic DNA	patient NA sampled 231 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,118I,120S,128D,148V,154K,169F,178T,187D,199R,200N,208G,225S
GQ276064	NA_231_04	Botswana			genomic DNA	patient NA sampled 231 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,118I,120S,128D,148V,154K,169F,178T,187D,199R,200N,208G,225S
GQ276065	NA_231_05	Botswana			genomic DNA	patient NA sampled 231 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,118I,120S,128D,148V,154K,169F,178T,187D,199R,200N,208G,225S
GQ276066	NA_231_06	Botswana			genomic DNA	patient NA sampled 231 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,118I,120S,128D,148V,154K,169F,178T,187D,199R,200N,208G,225S
GQ276067	NA_231_07	Botswana			genomic DNA	patient NA sampled 231 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,118I,120S,128D,148V,154K,169F,178T,187D,199R,200N,208G,225S
GQ276068	NA_231_08	Botswana			genomic DNA	patient NA sampled 231 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,200N,208G,225S
GQ276069	NA_231_10	Botswana			genomic DNA	patient NA sampled 231 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,118I,120S,128D,148V,154K,169F,178T,187D,199R,200N,208G,225S
GQ276070	NA_354_02	Botswana			genomic DNA	patient NA sampled 354 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,200N,208G,225S
GQ276071	NA_354_04	Botswana			genomic DNA	patient NA sampled 354 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,118I,128D,148V,154K,169F,178T,187D,199R,200N,208G,225S
GQ276072	NA_354_05	Botswana			genomic DNA	patient NA sampled 354 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,118I,120S,128D,148V,154K,169F,178T,187D,199R,200N,208G,225S
GQ276073	NA_354_06	Botswana			genomic DNA	patient NA sampled 354 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,200N,208G,225S
GQ276074	NA_354_09	Botswana			genomic DNA	patient NA sampled 354 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,118I,120S,128D,148V,154K,169F,178T,187D,199R,200N,208G,225S
GQ276075	NA_354_10	Botswana			genomic DNA	patient NA sampled 354 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,118I,120S,128D,148V,154K,169F,178T,187D,199R,200N,208G,225S
GQ276076	NA_354_11	Botswana			genomic DNA	patient NA sampled 354 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,200N,208G,225S
GQ276077	NA_354_12	Botswana			genomic DNA	patient NA sampled 354 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,200N,208G,225S
GQ276078	NA_448_02R	Botswana			genomic RNA	patient NA sampled 448 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,200N,208G,225S
GQ276079	NA_448_04R	Botswana			genomic RNA	patient NA sampled 448 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,200N,208G,225S
GQ276080	NA_448_05R	Botswana			genomic RNA	patient NA sampled 448 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,200N,208G,225S
GQ276081	NA_448_06R	Botswana			genomic RNA	patient NA sampled 448 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,200N,208G,225S
GQ276082	NA_448_07R	Botswana			genomic RNA	patient NA sampled 448 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,200N,208G,225S
GQ276083	NA_448_10R	Botswana			genomic RNA	patient NA sampled 448 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,200N,208G,225S
GQ276084	NA_448_11R	Botswana			genomic RNA	patient NA sampled 448 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,32S,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,200N,208G,225S
GQ276085	NA_448_12R	Botswana			genomic RNA	patient NA sampled 448 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,200N,208G,225S
GQ276086	NA_448_13R	Botswana			genomic RNA	patient NA sampled 448 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,200N,208G,225S
GQ276087	NA_448_14R	Botswana			genomic RNA	patient NA sampled 448 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,200N,208G,225S
GQ276088	NA_448_15R	Botswana			genomic RNA	patient NA sampled 448 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,33T,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,200N,208G,225S
GQ276089	NA_448_16R	Botswana			genomic RNA	patient NA sampled 448 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,200N,208G,225S
GQ276090	NA_448_17R	Botswana			genomic RNA	patient NA sampled 448 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,200N,208G,225S
GQ276091	NA_448_18R	Botswana			genomic RNA	patient NA sampled 448 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,200N,208G,225S
GQ276092	NA_448_19R	Botswana			genomic RNA	patient NA sampled 448 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,200N,208G,225S
GQ276093	NA_448_20R	Botswana			genomic RNA	patient NA sampled 448 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,118I,128D,148V,154K,169F,178T,187D,199R,200N,208G,225S
GQ276094	O1_006_01	Botswana			genomic DNA	patient O1 sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,115V,116A,120S,128D,136M,148V,169F,178T,199R,208G,225S
GQ276095	O1_006_02	Botswana			genomic DNA	patient O1 sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,115V,116A,120S,128D,136M,148V,169F,178T,199R,208G,225S
GQ276096	O1_006_03	Botswana			genomic DNA	patient O1 sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,115V,116A,120S,128D,136M,148V,169F,178T,199R,208G,225S
GQ276097	O1_006_04	Botswana			genomic DNA	patient O1 sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,115V,116A,120S,128D,136M,148V,169F,178T,199R,208G,225S
GQ276098	O1_006_05	Botswana			genomic DNA	patient O1 sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,115V,116A,120S,128D,136M,148V,169F,178T,199R,208G,225S
GQ276099	O1_006_06	Botswana			genomic DNA	patient O1 sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,115V,116A,120S,128D,136M,148V,169F,178T,199R,208G,225S
GQ276100	O1_006_07	Botswana			genomic DNA	patient O1 sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,115V,116A,120S,128D,136M,148V,169F,178T,199R,208G,225S
GQ276101	O1_006_08	Botswana			genomic DNA	patient O1 sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,115V,116A,120S,128D,136M,148V,169F,178T,199R,208G,225S
GQ276102	O1_006_09	Botswana			genomic DNA	patient O1 sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,115V,116A,120S,128D,136M,148V,169F,178T,199R,208G,225S
GQ276103	O1_006_10	Botswana			genomic DNA	patient O1 sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,115V,116A,120S,128D,136M,148V,169F,178T,199R,208G,225S
GQ276104	O1_094_01	Botswana			genomic DNA	patient O1 sampled 094 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,115V,116A,120S,128D,136M,148V,169F,178T,199R,208G,225S
GQ276105	O1_094_02	Botswana			genomic DNA	patient O1 sampled 094 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,115V,116A,120S,128D,136M,148V,169F,178T,199R,208G,224H,225S
GQ276106	O1_094_03	Botswana			genomic DNA	patient O1 sampled 094 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,115V,116A,120S,128D,136M,148V,169F,178T,199R,208G,225S
GQ276107	O1_094_04	Botswana			genomic DNA	patient O1 sampled 094 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,115V,116A,120S,128D,136M,148V,161C,169F,178T,199R,208G,225S
GQ276108	O1_094_05	Botswana			genomic DNA	patient O1 sampled 094 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,115V,116A,120S,128D,136M,137R,148V,169F,178T,199R,208G,225S
GQ276109	O1_094_07	Botswana			genomic DNA	patient O1 sampled 094 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,115V,116A,120S,128D,136M,148V,169F,178T,199R,208G,225S
GQ276110	O1_094_08	Botswana			genomic DNA	patient O1 sampled 094 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,115V,116A,120S,128D,136M,148V,169F,178T,199R,208G,225S
GQ276111	O1_185_01	Botswana			genomic DNA	patient O1 sampled 185 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,115V,116A,120S,128D,136M,148V,169F,178T,199R,208G,225S
GQ276112	O1_185_02	Botswana			genomic DNA	patient O1 sampled 185 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,115V,116A,120S,128D,136M,148V,169F,178T,199R,203S,208G,225S
GQ276113	O1_185_03	Botswana			genomic DNA	patient O1 sampled 185 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,115V,116A,120S,128D,136M,148V,169F,178T,199R,208G,225S
GQ276114	O1_185_04	Botswana			genomic DNA	patient O1 sampled 185 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,115V,116A,120S,128D,136M,148V,169F,178T,199R,208G,225S
GQ276115	O1_185_05	Botswana			genomic DNA	patient O1 sampled 185 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,115V,116A,120S,128D,136M,148V,169F,170*,178T,199R,208G,225S
GQ276116	O1_185_06	Botswana			genomic DNA	patient O1 sampled 185 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,115V,116A,120S,128D,136M,148V,169F,178T,199R,208G,225S
GQ276117	O1_185_07	Botswana			genomic DNA	patient O1 sampled 185 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,115V,116A,120S,128D,136M,148V,169F,178T,199R,208G,225S
GQ276118	O1_185_08	Botswana			genomic DNA	patient O1 sampled 185 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,45G,71D,83L,115V,116A,120S,128D,136M,148V,169F,178T,199R,208G,225S
GQ276119	O1_185_10	Botswana			genomic DNA	patient O1 sampled 185 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,115V,116A,120S,128D,136M,148V,169F,178T,199R,203R,208G,225S
GQ276120	O1_185_11	Botswana			genomic DNA	patient O1 sampled 185 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,115V,116A,120S,128D,136M,148V,169F,178T,199R,208G,225S
GQ276121	O1_185_12	Botswana			genomic DNA	patient O1 sampled 185 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,115V,116A,120S,128D,136M,148V,169F,178T,199R,203I,208G,225S
GQ276122	O1_185_13	Botswana			genomic DNA	patient O1 sampled 185 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,115V,116A,120S,128D,136M,148V,169F,178T,199R,203R,208G,225S
GQ276123	O1_243_01	Botswana			genomic DNA	patient O1 sampled 243 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,115V,116A,120S,128D,136M,148V,169F,178T,199R,208G,225S
GQ276124	O1_243_02	Botswana			genomic DNA	patient O1 sampled 243 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,115V,116A,120S,128D,136M,148V,169F,178T,199R,208G,225S
GQ276125	O1_243_03	Botswana			genomic DNA	patient O1 sampled 243 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,115V,116A,120S,128D,136M,148V,169F,178T,199R,208G,225S
GQ276126	O1_243_04	Botswana			genomic DNA	patient O1 sampled 243 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,115V,116A,120S,128D,136M,148V,169F,178T,199R,208G,225S
GQ276127	O1_243_05	Botswana			genomic DNA	patient O1 sampled 243 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,115V,116A,120S,128D,136M,148V,169F,178T,199R,208G,225S
GQ276128	O1_243_06	Botswana			genomic DNA	patient O1 sampled 243 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,115V,116A,120S,128D,136M,148V,169F,178T,199R,208G,225S
GQ276129	O1_243_09	Botswana			genomic DNA	patient O1 sampled 243 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,115V,116A,120S,128D,136M,148V,169F,178T,199R,208G,225S
GQ276130	O1_243_10	Botswana			genomic DNA	patient O1 sampled 243 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,115V,116A,120S,128D,136M,148V,169F,178T,199R,208G,225S
GQ276131	O1_312_01	Botswana			genomic DNA	patient O1 sampled 312 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,96I,115V,116A,120S,128D,136M,148V,169F,178T,199R,208G,225S
GQ276132	O1_312_02	Botswana			genomic DNA	patient O1 sampled 312 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,115V,116A,120S,128D,136M,148V,169F,178T,199R,208G,225S
GQ276133	O1_312_03	Botswana			genomic DNA	patient O1 sampled 312 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,115V,116A,120S,128D,136M,148V,169F,178T,199R,208G,225S
GQ276134	O1_312_04	Botswana			genomic DNA	patient O1 sampled 312 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,115V,116A,120S,128D,136M,148V,169F,178T,199R,208G,225S
GQ276135	O1_312_05	Botswana			genomic DNA	patient O1 sampled 312 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,35K,41T,71D,83L,116A,120S,128D,136M,148V,169F,178T,199R,208G,225S
GQ276136	O1_312_09	Botswana			genomic DNA	patient O1 sampled 312 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,96I,115V,116A,120S,128D,136M,148V,169F,178T,199R,208G,225S
GQ276137	OC_027_01	Botswana			genomic DNA	patient OC sampled 027 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276138	OC_027_02	Botswana			genomic DNA	patient OC sampled 027 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276139	OC_027_03	Botswana			genomic DNA	patient OC sampled 027 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276140	OC_027_04	Botswana			genomic DNA	patient OC sampled 027 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276141	OC_027_05	Botswana			genomic DNA	patient OC sampled 027 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276142	OC_027_06	Botswana			genomic DNA	patient OC sampled 027 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276143	OC_027_08	Botswana			genomic DNA	patient OC sampled 027 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276144	OC_027_09	Botswana			genomic DNA	patient OC sampled 027 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276145	OC_027_10	Botswana			genomic DNA	patient OC sampled 027 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276146	OC_027_11	Botswana			genomic DNA	patient OC sampled 027 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276147	OC_027_12	Botswana			genomic DNA	patient OC sampled 027 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,191A,203R,208G,210S
GQ276148	OC_027_14	Botswana			genomic DNA	patient OC sampled 027 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276149	OC_027_15	Botswana			genomic DNA	patient OC sampled 027 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276150	OC_027_16	Botswana			genomic DNA	patient OC sampled 027 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276151	OC_027_17	Botswana			genomic DNA	patient OC sampled 027 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276152	OC_027_18	Botswana			genomic DNA	patient OC sampled 027 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276153	OC_086_01	Botswana			genomic DNA	patient OC sampled 086 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276154	OC_086_02	Botswana			genomic DNA	patient OC sampled 086 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276155	OC_086_03	Botswana			genomic DNA	patient OC sampled 086 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276156	OC_086_04	Botswana			genomic DNA	patient OC sampled 086 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276157	OC_086_05	Botswana			genomic DNA	patient OC sampled 086 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276158	OC_086_06	Botswana			genomic DNA	patient OC sampled 086 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276159	OC_086_07	Botswana			genomic DNA	patient OC sampled 086 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276160	OC_086_09	Botswana			genomic DNA	patient OC sampled 086 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276161	OC_086_10	Botswana			genomic DNA	patient OC sampled 086 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276162	OC_086_11	Botswana			genomic DNA	patient OC sampled 086 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276163	OC_086_12	Botswana			genomic DNA	patient OC sampled 086 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276164	OC_086_13	Botswana			genomic DNA	patient OC sampled 086 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276165	OC_086_14	Botswana			genomic DNA	patient OC sampled 086 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276166	OC_086_15	Botswana			genomic DNA	patient OC sampled 086 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276167	OC_086_16	Botswana			genomic DNA	patient OC sampled 086 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276168	OC_208_01	Botswana			genomic DNA	patient OC sampled 208 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276169	OC_208_02	Botswana			genomic DNA	patient OC sampled 208 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276170	OC_208_04	Botswana			genomic DNA	patient OC sampled 208 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,116A,120S,128D,148V,154K,169F,177S,187D,193T,203R,208G,210S
GQ276171	OC_208_05	Botswana			genomic DNA	patient OC sampled 208 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276172	OC_208_06	Botswana			genomic DNA	patient OC sampled 208 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276173	OC_208_07	Botswana			genomic DNA	patient OC sampled 208 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276174	OC_208_08	Botswana			genomic DNA	patient OC sampled 208 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276175	OC_208_09	Botswana			genomic DNA	patient OC sampled 208 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,175K,177S,187D,203R,208G,210S
GQ276176	OC_208_10	Botswana			genomic DNA	patient OC sampled 208 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276177	OC_208_11	Botswana			genomic DNA	patient OC sampled 208 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276178	OC_208_12	Botswana			genomic DNA	patient OC sampled 208 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276179	OC_300_02	Botswana			genomic DNA	patient OC sampled 300 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,116A,119A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276180	OC_300_03	Botswana			genomic DNA	patient OC sampled 300 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276181	OC_300_04	Botswana			genomic DNA	patient OC sampled 300 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,116A,120S,128D,148V,154K,169F,171P,177S,187D,203R,208G,210S
GQ276182	OC_300_05	Botswana			genomic DNA	patient OC sampled 300 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276183	OC_300_06	Botswana			genomic DNA	patient OC sampled 300 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,116A,120S,128D,147S,148V,149T,154K,169F,177S,187D,197Y,203R,208G,210S
GQ276184	OC_300_07	Botswana			genomic DNA	patient OC sampled 300 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276185	OC_300_08	Botswana			genomic DNA	patient OC sampled 300 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276186	OC_300_09	Botswana			genomic DNA	patient OC sampled 300 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276187	OC_300_10	Botswana			genomic DNA	patient OC sampled 300 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276188	OC_300_11	Botswana			genomic DNA	patient OC sampled 300 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276189	OC_300_12	Botswana			genomic DNA	patient OC sampled 300 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276190	OC_300_13	Botswana			genomic DNA	patient OC sampled 300 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276191	OC_300_14	Botswana			genomic DNA	patient OC sampled 300 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276192	OC_300_15	Botswana			genomic DNA	patient OC sampled 300 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276193	OC_300_16	Botswana			genomic DNA	patient OC sampled 300 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,98K,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276194	OC_300_17	Botswana			genomic DNA	patient OC sampled 300 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276195	OC_300_19	Botswana			genomic DNA	patient OC sampled 300 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276196	OC_300_20	Botswana			genomic DNA	patient OC sampled 300 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276197	OC_393_01	Botswana			genomic DNA	patient OC sampled 393 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276198	OC_393_02	Botswana			genomic DNA	patient OC sampled 393 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276199	OC_393_03	Botswana			genomic DNA	patient OC sampled 393 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276200	OC_393_04	Botswana			genomic DNA	patient OC sampled 393 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276201	OC_393_05	Botswana			genomic DNA	patient OC sampled 393 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S,225A
GQ276202	OC_393_06	Botswana			genomic DNA	patient OC sampled 393 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276203	OC_393_07	Botswana			genomic DNA	patient OC sampled 393 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,18K,27I,41T,71D,83L,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S,223E
GQ276204	OC_393_08	Botswana			genomic DNA	patient OC sampled 393 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276205	OC_393_09	Botswana			genomic DNA	patient OC sampled 393 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276206	OC_393_10	Botswana			genomic DNA	patient OC sampled 393 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276207	OC_393_11	Botswana			genomic DNA	patient OC sampled 393 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276208	OC_393_12	Botswana			genomic DNA	patient OC sampled 393 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276209	OC_393_13	Botswana			genomic DNA	patient OC sampled 393 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276210	OC_393_14	Botswana			genomic DNA	patient OC sampled 393 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276211	OC_393_15	Botswana			genomic DNA	patient OC sampled 393 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276212	OC_393_16	Botswana			genomic DNA	patient OC sampled 393 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276213	OC_393_17	Botswana			genomic DNA	patient OC sampled 393 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276214	OC_393_18	Botswana			genomic DNA	patient OC sampled 393 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276215	OC_393_19	Botswana			genomic DNA	patient OC sampled 393 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276216	OC_482_02	Botswana			genomic DNA	patient OC sampled 482 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276217	OC_482_03	Botswana			genomic DNA	patient OC sampled 482 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,176H,177S,187D,203R,208G,210S
GQ276218	OC_482_04	Botswana			genomic DNA	patient OC sampled 482 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276219	OC_482_05	Botswana			genomic DNA	patient OC sampled 482 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276220	OC_482_07	Botswana			genomic DNA	patient OC sampled 482 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276221	OC_482_10	Botswana			genomic DNA	patient OC sampled 482 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,97G,116A,120S,127E,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276222	OC_575_02	Botswana			genomic DNA	patient OC sampled 575 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276223	OC_575_03	Botswana			genomic DNA	patient OC sampled 575 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276224	OC_575_04	Botswana			genomic DNA	patient OC sampled 575 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276225	OC_575_05	Botswana			genomic DNA	patient OC sampled 575 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276226	OC_575_06	Botswana			genomic DNA	patient OC sampled 575 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276227	OC_575_07	Botswana			genomic DNA	patient OC sampled 575 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276228	OC_575_08	Botswana			genomic DNA	patient OC sampled 575 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276229	OC_575_09	Botswana			genomic DNA	patient OC sampled 575 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276230	OC_575_11	Botswana			genomic DNA	patient OC sampled 575 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276231	OC_575_12	Botswana			genomic DNA	patient OC sampled 575 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276232	OC_575_13	Botswana			genomic DNA	patient OC sampled 575 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71G,83L,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276233	OC_666_01	Botswana			genomic DNA	patient OC sampled 666 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276234	OC_666_02	Botswana			genomic DNA	patient OC sampled 666 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276235	OC_666_03	Botswana			genomic DNA	patient OC sampled 666 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276236	OC_666_05	Botswana			genomic DNA	patient OC sampled 666 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,210S,221G
GQ276237	OC_666_06	Botswana			genomic DNA	patient OC sampled 666 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276238	OC_666_07	Botswana			genomic DNA	patient OC sampled 666 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276239	OC_666_08	Botswana			genomic DNA	patient OC sampled 666 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276240	OC_666_09	Botswana			genomic DNA	patient OC sampled 666 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,27I,41T,71D,83L,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276241	OC_666_10	Botswana			genomic DNA	patient OC sampled 666 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,210S
GQ276242	OC_755_01	Botswana			genomic DNA	patient OC sampled 755 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,110N,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276243	OC_755_03	Botswana			genomic DNA	patient OC sampled 755 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276244	OC_755_05	Botswana			genomic DNA	patient OC sampled 755 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,116A,120S,128D,148V,154K,169F,177S,187D,203R,208G,210S
GQ276245	OC_755_06	Botswana			genomic DNA	patient OC sampled 755 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,210S
GQ276246	OC_755_07	Botswana			genomic DNA	patient OC sampled 755 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,210S
GQ276247	OC_755_10	Botswana			genomic DNA	patient OC sampled 755 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,210S
GQ870874	OE	Botswana		OE_052_01R	genomic RNA		subtype: C	1	231	6L,27I,71D,83L,107S,116A,120S,124V,128D,136M,148V,154K,169F,178T,187D,208G,211I
GQ870875	OE	Botswana		OE_052_02R	genomic RNA		subtype: C	1	231	6L,27I,71D,83L,116A,120G,124V,128D,148V,154K,168L,169F,178T,187D,203R,208G,211I
GQ870876	OE	Botswana		OE_052_03R	genomic RNA		subtype: C	1	231	6L,27I,71D,83L,116A,120G,124V,128D,148V,154K,169F,178T,187D,203R,208G,211I
GQ870877	OE	Botswana		OE_052_04R	genomic RNA		subtype: C	1	231	6L,27I,71D,83L,116A,120G,124V,128D,148V,154K,169F,178T,187D,203R,208G,211I
GQ870878	OE	Botswana		OE_052_06R	genomic RNA		subtype: C	1	231	6L,27I,71D,83L,116A,120G,124V,128D,148V,154K,169F,178T,187D,203R,208G,211I
GQ870879	OE	Botswana		OE_052_07R	genomic RNA		subtype: C	1	231	6L,27I,71D,83L,107S,116A,120S,124V,128D,136M,148V,154K,169F,178T,187D,203R,208G,211I
GQ870880	OE	Botswana		OE_052_08R	genomic RNA		subtype: C	1	231	6L,27I,71D,83L,116A,120G,124V,128D,148V,154K,169F,178T,187D,203R,208G,211I
GQ870881	OE	Botswana		OE_052_09R	genomic RNA		subtype: C	1	231	6L,27I,71D,83L,116A,120G,124V,128D,148V,154K,169F,178T,187D,203R,208G,211I
GQ870882	OE	Botswana		OE_052_10R	genomic RNA		subtype: C	1	231	6L,27I,36A,71D,83L,116A,120G,124V,128D,148V,154K,169F,178T,187D,203R,208G,211I
GQ870883	OE	Botswana		OE_052_11R	genomic RNA		subtype: C	1	231	6L,27I,71D,83L,116A,120G,124V,128D,148V,154K,169F,178T,187D,203R,208G,211I
GQ870884	OE	Botswana		OE_052_12R	genomic RNA		subtype: C	1	231	6L,27I,71D,83L,107S,116A,120S,124V,128D,136M,148V,154K,169F,178T,187D,208G,211I
GQ870885	OE	Botswana		OE_052_13R	genomic RNA		subtype: C	1	231	6L,27I,71D,83L,107S,116A,120S,124V,128D,136M,148V,154K,169F,178T,187D,208G,211I
GQ870886	OE	Botswana		OE_052_14R	genomic RNA		subtype: C	1	231	6L,27I,71D,83L,116A,120G,124V,128D,148V,154K,169F,178T,187D,203R,208G,211I
GQ870887	OE	Botswana		OE_052_15R	genomic RNA		subtype: C	1	231	6L,27I,71D,83L,116A,120G,124V,128D,148V,154K,169F,178T,187D,203R,208G,211I
GQ870888	OE	Botswana		OE_052_16R	genomic RNA		subtype: C	1	231	6L,27I,71D,83L,107S,116A,120S,124V,128D,136M,148V,154K,169F,178T,187D,208G,211I
GQ870889	OE	Botswana		OE_052_17R	genomic RNA		subtype: C	1	231	6L,27I,71D,83L,107S,116A,120S,124V,128D,136M,148V,154K,169F,178T,187D,208G,211I
GQ870890	OE	Botswana		OE_081_01R	genomic RNA		subtype: C	1	231	6L,27I,71D,83L,116A,120S,124V,128D,136M,148V,154K,169F,178T,187D,203R,208G,211I
GQ870891	OE	Botswana		OE_081_02R	genomic RNA		subtype: C	1	231	6L,27I,71D,83L,116A,120G,124V,128D,148V,154K,169F,178T,187D,203R,208G,211I
GQ870892	OE	Botswana		OE_081_04R	genomic RNA		subtype: C	1	231	6L,27I,71D,83L,116A,120G,124V,128D,148V,154K,169F,178T,187D,203R,208G,211I
GQ870893	OE	Botswana		OE_081_06R	genomic RNA		subtype: C	1	231	6L,27I,71D,83L,116A,120G,124V,128D,148V,154K,169F,178T,187D,203R,208G,211I
GQ870894	OE	Botswana		OE_081_07R	genomic RNA		subtype: C	1	231	6L,27I,71D,83L,116A,120G,124V,128D,148V,154K,169F,178T,187D,203R,208G,211I
GQ870895	OE	Botswana		OE_081_08R	genomic RNA		subtype: C	1	231	6L,27I,71D,83L,116A,120G,124V,128D,148V,154K,169F,178T,187D,203R,208G,211I
GQ870896	OE	Botswana		OE_081_09R	genomic RNA		subtype: C	1	231	6L,27I,71D,83L,116A,120G,124V,128D,148V,154K,169F,178T,187D,203R,208G,211I
GQ870897	OE	Botswana		OE_081_10R	genomic RNA		subtype: C	1	231	6L,27I,71D,83L,116A,120G,124V,128D,148V,154K,169F,178T,187D,203R,208G,211I
GQ870898	OE	Botswana		OE_081_11R	genomic RNA		subtype: C	1	231	6L,27I,71D,83L,116A,120G,124V,128D,148V,154K,169F,178T,187D,203R,208G,211I
GQ870899	OE	Botswana		OE_081_12R	genomic RNA		subtype: C	1	231	6L,27I,71D,83S,116A,120G,124V,128D,148V,154K,169F,178T,187D,203R,208G,211I
GQ870900	OE	Botswana		OE_081_13R	genomic RNA		subtype: C	1	231	6L,27I,71D,83L,107S,116A,120S,124V,128D,136M,148V,154K,169F,178T,187D,208G,211I
GQ870901	OE	Botswana		OE_081_14R	genomic RNA		subtype: C	1	231	6L,27I,71D,83L,116A,120S,124V,128D,136M,148V,154K,169F,178T,187D,203R,208G,211I
GQ870902	OE	Botswana		OE_081_15R	genomic RNA		subtype: C	1	231	6L,27I,71D,83L,116A,120G,124V,128D,148V,154K,169F,178T,187D,203R,208G,211I
GQ870903	OE	Botswana		OE_081_16R	genomic RNA		subtype: C	1	231	6L,27I,71D,83L,116A,120G,124V,128D,148V,154K,169F,178T,187D,203R,208G,211I,228D
GQ870904	OE	Botswana		OE_081_17R	genomic RNA		subtype: C	1	231	6L,27I,71D,83L,116A,120G,124V,128D,148V,154K,169F,178T,187D,203R,208G,211I
GQ276248	OE_122_01	Botswana			genomic DNA	patient OE sampled 122 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,71D,83L,116A,120G,124V,128D,148V,154K,169F,178T,187D,203R,208G,211I
GQ276249	OE_122_03	Botswana			genomic DNA	patient OE sampled 122 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,71D,83L,107S,116A,120S,124V,128D,136M,148V,154K,169F,178T,187D,208G,211I
GQ276250	OE_122_04	Botswana			genomic DNA	patient OE sampled 122 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,71D,83L,116A,120G,124V,128D,148V,154K,169F,178T,187D,203R,208G,211I
GQ276251	OE_122_05	Botswana			genomic DNA	patient OE sampled 122 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,71D,83L,87Q,107S,116A,120S,124V,128D,136M,148V,154K,169F,178T,187D,203R,208G,211I
GQ276252	OE_122_06	Botswana			genomic DNA	patient OE sampled 122 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,71D,83L,116A,120G,124V,128D,148V,154K,169F,178T,187D,203R,208G,211I
GQ276253	OE_122_07	Botswana			genomic DNA	patient OE sampled 122 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,71D,83L,107S,116A,120S,124V,128D,136M,148V,154K,169F,178T,187D,203R,208G,211I
GQ276254	OE_122_08	Botswana			genomic DNA	patient OE sampled 122 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,71D,83L,116A,120G,124V,128D,148V,154K,169F,178T,187D,203R,208G,211I
GQ276255	OE_122_10	Botswana			genomic DNA	patient OE sampled 122 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,71D,83L,116A,120G,124V,128D,148V,154K,169F,178T,187D,203R,208G,211I
GQ276256	OE_122_11	Botswana			genomic DNA	patient OE sampled 122 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,71D,83L,107S,116A,120S,124V,128D,136M,148V,154K,169F,178T,187D,208G,211I
GQ276257	OE_122_12	Botswana			genomic DNA	patient OE sampled 122 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,71D,83L,116A,120G,124V,128D,148V,154K,169F,178T,187D,208G,211I
GQ276258	OE_122_13	Botswana			genomic DNA	patient OE sampled 122 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,71D,83L,107S,116A,120S,124V,128D,136M,148V,154K,169F,178T,187D,208G,211I
GQ276259	OE_122_14	Botswana			genomic DNA	patient OE sampled 122 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,71D,83L,116A,120G,124V,128D,148V,154K,169F,178T,187D,203R,208G,211I
GQ276260	OE_122_15	Botswana			genomic DNA	patient OE sampled 122 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,71D,83L,116A,120G,124V,128D,148V,154K,169F,178T,187D,203R,208G,211I
GQ276261	OE_122_16	Botswana			genomic DNA	patient OE sampled 122 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,71D,83L,116A,120G,124V,128D,148V,154K,169F,178T,187D,203R,208G,211I
GQ276262	OE_122_17	Botswana			genomic DNA	patient OE sampled 122 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,71D,83L,116A,120G,124V,128D,148V,154K,169F,178T,187D,203R,208G,211I
GQ276263	OE_122_18	Botswana			genomic DNA	patient OE sampled 122 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,71D,83L,107S,116A,120S,124V,128D,136M,148V,154K,169F,178T,187D,208G,211I
GQ276264	OE_122_19	Botswana			genomic DNA	patient OE sampled 122 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,71D,83L,116A,120G,124V,128D,148V,154K,169F,178T,187D,203R,208G,211I
GQ276265	OE_205_02	Botswana			genomic DNA	patient OE sampled 205 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,71D,83L,116A,120G,124V,128D,148V,154K,169F,178T,187D,203R,208G,211I
GQ276266	OE_205_03	Botswana			genomic DNA	patient OE sampled 205 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,71D,83L,116A,120G,124V,128D,148V,154K,169F,178T,187D,203R,208G,211I
GQ276267	OE_205_04	Botswana			genomic DNA	patient OE sampled 205 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,71D,83L,116A,120G,124V,128D,136M,148V,154K,169F,178T,187D,203R,208G,211I
GQ276268	OE_205_06	Botswana			genomic DNA	patient OE sampled 205 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,71D,83L,116A,120G,124V,128D,136M,148V,154K,169F,178T,187D,203R,208G,211I
GQ276269	OE_205_07	Botswana			genomic DNA	patient OE sampled 205 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,71D,83L,116A,120G,124V,128D,148V,154K,169F,178T,187D,203R,208G,211I
GQ276270	OE_205_08	Botswana			genomic DNA	patient OE sampled 205 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,71D,83L,116A,120G,124V,128D,136M,148V,154K,169F,178T,187D,203R,208G,211I
GQ276271	OE_205_09	Botswana			genomic DNA	patient OE sampled 205 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2M,6L,27I,43F,71D,83L,116A,120G,124V,128D,148V,154K,169F,178T,187D,197V,203R,208G,211I
GQ276272	OE_236_01	Botswana			genomic DNA	patient OE sampled 236 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,71D,83L,116A,120G,124V,128D,136M,148V,154K,169F,178T,187D,208G,211I
GQ276273	OE_236_03	Botswana			genomic DNA	patient OE sampled 236 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,71D,83L,116A,120G,124V,128D,148V,154K,169F,178T,187D,203R,208G,211I
GQ276274	OE_236_05	Botswana			genomic DNA	patient OE sampled 236 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,71D,83L,116A,120G,124V,128D,148V,154K,169F,178T,187D,198W,208G,211I
GQ276275	OE_236_07	Botswana			genomic DNA	patient OE sampled 236 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,71D,83L,116A,120G,124V,128D,148V,154K,169F,178T,187D,203R,208G,211I
GQ276276	OE_236_08	Botswana			genomic DNA	patient OE sampled 236 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,71D,83L,116A,120S,124V,128D,136M,148V,154K,169F,178T,187D,208G,211I
GQ276277	OE_236_09	Botswana			genomic DNA	patient OE sampled 236 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,71D,83L,116A,120G,124V,128D,148V,154K,169F,178T,187D,203R,208G,211I
GQ276278	OE_236_11	Botswana			genomic DNA	patient OE sampled 236 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,71D,83L,116A,120S,124V,128D,136M,148V,154K,169F,178T,187D,208G,211I
GQ276279	OE_236_12	Botswana			genomic DNA	patient OE sampled 236 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,71D,83L,116A,120S,124V,128D,136M,148V,154K,169F,178T,187D,203R,208G,211I
GQ276280	OE_236_13	Botswana			genomic DNA	patient OE sampled 236 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,71D,83L,116A,120G,124V,128D,148V,154K,169F,178T,187D,208G,211I
GQ276281	OE_236_15	Botswana			genomic DNA	patient OE sampled 236 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,71D,83L,116A,120G,124V,128D,136M,148V,154K,169F,178T,187D,203R,208G,211I
GQ276282	OE_236_16	Botswana			genomic DNA	patient OE sampled 236 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,71D,83L,116A,120S,124V,128D,136M,148V,154K,169F,178T,180D,187D,208G,211I
GQ276283	OE_236_18	Botswana			genomic DNA	patient OE sampled 236 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,71D,83L,116A,120G,124V,128D,148V,154K,169F,178T,187D,203R,208G,211I
GQ276284	OE_236_19	Botswana			genomic DNA	patient OE sampled 236 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,71D,83L,116A,120G,124V,128D,148V,154K,169F,178T,187D,203R,208G,211I
GQ276285	OG_104_02	Botswana			genomic DNA	patient OG sampled 104 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276286	OG_104_03	Botswana			genomic DNA	patient OG sampled 104 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,23*,27I,36I,41T,71D,83L,91A,120S,128D,137R,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276287	OG_104_04	Botswana			genomic DNA	patient OG sampled 104 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276288	OG_104_05	Botswana			genomic DNA	patient OG sampled 104 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276289	OG_104_06	Botswana			genomic DNA	patient OG sampled 104 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276290	OG_104_07	Botswana			genomic DNA	patient OG sampled 104 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276291	OG_104_08	Botswana			genomic DNA	patient OG sampled 104 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276292	OG_104_09	Botswana			genomic DNA	patient OG sampled 104 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276293	OG_104_10	Botswana			genomic DNA	patient OG sampled 104 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276294	OG_104_11	Botswana			genomic DNA	patient OG sampled 104 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276295	OG_104_12	Botswana			genomic DNA	patient OG sampled 104 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276296	OG_104_13	Botswana			genomic DNA	patient OG sampled 104 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276297	OG_104_14	Botswana			genomic DNA	patient OG sampled 104 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,178T,180D,186A,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276298	OG_104_15	Botswana			genomic DNA	patient OG sampled 104 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276299	OG_104_16	Botswana			genomic DNA	patient OG sampled 104 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276300	OG_104_17	Botswana			genomic DNA	patient OG sampled 104 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276301	OG_104_18	Botswana			genomic DNA	patient OG sampled 104 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276302	OG_104_20	Botswana			genomic DNA	patient OG sampled 104 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276303	OG_163_01	Botswana			genomic DNA	patient OG sampled 163 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276304	OG_163_02	Botswana			genomic DNA	patient OG sampled 163 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276305	OG_163_03	Botswana			genomic DNA	patient OG sampled 163 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276306	OG_163_05	Botswana			genomic DNA	patient OG sampled 163 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276307	OG_163_06	Botswana			genomic DNA	patient OG sampled 163 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276308	OG_163_08	Botswana			genomic DNA	patient OG sampled 163 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276309	OG_163_09	Botswana			genomic DNA	patient OG sampled 163 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276310	OG_163_10	Botswana			genomic DNA	patient OG sampled 163 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,120S,128D,148V,154K,169F,178T,183H,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276311	OG_194_01	Botswana			genomic DNA	patient OG sampled 194 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204V,207Q,208G,210S,225S
GQ276312	OG_194_02	Botswana			genomic DNA	patient OG sampled 194 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276313	OG_194_04	Botswana			genomic DNA	patient OG sampled 194 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276314	OG_194_07	Botswana			genomic DNA	patient OG sampled 194 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276315	OG_194_08	Botswana			genomic DNA	patient OG sampled 194 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276316	OG_194_09	Botswana			genomic DNA	patient OG sampled 194 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,223R,225S
GQ276317	OG_194_10	Botswana			genomic DNA	patient OG sampled 194 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276318	OG_194_11	Botswana			genomic DNA	patient OG sampled 194 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,91A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276319	OG_194_12	Botswana			genomic DNA	patient OG sampled 194 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276320	OG_194_13	Botswana			genomic DNA	patient OG sampled 194 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276321	OG_194_14	Botswana			genomic DNA	patient OG sampled 194 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,120S,128D,148V,154K,169F,178T,183H,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276322	OG_194_17	Botswana			genomic DNA	patient OG sampled 194 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276323	OG_194_18	Botswana			genomic DNA	patient OG sampled 194 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,178T,180D,182T,187D,191I,200I,204G,207H,208G,210S,225S
GQ276324	OG_194_19	Botswana			genomic DNA	patient OG sampled 194 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276325	OG_219_01	Botswana			genomic DNA	patient OG sampled 219 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276326	OG_219_02	Botswana			genomic DNA	patient OG sampled 219 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,213G,225S
GQ276327	OG_219_03	Botswana			genomic DNA	patient OG sampled 219 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276328	OG_219_05	Botswana			genomic DNA	patient OG sampled 219 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276329	OG_219_06	Botswana			genomic DNA	patient OG sampled 219 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,96I,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276330	OG_219_08	Botswana			genomic DNA	patient OG sampled 219 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276331	OG_219_09	Botswana			genomic DNA	patient OG sampled 219 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276332	OG_219_10	Botswana			genomic DNA	patient OG sampled 219 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276333	OG_219_11	Botswana			genomic DNA	patient OG sampled 219 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276334	OG_219_12	Botswana			genomic DNA	patient OG sampled 219 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276335	OG_219_14	Botswana			genomic DNA	patient OG sampled 219 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276336	OG_219_15	Botswana			genomic DNA	patient OG sampled 219 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276337	OG_317_01	Botswana			genomic DNA	patient OG sampled 317 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27~,28~,29~,30~,31~,32~,33~,34~,35~,36~,41T,71D,83L,91A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276338	OG_317_02	Botswana			genomic DNA	patient OG sampled 317 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276339	OG_317_03	Botswana			genomic DNA	patient OG sampled 317 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276340	OG_317_04	Botswana			genomic DNA	patient OG sampled 317 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S,229K
GQ276341	OG_317_05	Botswana			genomic DNA	patient OG sampled 317 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276342	OG_317_06	Botswana			genomic DNA	patient OG sampled 317 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276343	OG_317_07	Botswana			genomic DNA	patient OG sampled 317 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,55V,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276344	OG_317_09	Botswana			genomic DNA	patient OG sampled 317 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276345	OG_669_01	Botswana			genomic DNA	patient OG sampled 669 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276346	OG_669_04	Botswana			genomic DNA	patient OG sampled 669 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276347	OG_669_05	Botswana			genomic DNA	patient OG sampled 669 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,120S,128D,148V,154K,169F,178T,183H,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276348	OG_669_06	Botswana			genomic DNA	patient OG sampled 669 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,91A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276349	OG_669_09	Botswana			genomic DNA	patient OG sampled 669 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,178T,180D,187D,191I,200I,204G,207Q,208G,210S,225S
GQ276350	OJ_044_01	Botswana			genomic DNA	patient OJ sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276351	OJ_044_02	Botswana			genomic DNA	patient OJ sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276352	OJ_044_03	Botswana			genomic DNA	patient OJ sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276353	OJ_044_04	Botswana			genomic DNA	patient OJ sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276354	OJ_044_05	Botswana			genomic DNA	patient OJ sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276355	OJ_044_06	Botswana			genomic DNA	patient OJ sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276356	OJ_044_07	Botswana			genomic DNA	patient OJ sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276357	OJ_044_09	Botswana			genomic DNA	patient OJ sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276358	OJ_044_10	Botswana			genomic DNA	patient OJ sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276359	OJ_044_11	Botswana			genomic DNA	patient OJ sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276360	OJ_044_13	Botswana			genomic DNA	patient OJ sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276361	OJ_044_14	Botswana			genomic DNA	patient OJ sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276362	OJ_044_15	Botswana			genomic DNA	patient OJ sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276363	OJ_044_16	Botswana			genomic DNA	patient OJ sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276364	OJ_044_18	Botswana			genomic DNA	patient OJ sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276365	OJ_044_19	Botswana			genomic DNA	patient OJ sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276366	OJ_135_01	Botswana			genomic DNA	patient OJ sampled 135 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276367	OJ_135_02	Botswana			genomic DNA	patient OJ sampled 135 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276368	OJ_135_03	Botswana			genomic DNA	patient OJ sampled 135 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276369	OJ_135_04	Botswana			genomic DNA	patient OJ sampled 135 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,121T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276370	OJ_135_05	Botswana			genomic DNA	patient OJ sampled 135 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276371	OJ_135_06	Botswana			genomic DNA	patient OJ sampled 135 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276372	OJ_135_07	Botswana			genomic DNA	patient OJ sampled 135 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	230	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S,230E
GQ276373	OJ_135_08	Botswana			genomic DNA	patient OJ sampled 135 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276374	OJ_135_09	Botswana			genomic DNA	patient OJ sampled 135 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276375	OJ_135_10	Botswana			genomic DNA	patient OJ sampled 135 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,127R,128D,148V,169F,178T,187D,203R,208G,225S
GQ276376	OJ_135_11	Botswana			genomic DNA	patient OJ sampled 135 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276377	OJ_135_12	Botswana			genomic DNA	patient OJ sampled 135 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276378	OJ_135_13	Botswana			genomic DNA	patient OJ sampled 135 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276379	OJ_135_14	Botswana			genomic DNA	patient OJ sampled 135 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276380	OJ_135_15	Botswana			genomic DNA	patient OJ sampled 135 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276381	OJ_135_16	Botswana			genomic DNA	patient OJ sampled 135 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276382	OJ_135_17	Botswana			genomic DNA	patient OJ sampled 135 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276383	OJ_135_18	Botswana			genomic DNA	patient OJ sampled 135 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276384	OJ_224_01	Botswana			genomic DNA	patient OJ sampled 224 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276385	OJ_224_02	Botswana			genomic DNA	patient OJ sampled 224 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276386	OJ_224_03	Botswana			genomic DNA	patient OJ sampled 224 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50N,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276387	OJ_224_04	Botswana			genomic DNA	patient OJ sampled 224 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276388	OJ_224_05	Botswana			genomic DNA	patient OJ sampled 224 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276389	OJ_224_06	Botswana			genomic DNA	patient OJ sampled 224 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276390	OJ_224_07	Botswana			genomic DNA	patient OJ sampled 224 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276391	OJ_224_08	Botswana			genomic DNA	patient OJ sampled 224 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276392	OJ_224_09	Botswana			genomic DNA	patient OJ sampled 224 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276393	OJ_224_10	Botswana			genomic DNA	patient OJ sampled 224 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276394	OJ_224_11	Botswana			genomic DNA	patient OJ sampled 224 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276395	OJ_224_12	Botswana			genomic DNA	patient OJ sampled 224 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276396	OJ_224_13	Botswana			genomic DNA	patient OJ sampled 224 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276397	OJ_224_15	Botswana			genomic DNA	patient OJ sampled 224 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276398	OJ_224_16	Botswana			genomic DNA	patient OJ sampled 224 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276399	OJ_224_17	Botswana			genomic DNA	patient OJ sampled 224 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276400	OJ_224_18	Botswana			genomic DNA	patient OJ sampled 224 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276401	OJ_224_19	Botswana			genomic DNA	patient OJ sampled 224 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276402	OJ_224_20	Botswana			genomic DNA	patient OJ sampled 224 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276403	OJ_316_02	Botswana			genomic DNA	patient OJ sampled 316 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,210P,225S
GQ276404	OJ_316_03	Botswana			genomic DNA	patient OJ sampled 316 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,113D,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276405	OJ_316_04	Botswana			genomic DNA	patient OJ sampled 316 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276406	OJ_316_05	Botswana			genomic DNA	patient OJ sampled 316 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,83L,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276407	OJ_316_06	Botswana			genomic DNA	patient OJ sampled 316 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225T
GQ276408	OJ_316_07	Botswana			genomic DNA	patient OJ sampled 316 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,190V,203R,208G,225S
GQ276409	OJ_316_08	Botswana			genomic DNA	patient OJ sampled 316 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276410	OJ_316_09	Botswana			genomic DNA	patient OJ sampled 316 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276411	OJ_316_10	Botswana			genomic DNA	patient OJ sampled 316 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276412	OJ_666_01	Botswana			genomic DNA	patient OJ sampled 666 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276413	OJ_666_02	Botswana			genomic DNA	patient OJ sampled 666 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,152~,153~,169F,178T,187D,203R,208G,225S
GQ276414	OJ_666_03	Botswana			genomic DNA	patient OJ sampled 666 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276415	OJ_666_04	Botswana			genomic DNA	patient OJ sampled 666 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,120S,128D,148V,169F,178T,187D,203R,208G,225S
GQ276416	OJ_666_05	Botswana			genomic DNA	patient OJ sampled 666 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276417	OJ_666_06	Botswana			genomic DNA	patient OJ sampled 666 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	2V,6L,15L,27I,41T,50S,71D,96I,116T,128D,148V,169F,178T,187D,203R,208G,225S
GQ276418	OM_086_01	Botswana			genomic DNA	patient OM sampled 086 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,11I,27I,41T,71D,83L,115V,116A,118T,120G,148V,154K,169F,178T,180D,187D,200I,203R,204G,207Q,208G,210S,225S
GQ276419	OM_086_02	Botswana			genomic DNA	patient OM sampled 086 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,11I,27I,41T,71D,83L,110N,115V,116A,120G,148V,154K,169F,178T,180D,187D,200I,203R,204G,207Q,208G,210S,225S
GQ276420	OM_086_03	Botswana			genomic DNA	patient OM sampled 086 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,11I,27I,41T,71D,83L,110N,115V,116A,120G,148V,154K,169F,178T,180D,187D,200I,203R,204G,207Q,208G,210S,225S
GQ276421	OM_086_04	Botswana			genomic DNA	patient OM sampled 086 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,11I,27I,41T,71D,83L,115V,116A,120G,148V,154K,169F,178T,180D,187D,200I,203R,204G,207Q,208G,210S,225S
GQ276422	OM_086_05	Botswana			genomic DNA	patient OM sampled 086 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,11I,27I,41T,71D,83L,110N,115V,116A,120G,148V,154K,169F,178T,180D,187D,200I,203R,204G,207Q,208G,210S,225S
GQ276423	OM_086_06	Botswana			genomic DNA	patient OM sampled 086 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,11I,27I,41T,71D,83L,115V,116A,118T,120G,148V,154K,169F,178T,180D,187D,200I,203R,204G,207Q,208G,210S,225S
GQ276424	OM_086_07	Botswana			genomic DNA	patient OM sampled 086 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,11I,27I,41T,71D,83L,115V,116A,118T,120G,148V,154K,169F,178T,180D,187D,200I,203R,204G,207Q,208G,210S,225S
GQ276425	OM_086_08	Botswana			genomic DNA	patient OM sampled 086 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,11I,27I,41T,71D,83L,110N,115V,116A,120G,148V,154K,169F,178T,180D,187D,200I,203R,204G,207Q,208G,210S,225S
GQ276426	OM_086_09	Botswana			genomic DNA	patient OM sampled 086 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,11I,27I,41T,71D,83L,110N,115V,116A,120G,148V,154K,169F,178T,180D,187D,200I,203R,204G,207Q,208G,210S,225S
GQ276427	OM_086_10	Botswana			genomic DNA	patient OM sampled 086 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,11I,27I,41T,71D,83L,110N,115V,116A,120G,148V,154K,169F,178T,180D,187D,200I,203R,204G,207Q,208G,210S,225S
GQ276428	OM_086_11	Botswana			genomic DNA	patient OM sampled 086 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,11I,27I,41T,71D,83L,110N,115V,116A,120G,148V,154K,169F,178T,180D,187D,200I,203R,204G,207Q,208G,210S,225S
GQ276429	OM_086_12	Botswana			genomic DNA	patient OM sampled 086 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,11I,27I,41T,71D,83L,110N,115V,116A,120G,148V,154K,169F,178T,180D,187D,200I,203R,204G,207Q,208G,210S,225S
GQ276430	OM_086_13	Botswana			genomic DNA	patient OM sampled 086 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,11I,27I,41T,71D,83L,110N,115V,116A,120G,148V,154K,169F,178T,180D,187D,200I,203R,204G,207Q,208G,210S,225S
GQ276431	OM_086_14	Botswana			genomic DNA	patient OM sampled 086 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,11I,27I,41T,71D,83L,110N,115V,116A,120G,148V,154K,169F,178T,180D,187D,200I,203R,204G,207Q,208G,210S,225S
GQ276432	OM_086_15	Botswana			genomic DNA	patient OM sampled 086 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,11I,27I,41T,71D,83L,110N,115V,116A,120G,148V,154K,169F,178T,180D,187D,200I,203R,204G,207Q,208G,210S,225S
GQ276433	OM_086_16	Botswana			genomic DNA	patient OM sampled 086 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,11I,27I,41T,71D,83L,110N,115V,116A,120G,148V,154K,169F,178T,180D,187D,200I,203R,204G,207Q,208G,210S,225S
GQ276434	OM_086_17	Botswana			genomic DNA	patient OM sampled 086 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,11I,27I,41T,71D,83L,110N,115V,116A,120G,148V,154K,169F,178T,180D,187D,200I,203R,204G,207Q,208G,210S,225S
GQ276435	OM_086_19	Botswana			genomic DNA	patient OM sampled 086 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,11I,27I,41T,71D,83L,110N,115V,116A,120G,148V,154K,169F,178T,180D,187D,200I,203R,204G,207Q,208G,210S,225S
GQ276436	OM_086_20	Botswana			genomic DNA	patient OM sampled 086 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,11I,27I,41T,71D,83L,110N,115V,116A,120G,148V,154K,169F,178T,180D,187D,200I,203R,204G,207Q,208G,210S,225S
GQ276437	OM_086_21	Botswana			genomic DNA	patient OM sampled 086 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,11I,27I,41T,71D,83L,110N,115V,116A,120G,148V,154K,169F,178T,180D,187D,200I,203R,204G,207Q,208G,210S,225S
GQ276438	OM_086_22	Botswana			genomic DNA	patient OM sampled 086 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,11I,27I,41T,71D,83L,110N,115V,116A,120G,148V,154K,169F,178T,180D,187D,200I,203R,204G,207Q,208G,210S,225S
GQ276439	OM_178_01	Botswana			genomic DNA	patient OM sampled 178 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,11I,27I,41T,71D,83L,115V,116A,120G,148V,154K,169F,178T,180D,187D,200I,203R,204G,207Q,208G,210S,225S
GQ276440	OM_178_03	Botswana			genomic DNA	patient OM sampled 178 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,11I,27I,41T,71D,83L,115V,116A,118T,120G,148V,154K,169F,178T,180D,187D,200I,203R,204G,207Q,208G,210S,225S
GQ276441	OM_178_04	Botswana			genomic DNA	patient OM sampled 178 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,11I,27I,41T,71D,83L,115V,116A,118T,120G,148V,154K,169F,178T,180D,187D,200I,203R,204G,207Q,208G,210S,225S
GQ276442	OM_178_05	Botswana			genomic DNA	patient OM sampled 178 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,11I,27I,41T,71D,83L,110N,115V,116A,120G,148V,154K,169F,178T,180D,187D,200I,203R,204G,207Q,208G,210S,225S
GQ276443	OM_178_07	Botswana			genomic DNA	patient OM sampled 178 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,11I,27I,41T,71D,83L,115V,116A,118T,120G,148V,154K,169F,178T,180D,187D,200I,203R,204G,207Q,208G,210S,225S
GQ276444	OM_178_08	Botswana			genomic DNA	patient OM sampled 178 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,11I,27I,41T,71D,83L,110N,115V,116A,120G,148V,154K,169F,176H,178T,180D,187D,200I,203R,204G,207Q,208G,210S,225S
GQ276445	OM_178_09	Botswana			genomic DNA	patient OM sampled 178 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,11I,27I,41T,71D,83L,110N,115V,116A,120G,148V,154K,169F,178T,180D,187D,200I,203R,204G,207Q,208G,210S,225S
GQ276446	OM_178_10	Botswana			genomic DNA	patient OM sampled 178 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,11I,27I,41T,71D,83L,115V,116A,120G,148V,154K,169F,178T,180D,187D,200I,203R,204G,207Q,208G,210S,225S
GQ276447	OM_178_11	Botswana			genomic DNA	patient OM sampled 178 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,11I,27I,41T,71D,83L,115V,116A,118T,120G,148V,154K,169F,178T,180D,187D,200I,203R,204G,207Q,208G,210S,225S
GQ276448	OM_178_12	Botswana			genomic DNA	patient OM sampled 178 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,11I,27I,41T,71D,83L,115V,116A,120G,148V,154K,169F,178T,180D,187D,200I,203R,204G,207Q,208G,210S,225S
GQ276449	OM_178_13	Botswana			genomic DNA	patient OM sampled 178 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,11I,27I,41T,71D,83L,110N,116A,120G,148V,154K,169F,178T,180D,187D,200I,203R,204G,207Q,208G,210S,225S
GQ276450	OM_178_14	Botswana			genomic DNA	patient OM sampled 178 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,11I,27I,41T,71D,83L,115V,116A,118T,120G,148V,154K,169F,178T,180D,187D,200I,203R,204G,207Q,208G,210S,225S
GQ276451	OM_178_15	Botswana			genomic DNA	patient OM sampled 178 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,11I,27I,41T,71D,83L,110N,115V,116A,120G,148V,154K,169F,178T,180D,187D,200I,203R,204G,207Q,208G,210S,225S
GQ276452	OM_178_16	Botswana			genomic DNA	patient OM sampled 178 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,11I,27I,41T,71D,83L,115V,116A,118T,120G,148V,154K,169F,178T,180D,187D,200I,203R,204G,207Q,208G,210S,225S
GQ276453	OM_178_17	Botswana			genomic DNA	patient OM sampled 178 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,11I,27I,41T,71D,83L,115V,116A,118T,120G,148V,154K,169F,178T,180D,187D,200I,203R,204G,207Q,208G,210S,225S
GQ276454	OM_178_18	Botswana			genomic DNA	patient OM sampled 178 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,11I,27I,41T,71D,83L,115V,116A,118T,120G,148V,154K,169F,178T,180D,187D,200I,203R,204G,207Q,208G,210S,225S
GQ276455	OM_178_20	Botswana			genomic DNA	patient OM sampled 178 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,11I,27I,41T,71D,83L,115V,116A,118T,120G,148V,154K,169F,178T,180D,187D,200I,203R,204G,207Q,208G,210S,225S
GQ276456	OQ_052_01	Botswana			genomic DNA	patient OQ sampled 052 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14T,15L,27I,41T,50S,71D,83L,116A,120S,128D,148V,154K,169F,178T,180D,187D,207S,208G
GQ276457	OQ_052_02	Botswana			genomic DNA	patient OQ sampled 052 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14T,15L,27I,41T,50S,71D,83L,116A,120S,128D,148V,154K,169F,178T,180D,187D,207S,208G
GQ276458	OQ_052_03	Botswana			genomic DNA	patient OQ sampled 052 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14T,15L,27I,41T,50S,71D,83L,116A,120S,128D,148V,154K,169F,178T,180D,187D,207S,208G
GQ276459	OQ_052_05	Botswana			genomic DNA	patient OQ sampled 052 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14T,15L,27I,41T,50S,71D,83L,116A,120S,128D,148V,154K,169F,178K,180D,187D,207S,208G
GQ276460	OQ_052_06	Botswana			genomic DNA	patient OQ sampled 052 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14T,15L,27I,41T,50S,71D,83L,116A,120S,128D,148V,154K,169F,178T,180D,187D,207S,208G
GQ276461	OQ_052_07	Botswana			genomic DNA	patient OQ sampled 052 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14T,15L,27I,41T,50S,71D,83L,116A,120S,128D,148V,154K,169F,178R,180D,187D,207S,208G,218G
GQ276462	OQ_052_08	Botswana			genomic DNA	patient OQ sampled 052 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14T,15L,27I,41T,50S,71D,83L,116A,120S,128D,148V,154K,169F,178T,180D,187D,207S,208G
GQ276463	OQ_052_09	Botswana			genomic DNA	patient OQ sampled 052 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14T,15L,27I,41T,50S,71D,83L,116A,120S,128D,148V,154K,169F,178T,180D,187D,207S,208G
GQ276464	OQ_052_12	Botswana			genomic DNA	patient OQ sampled 052 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14T,15L,27I,41T,50S,71D,83L,116A,120S,128D,148V,154K,169F,178T,180D,187D,207S,208G
GQ276465	OQ_052_13	Botswana			genomic DNA	patient OQ sampled 052 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14T,15L,27I,41T,50S,71D,83L,116A,120S,128D,148V,154K,169F,178T,180D,187D,207S,208G
GQ276466	OQ_139_04	Botswana			genomic DNA	patient OQ sampled 139 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14T,15L,27I,41T,50S,71D,83L,116A,120S,128D,148V,154K,169F,178T,180D,187D,207S,208G
GQ276467	OQ_139_06	Botswana			genomic DNA	patient OQ sampled 139 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14T,15L,27I,41T,50S,71D,83L,116A,120S,128D,148V,154K,169F,178T,180D,187D,207S,208G
GQ276468	OQ_139_07	Botswana			genomic DNA	patient OQ sampled 139 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14T,15L,27I,41T,50S,71D,83L,116A,120S,128D,148V,154K,169F,178T,180D,187D,207S,208G
GQ276469	OQ_139_08	Botswana			genomic DNA	patient OQ sampled 139 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14T,15L,27I,41T,50S,71D,83L,116A,120S,128D,148V,154K,169F,178T,180D,187D,207S,208G
GQ276470	OQ_139_10	Botswana			genomic DNA	patient OQ sampled 139 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14T,15L,27I,41T,50S,71D,83L,93S,116A,120S,128D,148V,154K,169F,178T,180D,187D,207S,208G
GQ276471	OQ_139_12	Botswana			genomic DNA	patient OQ sampled 139 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14T,15L,27I,41T,50S,71D,83L,116A,120S,128D,148V,154K,169F,178T,180D,187D,207S,208G
GQ276472	OQ_139_14	Botswana			genomic DNA	patient OQ sampled 139 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14T,15L,27I,41T,50S,71D,83L,116A,120S,128D,148V,154K,169F,176H,178T,180D,187D,207S,208G
GQ276473	OQ_139_15	Botswana			genomic DNA	patient OQ sampled 139 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14T,15L,27I,41T,50S,71D,83L,116A,120S,128D,148V,154K,169F,178T,180D,187D,207S,208G
GQ276474	OQ_139_16	Botswana			genomic DNA	patient OQ sampled 139 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14T,15L,27I,41T,50S,71D,83L,116A,120S,128D,133*,148V,154K,169F,178T,180D,187D,207S,208G
GQ276475	OQ_139_17	Botswana			genomic DNA	patient OQ sampled 139 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14T,15L,27I,41T,50S,71D,83L,116A,120S,128D,148V,154K,169F,178T,180D,187D,207S,208G
GQ276476	OQ_139_18	Botswana			genomic DNA	patient OQ sampled 139 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14T,15L,27I,41T,50S,71D,83L,116A,120S,128D,148V,154K,169F,178T,180D,187D,207S,208G
GQ276477	OQ_139_19	Botswana			genomic DNA	patient OQ sampled 139 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14T,15L,27I,41T,50S,71D,83L,116A,120S,128D,148V,154K,162K,169F,178T,180D,187D,207S,208G
GQ276478	OQ_233_01	Botswana			genomic DNA	patient OQ sampled 233 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14T,15L,27I,41T,50S,71D,83L,116A,120S,128D,148V,154K,169F,178T,180D,187D,207S,208G
GQ276479	OQ_233_02	Botswana			genomic DNA	patient OQ sampled 233 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14T,15L,27I,41T,50S,71D,83L,116A,120S,128D,148V,154K,169F,178T,180D,187D,207S,208G
GQ276480	OQ_233_04	Botswana			genomic DNA	patient OQ sampled 233 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14T,15L,27I,41T,50S,71D,83L,116A,120S,128D,148V,154K,169F,178T,180D,187D,207S,208G
GQ276481	OQ_233_05	Botswana			genomic DNA	patient OQ sampled 233 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14T,15L,27I,41T,50S,71D,116A,120S,128D,148V,154K,169F,178T,180D,187D,207S,208G
GQ276482	OQ_233_06	Botswana			genomic DNA	patient OQ sampled 233 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14T,15L,27I,41T,50S,71D,83L,116A,120S,128D,148V,154K,169F,178T,180D,187D,207S,208G
GQ276483	OQ_233_07	Botswana			genomic DNA	patient OQ sampled 233 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14T,15L,27I,41T,50S,71D,83L,116A,120S,128D,148V,154K,169F,178T,180D,187D,207S,208G
GQ276484	OQ_233_08	Botswana			genomic DNA	patient OQ sampled 233 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14T,15L,27I,41T,50S,71D,83L,116A,120S,128D,148V,154K,169F,178T,180D,187D,207S,208G
GQ276485	OQ_320_01	Botswana			genomic DNA	patient OQ sampled 320 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14T,15L,27I,41T,50S,71D,83L,116A,120S,128D,148V,154K,169F,178T,180D,187D,207S,208G
GQ276486	OQ_320_02	Botswana			genomic DNA	patient OQ sampled 320 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14T,15L,27I,41T,50S,71D,116A,120S,128D,148V,154K,169F,178T,180D,187D,207S,208G
GQ276487	OQ_320_05	Botswana			genomic DNA	patient OQ sampled 320 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14T,15L,27I,41T,50S,71D,83L,116A,120S,128D,148V,154K,169F,178T,180D,187D,207S,208G
GQ276488	OQ_320_07	Botswana			genomic DNA	patient OQ sampled 320 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,11I,14T,15L,27I,41T,50S,71D,83L,116A,120S,128D,148V,154K,169F,178T,180D,187D,207S,208G
GQ276489	OQ_320_08	Botswana			genomic DNA	patient OQ sampled 320 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14T,15L,27I,41T,50S,71D,83L,116A,120S,128D,148V,154K,169F,178T,180D,187D,207S,208G
GQ276490	OQ_320_09	Botswana			genomic DNA	patient OQ sampled 320 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14T,15L,27I,41T,50S,71D,83L,116A,120S,128D,148V,154K,169F,178T,180D,187D,207S,208G
GQ276491	OQ_320_12	Botswana			genomic DNA	patient OQ sampled 320 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14T,15L,27I,41T,50S,71D,83L,116A,120S,128D,148V,154K,169F,178T,180D,187D,207S,208G
GQ276492	OQ_415_01	Botswana			genomic DNA	patient OQ sampled 415 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14T,15L,27I,41T,50S,71D,83L,116A,120S,128D,148V,154K,169F,178T,180D,187D,207S,208G
GQ276493	OQ_415_02	Botswana			genomic DNA	patient OQ sampled 415 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14T,15L,27I,41T,50S,71D,83L,116A,120S,128D,148V,154K,169F,178T,180D,187D,207S,208G
GQ276494	OQ_415_03	Botswana			genomic DNA	patient OQ sampled 415 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14T,15L,27I,41T,50S,71D,83L,116A,120S,128D,148V,154K,169F,178T,180D,187D,207S,208G
GQ276495	OQ_415_05	Botswana			genomic DNA	patient OQ sampled 415 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14T,15L,27I,41T,50S,71D,83L,116A,120S,128D,148V,154K,169F,178T,180D,187D,207S,208G
GQ276496	OQ_415_06	Botswana			genomic DNA	patient OQ sampled 415 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14T,15L,27I,41T,50S,71D,83L,116A,120S,128D,148V,154K,169F,178T,180D,187D,207S,208G
GQ276497	OQ_415_08	Botswana			genomic DNA	patient OQ sampled 415 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14T,15L,27I,41T,50S,71D,83L,116A,120S,128D,148V,154K,169F,178T,180D,187D,207S,208G
GQ276498	OQ_415_09	Botswana			genomic DNA	patient OQ sampled 415 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14T,15L,27I,41T,50S,71D,83L,116A,120S,128D,148V,154K,169F,178T,180D,187D,207S,208G
GQ276499	OQ_415_10	Botswana			genomic DNA	patient OQ sampled 415 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14T,15L,27I,41T,50S,71D,83L,116A,120S,128D,148V,154K,169F,178T,180D,187D,207S,208G
GQ276500	OS_062_07	Botswana			genomic DNA	patient OS sampled 062 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,81N,91V,116A,120S,124V,128D,133*,137E,148V,154K,162K,169F,177C,178T,179H,187D,203R,204G,208G,213K
GQ276501	OS_062_09	Botswana			genomic DNA	patient OS sampled 062 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,31V,36E,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276502	OS_062_10	Botswana			genomic DNA	patient OS sampled 062 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276503	OS_062_12	Botswana			genomic DNA	patient OS sampled 062 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,29K,35K,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276504	OS_062_13	Botswana			genomic DNA	patient OS sampled 062 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276505	OS_062_14	Botswana			genomic DNA	patient OS sampled 062 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276506	OS_062_15	Botswana			genomic DNA	patient OS sampled 062 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276507	OS_062_16	Botswana			genomic DNA	patient OS sampled 062 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276508	OS_062_17	Botswana			genomic DNA	patient OS sampled 062 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,107~,108~,109~,110~,111~,112~,113~,114~,115~,116~,117~,118~,119~,120~,121~,122~,123~,124~,125~,126~,127~,128~,129~,130~,131~,132~,133~,134~,135~,136~,137~,138~,139~,140~,141~,142~,143~,144~,145~,146~,147~,148~,149~,150~,151~,152~,153~,154~,155~,156~,157~,158~,169F,177C,178T,179H,187D,193K,203R,204G,208G,230E
GQ276509	OS_062_18	Botswana			genomic DNA	patient OS sampled 062 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276510	OS_153_01	Botswana			genomic DNA	patient OS sampled 153 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71V,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276511	OS_153_02	Botswana			genomic DNA	patient OS sampled 153 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276512	OS_153_03	Botswana			genomic DNA	patient OS sampled 153 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276513	OS_153_04	Botswana			genomic DNA	patient OS sampled 153 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276514	OS_153_05	Botswana			genomic DNA	patient OS sampled 153 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276515	OS_153_06	Botswana			genomic DNA	patient OS sampled 153 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276516	OS_153_07	Botswana			genomic DNA	patient OS sampled 153 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,202V,203R,204G,208G
GQ276517	OS_153_08	Botswana			genomic DNA	patient OS sampled 153 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276518	OS_153_09	Botswana			genomic DNA	patient OS sampled 153 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276519	OS_153_10	Botswana			genomic DNA	patient OS sampled 153 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276520	OS_153_11	Botswana			genomic DNA	patient OS sampled 153 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276521	OS_153_12	Botswana			genomic DNA	patient OS sampled 153 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276522	OS_153_13	Botswana			genomic DNA	patient OS sampled 153 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276523	OS_153_14	Botswana			genomic DNA	patient OS sampled 153 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,29K,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179*,180G,187D,203R,204G,208G
GQ276524	OS_153_15	Botswana			genomic DNA	patient OS sampled 153 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G,222E
GQ276525	OS_153_16	Botswana			genomic DNA	patient OS sampled 153 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276526	OS_153_17	Botswana			genomic DNA	patient OS sampled 153 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,77D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276527	OS_153_18	Botswana			genomic DNA	patient OS sampled 153 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276528	OS_153_19	Botswana			genomic DNA	patient OS sampled 153 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276529	OS_153_20	Botswana			genomic DNA	patient OS sampled 153 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276530	OS_153_21	Botswana			genomic DNA	patient OS sampled 153 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276531	OS_243_01	Botswana			genomic DNA	patient OS sampled 243 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,128K,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276532	OS_243_02	Botswana			genomic DNA	patient OS sampled 243 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276533	OS_243_03	Botswana			genomic DNA	patient OS sampled 243 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276534	OS_243_04	Botswana			genomic DNA	patient OS sampled 243 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,29K,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276535	OS_243_05	Botswana			genomic DNA	patient OS sampled 243 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6*,15L,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276536	OS_243_06	Botswana			genomic DNA	patient OS sampled 243 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,18K,29K,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276537	OS_243_07	Botswana			genomic DNA	patient OS sampled 243 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276538	OS_243_08	Botswana			genomic DNA	patient OS sampled 243 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276539	OS_243_09	Botswana			genomic DNA	patient OS sampled 243 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276540	OS_243_10	Botswana			genomic DNA	patient OS sampled 243 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276541	OS_243_11	Botswana			genomic DNA	patient OS sampled 243 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276542	OS_243_13	Botswana			genomic DNA	patient OS sampled 243 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276543	OS_326_01	Botswana			genomic DNA	patient OS sampled 326 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,176P,177C,178T,179H,187D,203R,204G,208G
GQ276544	OS_326_03	Botswana			genomic DNA	patient OS sampled 326 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276545	OS_326_04	Botswana			genomic DNA	patient OS sampled 326 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,49Q,71D,91V,116A,120S,124V,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276546	OS_326_05	Botswana			genomic DNA	patient OS sampled 326 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276547	OS_326_07	Botswana			genomic DNA	patient OS sampled 326 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276548	OS_326_10	Botswana			genomic DNA	patient OS sampled 326 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,83L,91V,116A,120S,124V,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276549	OS_411_01	Botswana			genomic DNA	patient OS sampled 411 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276550	OS_411_02	Botswana			genomic DNA	patient OS sampled 411 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276551	OS_411_03	Botswana			genomic DNA	patient OS sampled 411 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,128D,137E,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276552	OS_411_04	Botswana			genomic DNA	patient OS sampled 411 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276553	OS_411_05	Botswana			genomic DNA	patient OS sampled 411 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276554	OS_411_06	Botswana			genomic DNA	patient OS sampled 411 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276555	OS_411_07	Botswana			genomic DNA	patient OS sampled 411 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276556	OS_411_08	Botswana			genomic DNA	patient OS sampled 411 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276557	OS_411_09	Botswana			genomic DNA	patient OS sampled 411 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276558	OS_411_10	Botswana			genomic DNA	patient OS sampled 411 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276559	OS_411_11	Botswana			genomic DNA	patient OS sampled 411 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276560	OS_411_12	Botswana			genomic DNA	patient OS sampled 411 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276561	OS_411_14	Botswana			genomic DNA	patient OS sampled 411 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276562	OS_411_15	Botswana			genomic DNA	patient OS sampled 411 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276563	OS_411_16	Botswana			genomic DNA	patient OS sampled 411 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276564	OS_411_17	Botswana			genomic DNA	patient OS sampled 411 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276565	OS_411_19	Botswana			genomic DNA	patient OS sampled 411 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276566	OS_494_01	Botswana			genomic DNA	patient OS sampled 494 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,18K,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276567	OS_494_02	Botswana			genomic DNA	patient OS sampled 494 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,29K,41T,71D,91V,116A,120S,124V,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276568	OS_494_03	Botswana			genomic DNA	patient OS sampled 494 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276569	OS_494_04	Botswana			genomic DNA	patient OS sampled 494 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,148V,154K,169F,177C,178T,179H,185I,187D,203R,204G,208G
GQ276570	OS_494_05	Botswana			genomic DNA	patient OS sampled 494 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276571	OS_494_06	Botswana			genomic DNA	patient OS sampled 494 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276572	OS_494_07	Botswana			genomic DNA	patient OS sampled 494 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276573	OS_583_01	Botswana			genomic DNA	patient OS sampled 583 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G,212K
GQ276574	OS_583_02	Botswana			genomic DNA	patient OS sampled 583 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276575	OS_583_03	Botswana			genomic DNA	patient OS sampled 583 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276576	OS_583_04	Botswana			genomic DNA	patient OS sampled 583 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276577	OS_583_05	Botswana			genomic DNA	patient OS sampled 583 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276578	OS_583_06	Botswana			genomic DNA	patient OS sampled 583 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,128D,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276579	OS_583_07	Botswana			genomic DNA	patient OS sampled 583 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276580	OS_583_08	Botswana			genomic DNA	patient OS sampled 583 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,80*,91V,116A,120S,124V,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276581	OS_583_09	Botswana			genomic DNA	patient OS sampled 583 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276582	OS_583_10	Botswana			genomic DNA	patient OS sampled 583 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,41T,71D,91V,116A,120S,124V,148V,154K,169F,177C,178T,179H,187D,203R,204G,208G
GQ276583	OU_013_01	Botswana			genomic DNA	patient OU sampled 013 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276584	OU_013_02	Botswana			genomic DNA	patient OU sampled 013 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276585	OU_013_03	Botswana			genomic DNA	patient OU sampled 013 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276586	OU_013_04	Botswana			genomic DNA	patient OU sampled 013 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276587	OU_013_05	Botswana			genomic DNA	patient OU sampled 013 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276588	OU_013_06	Botswana			genomic DNA	patient OU sampled 013 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276589	OU_013_07	Botswana			genomic DNA	patient OU sampled 013 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276590	OU_013_08	Botswana			genomic DNA	patient OU sampled 013 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276591	OU_013_09	Botswana			genomic DNA	patient OU sampled 013 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276592	OU_013_10	Botswana			genomic DNA	patient OU sampled 013 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276593	OU_044_01R	Botswana			genomic RNA	patient OU sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276594	OU_044_02R	Botswana			genomic RNA	patient OU sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276595	OU_044_03R	Botswana			genomic RNA	patient OU sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276596	OU_044_04R	Botswana			genomic RNA	patient OU sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276597	OU_044_05R	Botswana			genomic RNA	patient OU sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276598	OU_044_06R	Botswana			genomic RNA	patient OU sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276599	OU_044_07R	Botswana			genomic RNA	patient OU sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276600	OU_044_08R	Botswana			genomic RNA	patient OU sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276601	OU_044_10R	Botswana			genomic RNA	patient OU sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276602	OU_044_11R	Botswana			genomic RNA	patient OU sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276603	OU_044_12R	Botswana			genomic RNA	patient OU sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276604	OU_044_13R	Botswana			genomic RNA	patient OU sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276605	OU_044_15R	Botswana			genomic RNA	patient OU sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276606	OU_104_01	Botswana			genomic DNA	patient OU sampled 104 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276607	OU_104_02	Botswana			genomic DNA	patient OU sampled 104 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276608	OU_104_03	Botswana			genomic DNA	patient OU sampled 104 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276609	OU_104_04	Botswana			genomic DNA	patient OU sampled 104 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,120T,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276610	OU_104_05	Botswana			genomic DNA	patient OU sampled 104 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31V,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276611	OU_104_06	Botswana			genomic DNA	patient OU sampled 104 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276612	OU_104_07	Botswana			genomic DNA	patient OU sampled 104 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276613	OU_104_08	Botswana			genomic DNA	patient OU sampled 104 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276614	OU_104_09	Botswana			genomic DNA	patient OU sampled 104 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276615	OU_104_10	Botswana			genomic DNA	patient OU sampled 104 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276617	OU_196_01	Botswana			genomic DNA	patient OU sampled 196 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276616	OU_196_01R	Botswana			genomic RNA	patient OU sampled 196 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276618	OU_196_02	Botswana			genomic DNA	patient OU sampled 196 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276620	OU_196_03	Botswana			genomic DNA	patient OU sampled 196 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276619	OU_196_03R	Botswana			genomic RNA	patient OU sampled 196 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276622	OU_196_04	Botswana			genomic DNA	patient OU sampled 196 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,210S,225S
GQ276621	OU_196_04R	Botswana			genomic RNA	patient OU sampled 196 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276624	OU_196_05	Botswana			genomic DNA	patient OU sampled 196 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276623	OU_196_05R	Botswana			genomic RNA	patient OU sampled 196 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276625	OU_196_06	Botswana			genomic DNA	patient OU sampled 196 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276627	OU_196_07	Botswana			genomic DNA	patient OU sampled 196 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276626	OU_196_07R	Botswana			genomic RNA	patient OU sampled 196 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276629	OU_196_08	Botswana			genomic DNA	patient OU sampled 196 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276628	OU_196_08R	Botswana			genomic RNA	patient OU sampled 196 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276631	OU_196_09	Botswana			genomic DNA	patient OU sampled 196 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276630	OU_196_09R	Botswana			genomic RNA	patient OU sampled 196 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276632	OU_196_10R	Botswana			genomic RNA	patient OU sampled 196 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276634	OU_196_11	Botswana			genomic DNA	patient OU sampled 196 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276633	OU_196_11R	Botswana			genomic RNA	patient OU sampled 196 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276636	OU_196_12	Botswana			genomic DNA	patient OU sampled 196 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276635	OU_196_12R	Botswana			genomic RNA	patient OU sampled 196 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,165E,169F,178T,180D,187D,203R,208G,225S
GQ276638	OU_196_13	Botswana			genomic DNA	patient OU sampled 196 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,210S,225S
GQ276637	OU_196_13R	Botswana			genomic RNA	patient OU sampled 196 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276639	OU_196_14R	Botswana			genomic RNA	patient OU sampled 196 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276641	OU_196_15	Botswana			genomic DNA	patient OU sampled 196 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276640	OU_196_15R	Botswana			genomic RNA	patient OU sampled 196 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,191A,203R,208G,225S
GQ276643	OU_196_16	Botswana			genomic DNA	patient OU sampled 196 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,176P,178T,180D,187D,203R,208G,225S
GQ276642	OU_196_16R	Botswana			genomic RNA	patient OU sampled 196 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276645	OU_196_17	Botswana			genomic DNA	patient OU sampled 196 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276644	OU_196_17R	Botswana			genomic RNA	patient OU sampled 196 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276646	OU_196_18	Botswana			genomic DNA	patient OU sampled 196 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276648	OU_196_19	Botswana			genomic DNA	patient OU sampled 196 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276647	OU_196_19R	Botswana			genomic RNA	patient OU sampled 196 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276649	OU_196_20R	Botswana			genomic RNA	patient OU sampled 196 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276650	OU_196_21	Botswana			genomic DNA	patient OU sampled 196 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276651	OU_196_22	Botswana			genomic DNA	patient OU sampled 196 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,108S,128D,147A,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276652	OU_289_01	Botswana			genomic DNA	patient OU sampled 289 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276653	OU_289_02	Botswana			genomic DNA	patient OU sampled 289 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276654	OU_289_03	Botswana			genomic DNA	patient OU sampled 289 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,60E,71D,83L,91V,128D,137S,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276655	OU_289_04	Botswana			genomic DNA	patient OU sampled 289 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276656	OU_289_05	Botswana			genomic DNA	patient OU sampled 289 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276657	OU_289_06	Botswana			genomic DNA	patient OU sampled 289 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276658	OU_289_07	Botswana			genomic DNA	patient OU sampled 289 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276659	OU_289_08	Botswana			genomic DNA	patient OU sampled 289 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276660	OU_289_09	Botswana			genomic DNA	patient OU sampled 289 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276661	OU_289_10	Botswana			genomic DNA	patient OU sampled 289 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276663	OU_349_01	Botswana			genomic DNA	patient OU sampled 349 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276662	OU_349_01R	Botswana			genomic RNA	patient OU sampled 349 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276664	OU_349_02R	Botswana			genomic RNA	patient OU sampled 349 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276665	OU_349_03R	Botswana			genomic RNA	patient OU sampled 349 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276666	OU_349_04	Botswana			genomic DNA	patient OU sampled 349 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276667	OU_349_05	Botswana			genomic DNA	patient OU sampled 349 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276668	OU_349_06	Botswana			genomic DNA	patient OU sampled 349 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276670	OU_349_08	Botswana			genomic DNA	patient OU sampled 349 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276669	OU_349_08R	Botswana			genomic RNA	patient OU sampled 349 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276671	OU_349_09	Botswana			genomic DNA	patient OU sampled 349 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276672	OU_349_10	Botswana			genomic DNA	patient OU sampled 349 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276673	OU_349_11R	Botswana			genomic RNA	patient OU sampled 349 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276674	OU_349_12R	Botswana			genomic RNA	patient OU sampled 349 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276675	OU_349_14R	Botswana			genomic RNA	patient OU sampled 349 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276676	OU_349_17R	Botswana			genomic RNA	patient OU sampled 349 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276677	OU_349_18R	Botswana			genomic RNA	patient OU sampled 349 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276678	OU_349_20R	Botswana			genomic RNA	patient OU sampled 349 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276679	OU_471_01	Botswana			genomic DNA	patient OU sampled 471 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276680	OU_471_02	Botswana			genomic DNA	patient OU sampled 471 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276681	OU_471_03	Botswana			genomic DNA	patient OU sampled 471 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276682	OU_471_04	Botswana			genomic DNA	patient OU sampled 471 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276683	OU_471_05	Botswana			genomic DNA	patient OU sampled 471 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276684	OU_471_06	Botswana			genomic DNA	patient OU sampled 471 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276685	OU_471_07	Botswana			genomic DNA	patient OU sampled 471 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276686	OU_471_08	Botswana			genomic DNA	patient OU sampled 471 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276687	OU_471_09	Botswana			genomic DNA	patient OU sampled 471 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276688	OU_471_10	Botswana			genomic DNA	patient OU sampled 471 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276689	OU_561_01	Botswana			genomic DNA	patient OU sampled 561 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276690	OU_561_02	Botswana			genomic DNA	patient OU sampled 561 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276691	OU_561_03	Botswana			genomic DNA	patient OU sampled 561 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,195T,203R,208G,225S
GQ276692	OU_561_04	Botswana			genomic DNA	patient OU sampled 561 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276693	OU_561_05	Botswana			genomic DNA	patient OU sampled 561 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276694	OU_561_06	Botswana			genomic DNA	patient OU sampled 561 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276695	OU_561_07	Botswana			genomic DNA	patient OU sampled 561 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276696	OU_561_08	Botswana			genomic DNA	patient OU sampled 561 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276697	OU_561_09	Botswana			genomic DNA	patient OU sampled 561 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276698	OU_561_10	Botswana			genomic DNA	patient OU sampled 561 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,31G,33N,71D,83L,91V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276699	OW_013_01	Botswana			genomic DNA	patient OW sampled 013 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,98D,116A,120S,124V,128D,148V,169F,178T,187D,203R,208G
GQ276700	OW_013_03	Botswana			genomic DNA	patient OW sampled 013 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,98D,116A,120S,124V,128D,148V,169F,178T,187D,203R,208G
GQ276701	OW_013_04	Botswana			genomic DNA	patient OW sampled 013 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,116A,120S,128D,148V,169F,178T,187D,203R,208G,229K
GQ276702	OW_013_05	Botswana			genomic DNA	patient OW sampled 013 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,116A,120S,128D,148V,169F,178T,187D,203R,208G,229K
GQ276703	OW_013_06	Botswana			genomic DNA	patient OW sampled 013 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,116A,120S,128D,148V,169F,178T,187D,203R,208G,229K
GQ276704	OW_013_08	Botswana			genomic DNA	patient OW sampled 013 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,116A,120S,128D,148V,169F,178T,187D,203R,208G,229K
GQ276705	OW_013_09	Botswana			genomic DNA	patient OW sampled 013 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,116A,120S,128D,148V,169F,178T,187D,203R,208G,229K
GQ276706	OW_013_10	Botswana			genomic DNA	patient OW sampled 013 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,116A,120S,128D,148V,169F,178T,187D,203R,208G,229K
GQ276707	OW_105_01	Botswana			genomic DNA	patient OW sampled 105 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,116A,120S,128D,148V,169F,178T,187D,203R,208G,229K
GQ276708	OW_105_02	Botswana			genomic DNA	patient OW sampled 105 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,116A,120S,128D,148V,169F,178T,187D,203R,208G,229K
GQ276709	OW_105_03	Botswana			genomic DNA	patient OW sampled 105 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,98D,116A,120S,124V,128D,148V,169F,178T,187D,203R,208G
GQ276710	OW_105_05	Botswana			genomic DNA	patient OW sampled 105 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,98D,116A,120S,124V,128D,148V,169F,178T,187D,203R,208G,229K
GQ276711	OW_105_06	Botswana			genomic DNA	patient OW sampled 105 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,116A,120S,128D,148V,164*,169F,178T,187D,203R,208G,229K
GQ276712	OW_105_07	Botswana			genomic DNA	patient OW sampled 105 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,98D,116A,120S,124V,128D,148V,169F,178T,187D,203R,208G
GQ276713	OW_105_08	Botswana			genomic DNA	patient OW sampled 105 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,116A,120S,128D,148V,169F,178T,187D,203G,208G,229K
GQ276714	OW_105_11	Botswana			genomic DNA	patient OW sampled 105 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,116A,120S,128D,148V,169F,178T,187D,203R,208G,229K
GQ276715	OW_105_13	Botswana			genomic DNA	patient OW sampled 105 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,116A,120S,128D,148V,169F,178T,187D,203R,208G,229K
GQ276716	OW_105_14	Botswana			genomic DNA	patient OW sampled 105 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,116A,120S,128D,148V,169F,178T,187D,203R,208G,229K
GQ276717	OW_105_15	Botswana			genomic DNA	patient OW sampled 105 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,116A,120S,124V,128D,148V,169F,178T,187D,203R,208G
GQ276718	OW_105_17	Botswana			genomic DNA	patient OW sampled 105 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,116A,120S,124V,128D,148V,169F,178T,187D,203R,208G,229K
GQ276719	OW_105_18	Botswana			genomic DNA	patient OW sampled 105 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,116A,120S,124V,128D,148V,169F,178T,187D,203R,208G,229K
GQ276720	OW_105_19	Botswana			genomic DNA	patient OW sampled 105 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,116A,120S,128D,148V,169F,178T,187D,203R,208G,229K
GQ276721	OW_105_20	Botswana			genomic DNA	patient OW sampled 105 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,116A,120S,128D,148V,169F,178T,187D,203R,208G,229K
GQ276722	OW_105_21	Botswana			genomic DNA	patient OW sampled 105 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,98D,116A,120S,124V,128D,148V,169F,178T,187D,203R,208G
GQ276723	OW_105_22	Botswana			genomic DNA	patient OW sampled 105 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,98D,116A,120S,124V,128D,148V,169F,178T,187D,203R,208G
GQ276724	OW_105_23	Botswana			genomic DNA	patient OW sampled 105 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,116A,120S,128D,148V,169F,178T,187D,203R,208G,229K
GQ276725	OW_105_24	Botswana			genomic DNA	patient OW sampled 105 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,116A,120S,128D,148V,169F,178T,187D,203R,208G,229K
GQ276726	OW_105_25	Botswana			genomic DNA	patient OW sampled 105 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,116A,120S,128D,148V,169F,178T,187D,203R,208G,229K
GQ276727	OW_105_26	Botswana			genomic DNA	patient OW sampled 105 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,98D,116A,120S,124V,128D,148V,169F,178T,187D,203R,208G
GQ276728	OW_105_27	Botswana			genomic DNA	patient OW sampled 105 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,98D,116A,120S,124V,128D,148V,169F,178T,187D,203R,208G,229K
GQ276729	OW_105_28	Botswana			genomic DNA	patient OW sampled 105 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,98D,116A,120S,124V,128D,148V,169F,178T,187D,203R,208G
GQ276730	OW_224_01	Botswana			genomic DNA	patient OW sampled 224 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,56V,71D,87Q,91V,116A,120S,128D,148V,169F,178T,187D,203R,208G,229K
GQ276731	OW_224_03	Botswana			genomic DNA	patient OW sampled 224 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,116A,120S,128D,148V,169F,178T,187D,203R,208G,229K
GQ276732	OW_224_04	Botswana			genomic DNA	patient OW sampled 224 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,116A,120S,128D,148V,159D,169F,178T,187D,203R,208G,229K
GQ276733	OW_224_05	Botswana			genomic DNA	patient OW sampled 224 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,98D,116A,120S,124V,128D,148V,169F,178T,187D,203R,208G,229K
GQ276734	OW_224_06	Botswana			genomic DNA	patient OW sampled 224 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,116A,120S,128D,148V,169F,178T,187D,203R,208G,223R,229K
GQ276735	OW_224_07	Botswana			genomic DNA	patient OW sampled 224 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,98D,116A,120S,124V,128D,148V,169F,178T,187D,203R,208G
GQ276736	OW_224_08	Botswana			genomic DNA	patient OW sampled 224 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,116A,120S,128D,148V,169F,178T,187D,203R,208G
GQ276737	OW_224_09	Botswana			genomic DNA	patient OW sampled 224 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,63P,71D,87Q,91V,98D,116A,120S,124V,128D,148V,169F,178T,187D,203R,208G,229K
GQ276738	OW_224_10	Botswana			genomic DNA	patient OW sampled 224 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,116A,120S,128D,148V,169F,178T,187D,203R,208G
GQ276739	OW_224_11	Botswana			genomic DNA	patient OW sampled 224 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,116A,120S,124V,128D,148V,164*,169F,178T,187D,191F,203R,208G
GQ276740	OW_224_12	Botswana			genomic DNA	patient OW sampled 224 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,116A,120S,128D,148V,169F,178T,187D,203R,208G,229K
GQ276741	OW_224_13	Botswana			genomic DNA	patient OW sampled 224 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,98D,116A,120S,124V,128D,148V,169F,178T,187D,203R,208G,229K
GQ276742	OW_224_14	Botswana			genomic DNA	patient OW sampled 224 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,98D,116A,120S,124V,128D,148V,169F,178T,187D,203R,208G,229K
GQ276743	OW_288_01	Botswana			genomic DNA	patient OW sampled 288 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,98D,116A,120S,124V,128D,148V,169F,178T,187D,203R,208G,225S
GQ276744	OW_288_03	Botswana			genomic DNA	patient OW sampled 288 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,116A,120S,124V,128D,148V,169F,178T,187D,203R,208G,229K
GQ276745	OW_288_05	Botswana			genomic DNA	patient OW sampled 288 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,116A,120S,128D,148V,169F,178T,187D,203R,208G,229K
GQ276746	OW_288_06	Botswana			genomic DNA	patient OW sampled 288 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,98D,116A,120S,124V,128D,148V,169F,178T,187D,203R,208G,229K
GQ276747	OW_288_07	Botswana			genomic DNA	patient OW sampled 288 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,98D,116A,120S,124V,128D,148V,169F,178T,187D,203R,208G,229K
GQ276748	OW_288_08	Botswana			genomic DNA	patient OW sampled 288 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,116A,120S,124V,128D,148V,169F,178T,187D,203R,208G,229K
GQ276749	OW_288_09	Botswana			genomic DNA	patient OW sampled 288 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,116A,120S,124V,128D,148V,169F,178T,187D,203R,208G,229K
GQ276750	OW_288_10	Botswana			genomic DNA	patient OW sampled 288 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,116A,120S,124V,128D,147L,148V,169F,178T,187D,203R,208G,229K
GQ276751	OW_288_11	Botswana			genomic DNA	patient OW sampled 288 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,98D,116A,120S,124V,128D,148V,169F,178T,187D,203R,208E,229K
GQ276752	OW_288_12	Botswana			genomic DNA	patient OW sampled 288 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,98D,116A,120S,124V,128D,148V,169F,178T,187D,203R,208G,229K
GQ276753	OW_288_13	Botswana			genomic DNA	patient OW sampled 288 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,98D,116A,120S,124V,128D,148V,169F,178T,187D,203R,208G
GQ276754	OW_288_14	Botswana			genomic DNA	patient OW sampled 288 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,98D,116A,120S,124V,128D,148V,169F,178T,187D,203R,208G
GQ276755	OW_382_01	Botswana			genomic DNA	patient OW sampled 382 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,116A,120S,128D,148V,169F,178T,187D,203R,208G,229K
GQ276756	OW_382_04	Botswana			genomic DNA	patient OW sampled 382 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,116A,120S,128D,148V,169F,178T,187D,203R,208G,229K
GQ276757	OW_382_05	Botswana			genomic DNA	patient OW sampled 382 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,98D,116A,120S,124V,128D,148V,169F,178T,187D,203R,208G,229K
GQ276758	OW_382_08	Botswana			genomic DNA	patient OW sampled 382 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,98D,116A,120S,124V,128D,148V,169F,178T,187D,203R,208G,223E
GQ276759	OW_382_09	Botswana			genomic DNA	patient OW sampled 382 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,98D,116A,120G,124V,128D,148V,169F,178T,187D,203R,208G,229K
GQ276760	OW_382_10	Botswana			genomic DNA	patient OW sampled 382 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128D,148V,169F,178T,187D,203R,208G,229K
GQ276761	OW_469_01	Botswana			genomic DNA	patient OW sampled 469 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,116A,120S,128D,148V,169F,178T,187D,203R,208G,229K
GQ276762	OW_469_04	Botswana			genomic DNA	patient OW sampled 469 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,98D,116A,120S,124V,128D,148V,169F,178T,187D,203R,208G
GQ276763	OW_469_05	Botswana			genomic DNA	patient OW sampled 469 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,98D,116A,120G,124V,128D,148V,169F,178T,187D,203R,208G,229K
GQ276764	OW_469_07	Botswana			genomic DNA	patient OW sampled 469 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,116A,120S,128D,148V,169F,178T,187D,203R,208G,229K
GQ276765	OW_469_08	Botswana			genomic DNA	patient OW sampled 469 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,87Q,91V,116A,120S,128D,148V,169F,178T,187D,203R,208G,229K
GQ276766	OX_058_01	Botswana			genomic DNA	patient OX sampled 058 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,194T,209G,225A
GQ276767	OX_058_04	Botswana			genomic DNA	patient OX sampled 058 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,225A,226P
GQ276768	OX_058_05	Botswana			genomic DNA	patient OX sampled 058 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,45K,71D,83L,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,225A
GQ276769	OX_058_07	Botswana			genomic DNA	patient OX sampled 058 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,225A
GQ276770	OX_058_08	Botswana			genomic DNA	patient OX sampled 058 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,101E,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,225A
GQ276771	OX_058_09	Botswana			genomic DNA	patient OX sampled 058 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,225A,230I
GQ276772	OX_058_10	Botswana			genomic DNA	patient OX sampled 058 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,225A
GQ276773	OX_058_11	Botswana			genomic DNA	patient OX sampled 058 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,225A
GQ276774	OX_058_14	Botswana			genomic DNA	patient OX sampled 058 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110N,116A,120G,124V,148V,154K,169F,171F,178T,180D,225A,230I
GQ276775	OX_058_16	Botswana			genomic DNA	patient OX sampled 058 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,225A,230I
GQ276776	OX_058_20	Botswana			genomic DNA	patient OX sampled 058 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110N,116A,120G,124V,144I,148V,154K,169F,171V,178T,180D,225A,230I
GQ276777	OX_058_21	Botswana			genomic DNA	patient OX sampled 058 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,225A
GQ276778	OX_058_22	Botswana			genomic DNA	patient OX sampled 058 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,225A
GQ276779	OX_152_01	Botswana			genomic DNA	patient OX sampled 152 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,225A,230I
GQ276780	OX_152_02	Botswana			genomic DNA	patient OX sampled 152 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,225A
GQ276781	OX_152_03	Botswana			genomic DNA	patient OX sampled 152 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,225A,230I
GQ276782	OX_152_04	Botswana			genomic DNA	patient OX sampled 152 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,82K,83L,91V,110N,116A,120G,124V,148V,154K,169F,171V,177P,178T,180D,192T,193D,225A
GQ276783	OX_152_07	Botswana			genomic DNA	patient OX sampled 152 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,225A
GQ276784	OX_152_09	Botswana			genomic DNA	patient OX sampled 152 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,225A
GQ276785	OX_152_10	Botswana			genomic DNA	patient OX sampled 152 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,225A,230I
GQ276786	OX_152_11	Botswana			genomic DNA	patient OX sampled 152 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,225A
GQ276787	OX_245_01	Botswana			genomic DNA	patient OX sampled 245 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,225A
GQ276788	OX_245_02	Botswana			genomic DNA	patient OX sampled 245 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,225A
GQ276789	OX_245_03	Botswana			genomic DNA	patient OX sampled 245 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110S,116A,120G,124V,148V,154K,169F,171V,178T,180D,225A
GQ276790	OX_245_04	Botswana			genomic DNA	patient OX sampled 245 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,225A
GQ276791	OX_245_05	Botswana			genomic DNA	patient OX sampled 245 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110S,116A,120G,124V,148V,154K,169F,171V,178T,180D,225A
GQ276792	OX_245_06	Botswana			genomic DNA	patient OX sampled 245 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,225A
GQ276793	OX_341_01	Botswana			genomic DNA	patient OX sampled 341 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,225A
GQ276794	OX_341_02	Botswana			genomic DNA	patient OX sampled 341 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,225A
GQ276795	OX_341_03	Botswana			genomic DNA	patient OX sampled 341 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,225A
GQ276796	OX_341_04	Botswana			genomic DNA	patient OX sampled 341 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,8R,15L,23*,27I,41T,71D,80*,83L,91V,110S,116A,117*,120G,124V,148V,154K,169F,171V,178T,180D,206R,225A,229K
GQ276797	OX_341_06	Botswana			genomic DNA	patient OX sampled 341 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,225A
GQ276798	OX_341_07	Botswana			genomic DNA	patient OX sampled 341 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,225A
GQ276799	OX_341_08	Botswana			genomic DNA	patient OX sampled 341 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,225A
GQ276800	OX_341_09	Botswana			genomic DNA	patient OX sampled 341 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,225A
GQ276801	OX_407_01	Botswana			genomic DNA	patient OX sampled 407 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110S,116A,120G,124V,148V,154K,169F,171V,178T,180D,225A
GQ276802	OX_407_02	Botswana			genomic DNA	patient OX sampled 407 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110S,116A,120G,124V,148V,154K,169F,171V,178T,180D,225A
GQ276803	OX_407_03	Botswana			genomic DNA	patient OX sampled 407 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,225A
GQ276804	OX_407_04	Botswana			genomic DNA	patient OX sampled 407 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110S,116A,120G,124V,148V,154K,169F,171V,178T,180D,225A
GQ276805	OX_407_05	Botswana			genomic DNA	patient OX sampled 407 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,225A
GQ276806	OX_407_06	Botswana			genomic DNA	patient OX sampled 407 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,225A
GQ276807	OX_407_07	Botswana			genomic DNA	patient OX sampled 407 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,225A
GQ276808	OX_407_09	Botswana			genomic DNA	patient OX sampled 407 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110S,116A,120G,124V,148V,154K,169F,171V,178T,180D,225A
GQ276809	OX_407_10	Botswana			genomic DNA	patient OX sampled 407 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110S,116A,120G,124V,148V,154K,169F,171V,178T,180D,225A
GQ276810	OX_464_01	Botswana			genomic DNA	patient OX sampled 464 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110S,116A,120G,124V,148V,154K,169F,171V,178T,180D,203R,225A
GQ276811	OX_464_02	Botswana			genomic DNA	patient OX sampled 464 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110S,116A,120G,124V,148V,154K,169F,171V,178T,180D,225A
GQ276812	OX_464_03	Botswana			genomic DNA	patient OX sampled 464 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110S,116A,120G,124V,148V,154K,169F,171V,178T,180D,225A
GQ276813	OX_464_04	Botswana			genomic DNA	patient OX sampled 464 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110S,116A,120G,124V,148V,154K,169F,171V,178T,180D,225A
GQ276814	OX_464_05	Botswana			genomic DNA	patient OX sampled 464 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,18K,27I,41T,71D,83L,91V,110S,116A,120G,124V,148V,154K,169F,171V,178T,180D,198F,203R,225A
GQ276815	OX_464_06	Botswana			genomic DNA	patient OX sampled 464 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110S,116A,120G,124V,148V,154K,169F,171V,178T,180D,225A
GQ276816	OX_464_08	Botswana			genomic DNA	patient OX sampled 464 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110S,116A,120G,124V,148V,154K,169F,171V,178T,180D,225A
GQ276817	OX_555_01	Botswana			genomic DNA	patient OX sampled 555 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110S,116A,120G,124V,148V,154K,169F,171V,178T,180D,225A
GQ276818	OX_555_03	Botswana			genomic DNA	patient OX sampled 555 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110S,116A,120G,124V,148V,154K,169F,171V,178T,180D,225A
GQ276819	OX_555_04	Botswana			genomic DNA	patient OX sampled 555 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110S,116A,120G,124V,148V,154K,169F,171V,178T,180D,225A
GQ276820	OX_555_05	Botswana			genomic DNA	patient OX sampled 555 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110S,116A,120G,124V,148V,154K,169F,171V,178T,180D,225A
GQ276821	OX_555_06	Botswana			genomic DNA	patient OX sampled 555 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110S,116A,120G,124V,148V,154K,169F,171V,178T,180D,225A,229K
GQ276822	OX_555_08	Botswana			genomic DNA	patient OX sampled 555 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110S,116A,120G,124V,148V,154K,169F,171V,178T,180D,225A
GQ276823	OX_555_10	Botswana			genomic DNA	patient OX sampled 555 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,110S,116A,120G,124V,148V,154K,169F,171V,178T,180D,225A
GQ276824	OY_051_01	Botswana			genomic DNA	patient OY sampled 051 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,27I,41T,71D,75D,83L,86I,91V,116A,120S,128V,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276825	OY_051_02	Botswana			genomic DNA	patient OY sampled 051 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,27I,41T,71D,75D,83L,86I,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276826	OY_143_01	Botswana			genomic DNA	patient OY sampled 143 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,27I,41T,71D,74H,75D,83L,86I,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276827	OY_143_04	Botswana			genomic DNA	patient OY sampled 143 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,27I,41T,71D,75D,83L,86I,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276828	OY_233_01	Botswana			genomic DNA	patient OY sampled 233 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,27I,41T,53H,71D,75D,83L,86I,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276829	OY_233_03	Botswana			genomic DNA	patient OY sampled 233 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,27I,41T,71D,75D,83L,86I,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276830	OY_233_04	Botswana			genomic DNA	patient OY sampled 233 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,27I,41T,71D,75D,83L,86I,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276831	OY_233_05	Botswana			genomic DNA	patient OY sampled 233 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,27I,41T,71D,75D,83L,86I,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276832	OY_233_06	Botswana			genomic DNA	patient OY sampled 233 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,27I,41T,71D,75D,83L,86I,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276833	OY_233_07	Botswana			genomic DNA	patient OY sampled 233 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,27I,41T,71D,75D,83L,86I,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276834	OY_233_08	Botswana			genomic DNA	patient OY sampled 233 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,27I,41T,71D,75D,83L,86I,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276835	OY_233_09	Botswana			genomic DNA	patient OY sampled 233 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,27I,41T,71D,75D,83L,86I,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276836	OY_233_10	Botswana			genomic DNA	patient OY sampled 233 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,27I,41T,71D,75D,83L,86I,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276837	OY_328_01	Botswana			genomic DNA	patient OY sampled 328 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,12L,14S,15L,27I,41T,71D,75D,83L,86I,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276838	OY_328_03	Botswana			genomic DNA	patient OY sampled 328 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,27I,41T,71D,75D,83L,86I,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276839	OY_328_06	Botswana			genomic DNA	patient OY sampled 328 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,27I,41T,71D,75D,83L,86I,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276840	OY_328_07	Botswana			genomic DNA	patient OY sampled 328 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,27I,41T,71D,75D,83L,86I,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276841	OY_328_10	Botswana			genomic DNA	patient OY sampled 328 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,27I,41T,71D,75D,83L,86I,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276842	OY_391_02	Botswana			genomic DNA	patient OY sampled 391 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,27I,41T,71D,75D,83L,86I,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276843	OY_423_01	Botswana			genomic DNA	patient OY sampled 423 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,75D,83L,86I,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276844	OY_423_02	Botswana			genomic DNA	patient OY sampled 423 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,27I,41T,71D,75D,83L,86I,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276845	OY_423_03	Botswana			genomic DNA	patient OY sampled 423 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,27I,41T,71D,75D,83L,86I,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276846	OY_423_05	Botswana			genomic DNA	patient OY sampled 423 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,27I,41T,71D,75D,83L,86I,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276847	OY_514_01	Botswana			genomic DNA	patient OY sampled 514 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,27I,41T,71D,75D,83L,86I,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276848	OY_514_02	Botswana			genomic DNA	patient OY sampled 514 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,27I,41T,71D,75D,83L,86I,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276849	OY_514_03	Botswana			genomic DNA	patient OY sampled 514 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,27I,41T,71D,75D,81N,83L,86I,91V,101E,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,212K,214I,225S
GQ276850	OY_514_04	Botswana			genomic DNA	patient OY sampled 514 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,27I,41T,71D,75D,83L,86I,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276851	OY_514_05	Botswana			genomic DNA	patient OY sampled 514 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,27I,41T,71D,75D,83L,86I,91V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ276852	OZ_078_01	Botswana			genomic DNA	patient OZ sampled 078 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276853	OZ_078_02	Botswana			genomic DNA	patient OZ sampled 078 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276854	OZ_078_03	Botswana			genomic DNA	patient OZ sampled 078 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276855	OZ_078_04	Botswana			genomic DNA	patient OZ sampled 078 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276856	OZ_078_05	Botswana			genomic DNA	patient OZ sampled 078 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276857	OZ_078_07	Botswana			genomic DNA	patient OZ sampled 078 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276858	OZ_078_08	Botswana			genomic DNA	patient OZ sampled 078 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,56I,67K,71D,83M,84Y,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276859	OZ_078_09	Botswana			genomic DNA	patient OZ sampled 078 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276860	OZ_078_10	Botswana			genomic DNA	patient OZ sampled 078 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276861	OZ_078_11	Botswana			genomic DNA	patient OZ sampled 078 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276862	OZ_078_14	Botswana			genomic DNA	patient OZ sampled 078 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276863	OZ_078_15	Botswana			genomic DNA	patient OZ sampled 078 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276864	OZ_078_16	Botswana			genomic DNA	patient OZ sampled 078 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276865	OZ_078_18	Botswana			genomic DNA	patient OZ sampled 078 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276866	OZ_078_20	Botswana			genomic DNA	patient OZ sampled 078 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,35K,36I,41T,71D,76K,81N,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276867	OZ_078_21	Botswana			genomic DNA	patient OZ sampled 078 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276868	OZ_078_22	Botswana			genomic DNA	patient OZ sampled 078 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276869	OZ_170_01	Botswana			genomic DNA	patient OZ sampled 170 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276870	OZ_170_02	Botswana			genomic DNA	patient OZ sampled 170 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276871	OZ_170_04	Botswana			genomic DNA	patient OZ sampled 170 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276872	OZ_170_05	Botswana			genomic DNA	patient OZ sampled 170 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276873	OZ_170_08	Botswana			genomic DNA	patient OZ sampled 170 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276874	OZ_170_09	Botswana			genomic DNA	patient OZ sampled 170 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276875	OZ_170_10	Botswana			genomic DNA	patient OZ sampled 170 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276876	OZ_170_11	Botswana			genomic DNA	patient OZ sampled 170 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276877	OZ_170_12	Botswana			genomic DNA	patient OZ sampled 170 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276878	OZ_170_13	Botswana			genomic DNA	patient OZ sampled 170 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276879	OZ_170_15	Botswana			genomic DNA	patient OZ sampled 170 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276880	OZ_170_16	Botswana			genomic DNA	patient OZ sampled 170 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276881	OZ_170_17	Botswana			genomic DNA	patient OZ sampled 170 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276882	OZ_170_18	Botswana			genomic DNA	patient OZ sampled 170 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276883	OZ_170_19	Botswana			genomic DNA	patient OZ sampled 170 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276884	OZ_170_20	Botswana			genomic DNA	patient OZ sampled 170 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276885	OZ_170_21	Botswana			genomic DNA	patient OZ sampled 170 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276886	OZ_170_22	Botswana			genomic DNA	patient OZ sampled 170 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276887	OZ_170_23	Botswana			genomic DNA	patient OZ sampled 170 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276888	OZ_170_25	Botswana			genomic DNA	patient OZ sampled 170 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276889	OZ_261_04	Botswana			genomic DNA	patient OZ sampled 261 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276890	OZ_261_05	Botswana			genomic DNA	patient OZ sampled 261 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276891	OZ_261_06	Botswana			genomic DNA	patient OZ sampled 261 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276892	OZ_261_09	Botswana			genomic DNA	patient OZ sampled 261 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276893	OZ_261_10	Botswana			genomic DNA	patient OZ sampled 261 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276894	OZ_261_11	Botswana			genomic DNA	patient OZ sampled 261 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276895	OZ_261_12	Botswana			genomic DNA	patient OZ sampled 261 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276896	OZ_261_13	Botswana			genomic DNA	patient OZ sampled 261 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276897	OZ_280_01	Botswana			genomic DNA	patient OZ sampled 280 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276898	OZ_280_02	Botswana			genomic DNA	patient OZ sampled 280 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276899	OZ_280_03	Botswana			genomic DNA	patient OZ sampled 280 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276900	OZ_280_04	Botswana			genomic DNA	patient OZ sampled 280 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276901	OZ_280_05	Botswana			genomic DNA	patient OZ sampled 280 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276902	OZ_280_06	Botswana			genomic DNA	patient OZ sampled 280 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276904	OZ_280_08	Botswana			genomic DNA	patient OZ sampled 280 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276905	OZ_280_09	Botswana			genomic DNA	patient OZ sampled 280 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276906	OZ_326_09	Botswana			genomic DNA	patient OZ sampled 326 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276907	OZ_326_10	Botswana			genomic DNA	patient OZ sampled 326 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276908	OZ_326_11	Botswana			genomic DNA	patient OZ sampled 326 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S,226P
GQ276909	OZ_326_12	Botswana			genomic DNA	patient OZ sampled 326 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276910	OZ_326_14	Botswana			genomic DNA	patient OZ sampled 326 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276911	OZ_326_15	Botswana			genomic DNA	patient OZ sampled 326 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276912	OZ_326_16	Botswana			genomic DNA	patient OZ sampled 326 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276913	OZ_395_01	Botswana			genomic DNA	patient OZ sampled 395 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276914	OZ_395_02	Botswana			genomic DNA	patient OZ sampled 395 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,222R,225S
GQ276915	OZ_540_01	Botswana			genomic DNA	patient OZ sampled 540 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276916	OZ_540_02	Botswana			genomic DNA	patient OZ sampled 540 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276917	OZ_540_03	Botswana			genomic DNA	patient OZ sampled 540 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276918	OZ_540_04	Botswana			genomic DNA	patient OZ sampled 540 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276919	OZ_540_05	Botswana			genomic DNA	patient OZ sampled 540 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,162K,169F,180D,187D,203R,208G,223E,225S
GQ276920	OZ_540_06	Botswana			genomic DNA	patient OZ sampled 540 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,178T,180D,187D,203R,208G,225S
GQ276921	OZ_540_07	Botswana			genomic DNA	patient OZ sampled 540 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,178T,180D,187D,203R,208G,225S
GQ276922	OZ_540_08	Botswana			genomic DNA	patient OZ sampled 540 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276923	OZ_540_09	Botswana			genomic DNA	patient OZ sampled 540 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ276924	OZ_540_10	Botswana			genomic DNA	patient OZ sampled 540 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,36I,41T,71D,83M,116A,120S,124V,128D,148V,169F,180D,187D,203R,208G,225S
GQ870905	PA	Botswana		PA_129_01R	genomic RNA		subtype: C	1	231	6A,14P,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ870906	PA	Botswana		PA_129_02R	genomic RNA		subtype: C	1	231	6A,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ870907	PA	Botswana		PA_129_03R	genomic RNA		subtype: C	1	231	6A,14S,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ870908	PA	Botswana		PA_129_04R	genomic RNA		subtype: C	1	231	6A,14P,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ870909	PA	Botswana		PA_129_05R	genomic RNA		subtype: C	1	231	6A,14P,24E,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ870910	PA	Botswana		PA_129_06R	genomic RNA		subtype: C	1	231	6A,14S,27I,41T,71D,83L,110S,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ870911	PA	Botswana		PA_129_07R	genomic RNA		subtype: C	1	231	6A,14P,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ870912	PA	Botswana		PA_129_08R	genomic RNA		subtype: C	1	231	6A,14P,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ870913	PA	Botswana		PA_129_09R	genomic RNA		subtype: C	1	231	6A,14P,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ870914	PA	Botswana		PA_129_10R	genomic RNA		subtype: C	1	231	6A,14P,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ870915	PA	Botswana		PA_129_11R	genomic RNA		subtype: C	1	231	6A,14P,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ870916	PA	Botswana		PA_129_12R	genomic RNA		subtype: C	1	231	6A,14P,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ870917	PA	Botswana		PA_129_13R	genomic RNA		subtype: C	1	231	6A,14S,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ870918	PA	Botswana		PA_129_14R	genomic RNA		subtype: C	1	231	6A,14P,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ870919	PA	Botswana		PA_129_15R	genomic RNA		subtype: C	1	231	6A,14P,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ870920	PA	Botswana		PA_129_16R	genomic RNA		subtype: C	1	231	6A,14P,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ870921	PA	Botswana		PA_129_17R	genomic RNA		subtype: C	1	231	6A,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ870922	PA	Botswana		PA_129_18R	genomic RNA		subtype: C	1	231	6A,14S,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ276925	PA_065_01	Botswana			genomic DNA	patient PA sampled 065 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14P,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ276926	PA_065_02	Botswana			genomic DNA	patient PA sampled 065 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14P,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ276927	PA_065_03	Botswana			genomic DNA	patient PA sampled 065 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14P,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ276928	PA_065_05	Botswana			genomic DNA	patient PA sampled 065 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14P,27I,41T,71D,83L,110N,116A,120G,123S,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ276929	PA_065_06	Botswana			genomic DNA	patient PA sampled 065 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14P,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ276930	PA_065_07	Botswana			genomic DNA	patient PA sampled 065 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14S,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ276931	PA_065_08	Botswana			genomic DNA	patient PA sampled 065 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14P,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ276932	PA_065_09	Botswana			genomic DNA	patient PA sampled 065 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14P,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ276933	PA_065_10	Botswana			genomic DNA	patient PA sampled 065 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14P,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ276934	PA_065_11	Botswana			genomic DNA	patient PA sampled 065 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14P,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ276935	PA_065_12	Botswana			genomic DNA	patient PA sampled 065 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14P,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ276936	PA_065_13	Botswana			genomic DNA	patient PA sampled 065 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14P,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ276937	PA_065_14	Botswana			genomic DNA	patient PA sampled 065 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14P,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ276938	PA_065_15	Botswana			genomic DNA	patient PA sampled 065 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14P,27I,41T,71D,83L,110N,116A,120G,123S,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ276939	PA_065_16	Botswana			genomic DNA	patient PA sampled 065 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14P,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ276940	PA_065_17	Botswana			genomic DNA	patient PA sampled 065 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14P,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ276941	PA_065_18	Botswana			genomic DNA	patient PA sampled 065 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14P,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ276942	PA_065_20	Botswana			genomic DNA	patient PA sampled 065 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14P,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ276943	PA_065_21	Botswana			genomic DNA	patient PA sampled 065 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14P,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ276944	PA_065_22	Botswana			genomic DNA	patient PA sampled 065 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14P,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ276945	PA_065_23	Botswana			genomic DNA	patient PA sampled 065 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	1S,6A,14P,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ276946	PA_065_24	Botswana			genomic DNA	patient PA sampled 065 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14P,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ276947	PA_065_25	Botswana			genomic DNA	patient PA sampled 065 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	1F,6A,14T,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ276948	PA_065_26	Botswana			genomic DNA	patient PA sampled 065 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14T,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ276949	PA_065_27	Botswana			genomic DNA	patient PA sampled 065 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14P,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ276950	PA_065_28	Botswana			genomic DNA	patient PA sampled 065 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14P,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ276951	PA_065_29	Botswana			genomic DNA	patient PA sampled 065 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14P,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ276952	PA_065_30	Botswana			genomic DNA	patient PA sampled 065 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14P,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ276953	PA_065_31	Botswana			genomic DNA	patient PA sampled 065 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14P,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ276954	PA_065_32	Botswana			genomic DNA	patient PA sampled 065 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14P,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ276955	PA_164_01	Botswana			genomic DNA	patient PA sampled 164 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ276956	PA_164_02	Botswana			genomic DNA	patient PA sampled 164 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ276957	PA_164_03	Botswana			genomic DNA	patient PA sampled 164 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14P,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ276958	PA_164_04	Botswana			genomic DNA	patient PA sampled 164 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14P,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ276959	PA_164_05	Botswana			genomic DNA	patient PA sampled 164 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14P,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ276960	PA_164_06	Botswana			genomic DNA	patient PA sampled 164 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14P,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ276961	PA_164_07	Botswana			genomic DNA	patient PA sampled 164 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14P,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ276962	PA_164_08	Botswana			genomic DNA	patient PA sampled 164 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14P,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ276963	PA_164_09	Botswana			genomic DNA	patient PA sampled 164 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14P,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ276964	PA_164_10	Botswana			genomic DNA	patient PA sampled 164 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14S,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ276965	PA_227_02	Botswana			genomic DNA	patient PA sampled 227 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14P,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ276966	PA_227_03	Botswana			genomic DNA	patient PA sampled 227 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14P,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ276967	PA_227_04	Botswana			genomic DNA	patient PA sampled 227 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14P,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ276968	PA_227_05	Botswana			genomic DNA	patient PA sampled 227 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14P,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ276969	PA_227_06	Botswana			genomic DNA	patient PA sampled 227 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14P,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ276970	PA_227_07	Botswana			genomic DNA	patient PA sampled 227 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ276971	PA_227_08	Botswana			genomic DNA	patient PA sampled 227 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,27I,41T,71D,83L,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ276972	PA_227_09	Botswana			genomic DNA	patient PA sampled 227 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14P,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ276973	PA_227_10	Botswana			genomic DNA	patient PA sampled 227 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6A,14P,27I,41T,71D,83L,110N,116A,120G,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ870923	PC	Botswana		PC_388_01R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ870924	PC	Botswana		PC_388_02R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ870925	PC	Botswana		PC_388_03R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ870926	PC	Botswana		PC_388_04R	genomic RNA		subtype: C	1	231	6L,27I,34L,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ870927	PC	Botswana		PC_388_05R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ870928	PC	Botswana		PC_388_06R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ870929	PC	Botswana		PC_388_07R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ870930	PC	Botswana		PC_388_08R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ870931	PC	Botswana		PC_388_09R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ870932	PC	Botswana		PC_388_10R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ870933	PC	Botswana		PC_388_11R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ870934	PC	Botswana		PC_388_12R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ870935	PC	Botswana		PC_388_13R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ870936	PC	Botswana		PC_388_14R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ870937	PC	Botswana		PC_388_15R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ870938	PC	Botswana		PC_388_16R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ870939	PC	Botswana		PC_388_17R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ276975	PC_054_01	Botswana			genomic DNA	patient PC sampled 054 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,207S,208G,225S
GQ276974	PC_054_01R	Botswana			genomic RNA	patient PC sampled 054 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,207S,208G,225S
GQ276977	PC_054_02	Botswana			genomic DNA	patient PC sampled 054 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,207S,208G,225S
GQ276976	PC_054_02R	Botswana			genomic RNA	patient PC sampled 054 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,207S,208G,225S
GQ276979	PC_054_03	Botswana			genomic DNA	patient PC sampled 054 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,207S,208G,225S
GQ276978	PC_054_03R	Botswana			genomic RNA	patient PC sampled 054 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,207S,208G,225S
GQ276981	PC_054_04	Botswana			genomic DNA	patient PC sampled 054 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,207S,208G,225S
GQ276980	PC_054_04R	Botswana			genomic RNA	patient PC sampled 054 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,207S,208G,225S
GQ276983	PC_054_05	Botswana			genomic DNA	patient PC sampled 054 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,207S,208G,225S
GQ276982	PC_054_05R	Botswana			genomic RNA	patient PC sampled 054 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,207S,208G,225S
GQ276985	PC_054_06	Botswana			genomic DNA	patient PC sampled 054 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,207S,208G,225S
GQ276984	PC_054_06R	Botswana			genomic RNA	patient PC sampled 054 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,207S,208G,225S
GQ276986	PC_054_07	Botswana			genomic DNA	patient PC sampled 054 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,207S,208G,225S
GQ276987	PC_054_08	Botswana			genomic DNA	patient PC sampled 054 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,207S,208G,225S
GQ276988	PC_054_09	Botswana			genomic DNA	patient PC sampled 054 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,207S,208G,225S
GQ276989	PC_054_10	Botswana			genomic DNA	patient PC sampled 054 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,207S,208G,225S
GQ276990	PC_054_11	Botswana			genomic DNA	patient PC sampled 054 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,207S,208G,225S
GQ276992	PC_054_12	Botswana			genomic DNA	patient PC sampled 054 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,207S,208G,225S
GQ276991	PC_054_12R	Botswana			genomic RNA	patient PC sampled 054 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,207S,208G,225S
GQ276994	PC_054_13	Botswana			genomic DNA	patient PC sampled 054 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,48P,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,207S,208G,225S
GQ276993	PC_054_13R	Botswana			genomic RNA	patient PC sampled 054 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,207S,208G,225S
GQ276995	PC_054_14R	Botswana			genomic RNA	patient PC sampled 054 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,207S,208G,225S
GQ276996	PC_054_15R	Botswana			genomic RNA	patient PC sampled 054 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,207S,208G,225S
GQ276997	PC_054_16R	Botswana			genomic RNA	patient PC sampled 054 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,207S,208G,225S
GQ276998	PC_054_17R	Botswana			genomic RNA	patient PC sampled 054 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,207S,208G,225S
GQ276999	PC_054_18R	Botswana			genomic RNA	patient PC sampled 054 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,207S,208G,225S
GQ277000	PC_054_19R	Botswana			genomic RNA	patient PC sampled 054 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,207S,208G,225S
GQ277001	PC_054_20R	Botswana			genomic RNA	patient PC sampled 054 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,207S,208G,225S
GQ277002	PC_146_01	Botswana			genomic DNA	patient PC sampled 146 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ277003	PC_146_02	Botswana			genomic DNA	patient PC sampled 146 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ277004	PC_146_03	Botswana			genomic DNA	patient PC sampled 146 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ277005	PC_146_04	Botswana			genomic DNA	patient PC sampled 146 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,207S,208G,225S
GQ277006	PC_146_05	Botswana			genomic DNA	patient PC sampled 146 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ277007	PC_146_06	Botswana			genomic DNA	patient PC sampled 146 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ277008	PC_146_08	Botswana			genomic DNA	patient PC sampled 146 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,207S,208G,225S
GQ277009	PC_146_09	Botswana			genomic DNA	patient PC sampled 146 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,207S,208G,225S
GQ277010	PC_146_10	Botswana			genomic DNA	patient PC sampled 146 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ277011	PC_146_11	Botswana			genomic DNA	patient PC sampled 146 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ277012	PC_236_01	Botswana			genomic DNA	patient PC sampled 236 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ277013	PC_236_04	Botswana			genomic DNA	patient PC sampled 236 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ277014	PC_236_05	Botswana			genomic DNA	patient PC sampled 236 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ277015	PC_236_06	Botswana			genomic DNA	patient PC sampled 236 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ277016	PC_236_11	Botswana			genomic DNA	patient PC sampled 236 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,162K,169F,173T,177S,178T,187D,203R,208G,225S
GQ277017	PC_236_12	Botswana			genomic DNA	patient PC sampled 236 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ277018	PC_333_01	Botswana			genomic DNA	patient PC sampled 333 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ277019	PC_333_02	Botswana			genomic DNA	patient PC sampled 333 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ277020	PC_333_03	Botswana			genomic DNA	patient PC sampled 333 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ277021	PC_333_04	Botswana			genomic DNA	patient PC sampled 333 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ277022	PC_333_05	Botswana			genomic DNA	patient PC sampled 333 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ277023	PC_333_06	Botswana			genomic DNA	patient PC sampled 333 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ277024	PC_333_07	Botswana			genomic DNA	patient PC sampled 333 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ277025	PC_333_08	Botswana			genomic DNA	patient PC sampled 333 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ277026	PC_333_09	Botswana			genomic DNA	patient PC sampled 333 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ277027	PC_333_10	Botswana			genomic DNA	patient PC sampled 333 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ277028	PC_418_01	Botswana			genomic DNA	patient PC sampled 418 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ277029	PC_418_02	Botswana			genomic DNA	patient PC sampled 418 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ277030	PC_418_03	Botswana			genomic DNA	patient PC sampled 418 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ277031	PC_418_04	Botswana			genomic DNA	patient PC sampled 418 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ277032	PC_418_05	Botswana			genomic DNA	patient PC sampled 418 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ277033	PC_418_06	Botswana			genomic DNA	patient PC sampled 418 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ277034	PC_418_07	Botswana			genomic DNA	patient PC sampled 418 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ277035	PC_418_08	Botswana			genomic DNA	patient PC sampled 418 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ277036	PC_418_10	Botswana			genomic DNA	patient PC sampled 418 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ277037	PD_059_01	Botswana			genomic DNA	patient PD sampled 059 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,187D,210S,225S
GQ277038	PD_059_02	Botswana			genomic DNA	patient PD sampled 059 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,187D,210S,225S
GQ277039	PD_059_03	Botswana			genomic DNA	patient PD sampled 059 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,187D,210S,225S
GQ277040	PD_059_05	Botswana			genomic DNA	patient PD sampled 059 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,187D,210S,225S
GQ277041	PD_059_06	Botswana			genomic DNA	patient PD sampled 059 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,187D,210S,225S
GQ277042	PD_059_07	Botswana			genomic DNA	patient PD sampled 059 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,187D,210S,225S
GQ277043	PD_059_08	Botswana			genomic DNA	patient PD sampled 059 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,187D,210S,225S
GQ277044	PD_059_09	Botswana			genomic DNA	patient PD sampled 059 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,187D,210S,225S
GQ277045	PD_059_10	Botswana			genomic DNA	patient PD sampled 059 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,187D,210S,225S
GQ277046	PD_150_01	Botswana			genomic DNA	patient PD sampled 150 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,187D,210S,225S
GQ277047	PD_150_02	Botswana			genomic DNA	patient PD sampled 150 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,27I,41T,71D,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,187D,210S,225S
GQ277048	PD_150_03	Botswana			genomic DNA	patient PD sampled 150 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,27I,41T,71D,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,187D,210S,225S
GQ277049	PD_150_04	Botswana			genomic DNA	patient PD sampled 150 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,187D,210S,225S
GQ277050	PD_150_05	Botswana			genomic DNA	patient PD sampled 150 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,187D,210S,225S
GQ277051	PD_150_06	Botswana			genomic DNA	patient PD sampled 150 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,187D,210S,225S
GQ277052	PD_150_07	Botswana			genomic DNA	patient PD sampled 150 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,187D,210S,225S
GQ277053	PD_150_08	Botswana			genomic DNA	patient PD sampled 150 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,27I,41T,71D,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,187D,210S,225S
GQ277054	PD_150_09	Botswana			genomic DNA	patient PD sampled 150 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,187D,210S,225S
GQ277055	PD_150_10	Botswana			genomic DNA	patient PD sampled 150 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,187D,210S,225S
GQ277056	PD_242_01	Botswana			genomic DNA	patient PD sampled 242 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,27I,41T,71D,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,187D,210S,225S
GQ277057	PD_242_03	Botswana			genomic DNA	patient PD sampled 242 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,27I,41T,71D,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,187D,207S,210S,225S
GQ277058	PD_242_04	Botswana			genomic DNA	patient PD sampled 242 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,27I,41T,71D,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,187D,210S,225S
GQ277059	PD_242_05	Botswana			genomic DNA	patient PD sampled 242 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,27I,41T,71D,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,187D,210S,225S
GQ277060	PD_242_06	Botswana			genomic DNA	patient PD sampled 242 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,187D,210S,225S
GQ277061	PD_242_07	Botswana			genomic DNA	patient PD sampled 242 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,27I,41T,71D,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,187D,210S,225S
GQ277062	PD_242_08	Botswana			genomic DNA	patient PD sampled 242 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,27I,41T,71D,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,187D,210S,225S
GQ277063	PD_242_09	Botswana			genomic DNA	patient PD sampled 242 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,27I,41T,71D,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,187D,210S,225S
GQ277064	PD_242_10	Botswana			genomic DNA	patient PD sampled 242 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,27I,41T,71D,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,187D,210S,225S
GQ277065	PD_334_01	Botswana			genomic DNA	patient PD sampled 334 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,27I,41T,71D,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,187D,210S,225S
GQ277066	PD_334_02	Botswana			genomic DNA	patient PD sampled 334 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,27I,41T,71D,91V,110S,116A,120G,124V,148V,154K,169F,171V,178T,180D,187D,210S,225S
GQ277067	PD_334_03	Botswana			genomic DNA	patient PD sampled 334 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,27I,41T,71D,91V,110S,116A,120G,124V,148V,154K,169F,171V,178T,180D,187D,210S,225S
GQ277068	PD_334_04	Botswana			genomic DNA	patient PD sampled 334 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,27I,41T,71D,91V,110S,116A,120G,124V,148V,154K,169F,171V,178T,180D,187D,210S,225S
GQ277069	PD_334_06	Botswana			genomic DNA	patient PD sampled 334 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,27I,41T,71D,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,187D,210S,225S
GQ277070	PD_334_07	Botswana			genomic DNA	patient PD sampled 334 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,27I,41T,71D,91V,110S,116A,120G,124V,148V,154K,169F,171V,178T,180D,187D,210S,225S
GQ277071	PD_334_08	Botswana			genomic DNA	patient PD sampled 334 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,27I,41T,71D,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,187D,210S,225S
GQ277072	PD_334_09	Botswana			genomic DNA	patient PD sampled 334 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,27I,41T,71D,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,187D,210S,225S
GQ277073	PD_334_10	Botswana			genomic DNA	patient PD sampled 334 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,27I,41T,71D,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,187D,210S,225S
GQ277074	PD_428_01	Botswana			genomic DNA	patient PD sampled 428 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,27I,41T,71D,91V,110S,116A,120G,124V,148V,154K,169F,171V,178T,180D,187D,210S,225S
GQ277075	PD_428_02	Botswana			genomic DNA	patient PD sampled 428 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,27I,41T,71D,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,187D,210S,225S
GQ277076	PD_428_04	Botswana			genomic DNA	patient PD sampled 428 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,27I,41T,71D,91V,110S,116A,120G,124V,148V,154K,169F,171V,178T,180D,187D,210S,225S
GQ277077	PD_428_05	Botswana			genomic DNA	patient PD sampled 428 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,91V,110N,116A,120G,124V,148V,154K,169F,171V,178T,180D,187D,210S,225S
GQ277078	PD_428_06	Botswana			genomic DNA	patient PD sampled 428 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,27I,41T,71D,91V,110S,116A,120G,124V,148V,154K,169F,171V,178T,180D,187D,210S,225S
GQ277079	PD_428_07	Botswana			genomic DNA	patient PD sampled 428 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,27I,41T,71D,91V,110S,116A,120G,124V,148V,154K,169F,171V,178T,180D,187D,210S,225S
GQ277080	PD_428_08	Botswana			genomic DNA	patient PD sampled 428 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,27I,41T,71D,91V,110S,116A,120G,124V,148V,154K,169F,171V,178T,180D,187D,210S,225S
GQ870940	PK	Botswana		PK_108_01R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,110N,116A,128D,148V,154K,169F,178T,187D,200N,203R,208G,225S
GQ870941	PK	Botswana		PK_108_02R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,110N,116A,128D,148V,154K,169F,178T,187D,200N,203R,208G,225S
GQ870942	PK	Botswana		PK_108_03R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,110N,116A,128D,148V,154K,169F,178T,187D,200N,203R,208G,225S
GQ870943	PK	Botswana		PK_108_04R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,110N,116A,128D,133R,148V,154K,169F,178T,187D,200N,203R,208G,225S
GQ870944	PK	Botswana		PK_108_05R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,110N,116A,128D,148V,154K,169F,178T,187D,200N,203R,208G,225S
GQ870945	PK	Botswana		PK_108_06R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,110N,116A,128D,148V,154K,169F,178T,187D,200N,203R,208G,225S
GQ870946	PK	Botswana		PK_108_07R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,110N,116A,128D,148V,154K,169F,178T,187D,200N,203R,208G,225S
GQ870947	PK	Botswana		PK_108_09R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,110N,116A,128D,148V,154K,169F,178T,187D,200N,203R,208G,225S
GQ870948	PK	Botswana		PK_108_10R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,110N,116A,128D,148V,154K,169F,178T,187D,200N,203R,208G,225S
GQ870949	PK	Botswana		PK_108_11R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,110N,116A,128D,148V,154K,169F,178T,187D,200N,203R,208G,225S
GQ870950	PK	Botswana		PK_108_12R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,110N,116A,128D,148V,154K,169F,178T,187D,200N,203R,208G,225S
GQ870951	PK	Botswana		PK_108_13R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,110N,116A,128D,148V,154K,169F,178T,187D,200N,203R,208G,225S
GQ870952	PK	Botswana		PK_108_14R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,110N,116A,128D,148V,154K,169F,178T,187D,200N,203R,208G,225S
GQ870953	PK	Botswana		PK_108_15R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,110N,116A,128D,148V,154K,169F,178T,187D,200N,203R,208G,225S
GQ870954	PK	Botswana		PK_108_16R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,110N,116A,128D,148V,154K,169F,178T,187D,200N,203R,208G,225S
GQ870955	PK	Botswana		PK_108_17R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,110N,116A,128D,148V,154K,169F,178T,187D,200N,203R,208G,225S
GQ870956	PK	Botswana		PK_108_19R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,110N,116A,128D,148V,154K,169F,178T,187D,200N,203R,208G,225S
GQ277081	PK_047_01	Botswana			genomic DNA	patient PK sampled 047 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,71D,83L,116A,128D,148V,154K,169F,178T,187D,200N,203R,208G,225S
GQ277082	PK_047_02	Botswana			genomic DNA	patient PK sampled 047 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,71D,83L,110N,116A,128D,148V,154K,169F,178T,187D,200N,203R,208G,225S
GQ277083	PK_047_03	Botswana			genomic DNA	patient PK sampled 047 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,71D,83L,110N,116A,128D,148V,154K,169F,178T,187D,200N,203R,208G,225S
GQ277084	PK_047_04	Botswana			genomic DNA	patient PK sampled 047 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,71D,83L,110N,116A,128D,148V,154K,169F,178T,187D,200N,203R,208G,225S
GQ277085	PK_047_05	Botswana			genomic DNA	patient PK sampled 047 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,71D,83L,110N,116A,128D,148V,154K,169F,178T,187D,200N,203R,208G,225S
GQ277086	PK_047_06	Botswana			genomic DNA	patient PK sampled 047 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,71D,75D,83L,116A,128D,148V,154K,169F,178T,187D,200N,203R,208G,225S
GQ277087	PK_047_07	Botswana			genomic DNA	patient PK sampled 047 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,71D,83L,110N,116A,128D,148V,154K,169F,178T,187D,200N,203R,208G,225S
GQ277088	PK_135_01	Botswana			genomic DNA	patient PK sampled 135 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,71D,83L,110N,116A,128D,148V,154K,169F,178T,187D,200N,203R,208G,225S
GQ277089	PK_135_03	Botswana			genomic DNA	patient PK sampled 135 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,71D,83L,110N,116A,128D,148V,154K,169F,178T,187D,200N,203R,208G,225S
GQ277090	PK_135_05	Botswana			genomic DNA	patient PK sampled 135 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,71D,83L,110N,116A,128D,148V,154K,169F,178T,187D,200N,203R,208G,225S
GQ277091	PK_135_07	Botswana			genomic DNA	patient PK sampled 135 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,71D,83L,110N,116A,128D,148V,154K,169F,178T,187D,200N,203R,208G,225S
GQ277092	PK_135_08	Botswana			genomic DNA	patient PK sampled 135 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,71D,83L,110N,116A,128D,148V,154K,169F,178T,187D,200N,203R,208G,225S
GQ277093	PK_135_09	Botswana			genomic DNA	patient PK sampled 135 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,71D,83L,110N,116A,128D,148V,154K,169F,178T,187D,200N,203R,208G,225S
GQ277094	PK_135_10	Botswana			genomic DNA	patient PK sampled 135 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,71D,83L,110N,116A,128D,148V,154K,169F,178T,187D,200N,203R,208G,225S
GQ277095	PK_195_01	Botswana			genomic DNA	patient PK sampled 195 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,71D,83L,110N,116A,128D,148V,154K,169F,178T,187D,200N,203R,208G,225S
GQ277096	PK_195_02	Botswana			genomic DNA	patient PK sampled 195 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,71D,83L,110N,116A,128D,148V,154K,169F,178T,187D,200N,203R,208G,225S
GQ277097	PK_195_03	Botswana			genomic DNA	patient PK sampled 195 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,71D,83L,110N,116A,128D,148V,154K,169F,178T,187D,200N,203R,208G,225S
GQ277098	PK_195_04	Botswana			genomic DNA	patient PK sampled 195 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,71D,83L,110N,116A,128D,148V,154K,169F,178T,187D,200N,203R,208G,225S
GQ277099	PK_195_05	Botswana			genomic DNA	patient PK sampled 195 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,71D,83L,110N,116A,128D,148V,154K,169F,178T,187D,200N,203R,208G,222R,225S
GQ277100	PK_195_07	Botswana			genomic DNA	patient PK sampled 195 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,71D,83L,110N,116A,128D,148V,154K,169F,178T,187D,200N,203R,208G,225S
GQ277101	PK_195_08	Botswana			genomic DNA	patient PK sampled 195 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,68I,71D,83L,110N,116A,128D,148V,154K,169F,178T,187D,200N,203R,208G,225S
GQ277102	PK_195_09	Botswana			genomic DNA	patient PK sampled 195 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,71D,83L,110N,116A,128D,148V,154K,169F,178T,187D,200N,203R,208G,225S
GQ277103	PK_195_10	Botswana			genomic DNA	patient PK sampled 195 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,71D,83L,110N,116A,128D,148V,154K,169F,178T,187D,200N,203R,208G,225S
GQ277104	PO_006_01	Botswana			genomic DNA	patient PO sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,27I,41T,68I,71D,83L,116A,120S,128D,148V,169F,178T,180D,203R,208G
GQ277105	PO_006_02	Botswana			genomic DNA	patient PO sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,27I,41T,68I,71D,83L,116A,120S,128D,148V,169F,178T,180D,203R,208G
GQ277106	PO_006_03	Botswana			genomic DNA	patient PO sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,27I,41T,68I,71D,83L,116A,120S,128D,148V,169F,178T,180D,203R,208G
GQ277107	PO_006_04	Botswana			genomic DNA	patient PO sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,27I,41T,68I,71D,83L,116A,120S,128D,148V,169F,178T,180D,203R,208G
GQ277108	PO_006_05	Botswana			genomic DNA	patient PO sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,27I,41T,68I,71D,83L,116A,120S,128D,148V,169F,178T,180D,203R,208G
GQ277109	PO_006_06	Botswana			genomic DNA	patient PO sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,27I,41T,68I,71D,83L,116A,120S,128D,148V,169F,178T,180D,203R,208G
GQ277110	PO_006_07	Botswana			genomic DNA	patient PO sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,27I,41T,68I,71D,83L,116A,120S,128D,148V,169F,178T,180D,203R,208G
GQ277111	PO_006_08	Botswana			genomic DNA	patient PO sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,27I,41T,68I,71D,83L,116A,120S,128D,148V,169F,178T,180D,203R,208G
GQ277112	PO_006_09	Botswana			genomic DNA	patient PO sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,27I,41T,68I,71D,83L,116A,120S,128D,148V,169F,178T,180D,203R,208G
GQ277113	PO_006_10	Botswana			genomic DNA	patient PO sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,27I,41T,68I,71D,83L,116A,120S,128D,148V,169F,178T,180D,203R,208G
GQ277114	PO_034_01	Botswana			genomic DNA	patient PO sampled 034 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,27I,41T,68I,71D,83L,116A,120S,128D,148V,169F,178T,180D,203R,208G
GQ277115	PO_034_02	Botswana			genomic DNA	patient PO sampled 034 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,27I,41T,68I,71D,83L,116A,120S,128D,148V,169F,178T,180D,203R,208G
GQ277116	PO_034_03	Botswana			genomic DNA	patient PO sampled 034 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,27I,41T,68I,71D,83L,116A,120S,128D,148V,169F,178T,180D,203R,208G
GQ277117	PO_034_04	Botswana			genomic DNA	patient PO sampled 034 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,27I,41T,68I,71D,83L,116A,120S,128D,148V,169F,178T,180D,203R,208G
GQ277118	PO_034_05	Botswana			genomic DNA	patient PO sampled 034 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,27I,41T,68I,71D,83L,116A,120S,128D,148V,169F,178T,180D,203R,208G
GQ277119	PO_034_06	Botswana			genomic DNA	patient PO sampled 034 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,27I,41T,68I,71D,83L,116A,120S,128D,148V,169F,178T,180D,203R,208G
GQ277120	PO_034_07	Botswana			genomic DNA	patient PO sampled 034 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,27I,41T,68I,71D,83L,116A,120S,128D,148V,169F,178T,180D,203R,208G
GQ277121	PO_034_08	Botswana			genomic DNA	patient PO sampled 034 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,27I,41T,68I,71D,83L,116A,120S,128D,148V,169F,178T,180D,203R,208G
GQ277122	PO_034_09	Botswana			genomic DNA	patient PO sampled 034 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,27I,41T,68I,71D,83L,116A,120S,128D,148V,169F,178T,180D,203R,208G
GQ277123	PO_034_10	Botswana			genomic DNA	patient PO sampled 034 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,27I,41T,68I,71D,83L,116A,120S,128D,148V,169F,178T,180D,203R,208G,224S
GQ277124	PO_097_01	Botswana			genomic DNA	patient PO sampled 097 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,27I,41T,68I,71D,83L,116A,120S,128D,148V,169F,178T,180D,203R,208G
GQ277125	PO_097_05	Botswana			genomic DNA	patient PO sampled 097 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,27I,41T,68I,71D,83L,116A,120S,128D,148V,169F,178T,180D,203R,208G
GQ277126	PO_097_06	Botswana			genomic DNA	patient PO sampled 097 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,27I,41T,68I,71D,83L,116A,120S,128D,148V,169F,178T,180D,203R,208G
GQ277127	PO_097_07	Botswana			genomic DNA	patient PO sampled 097 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,27I,41T,68I,71D,83L,116A,120S,128D,148V,169F,178T,180D,203R,208G
GQ277128	PO_097_08	Botswana			genomic DNA	patient PO sampled 097 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,27I,41T,68I,71D,83L,116A,120S,128D,148V,169F,178T,180D,203R,208G
GQ277129	PO_193_01	Botswana			genomic DNA	patient PO sampled 193 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,27I,41T,68I,71D,83L,113D,116A,120S,128D,148V,169F,178T,180D,203R,208G
GQ277130	PO_193_04	Botswana			genomic DNA	patient PO sampled 193 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,27I,41T,68I,71D,83L,116A,118I,128D,148V,169F,178T,180D,203R,208G
GQ277131	PO_193_05	Botswana			genomic DNA	patient PO sampled 193 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,27I,41T,68I,71D,83L,116A,120S,128D,148V,169F,178T,180D,203R,208G
GQ277132	PO_193_06	Botswana			genomic DNA	patient PO sampled 193 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,27I,41T,68I,71D,83L,110N,116A,120S,128D,148V,169F,178T,180D,203R,208G
GQ277133	PO_193_07	Botswana			genomic DNA	patient PO sampled 193 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,27I,41T,68I,71D,83L,110N,116A,120S,128D,148V,169F,178T,180D,203R,208G
GQ277134	PO_193_08	Botswana			genomic DNA	patient PO sampled 193 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,27I,41T,68I,71D,83L,116A,120S,128D,148V,169F,178T,180D,203R,208G
GQ277135	PO_193_09	Botswana			genomic DNA	patient PO sampled 193 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,27I,41T,68I,71D,83L,110N,116A,120S,128D,148V,169F,178T,180D,185I,203R,208G
GQ277136	PO_193_10	Botswana			genomic DNA	patient PO sampled 193 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,27I,41T,68I,71D,83L,116A,120S,128D,148V,169F,178T,180D,203R,208G
GQ277137	PO_193_11	Botswana			genomic DNA	patient PO sampled 193 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,27I,41T,68I,71D,83L,116A,120S,128D,148V,169F,178T,180D,203R,208G
GQ277138	PO_193_12	Botswana			genomic DNA	patient PO sampled 193 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,27I,41T,68I,71D,83L,116A,120S,128D,148V,169F,178T,180D,203R,208G
GQ277139	PO_193_13	Botswana			genomic DNA	patient PO sampled 193 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,27I,41T,68I,71D,83L,116A,120S,128D,148V,169F,178T,180D,203R,208G
GQ277140	PO_277_03	Botswana			genomic DNA	patient PO sampled 277 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,27I,41T,68I,71D,83L,110N,116A,120S,128D,148V,169F,178T,180D,203R,208G
GQ277141	PO_277_04	Botswana			genomic DNA	patient PO sampled 277 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,27I,41T,68I,71D,83L,110N,116A,120S,128D,148V,169F,178T,180D,203R,208G
GQ277142	PO_277_05	Botswana			genomic DNA	patient PO sampled 277 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,27I,41T,68I,71D,83L,110N,116A,120S,128D,148V,169F,178T,180D,203R,208G
GQ277143	PO_277_06	Botswana			genomic DNA	patient PO sampled 277 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,27I,41T,68I,71D,83L,110N,116A,120S,128D,148V,169F,178T,180D,203R,208G
GQ277144	PO_277_07	Botswana			genomic DNA	patient PO sampled 277 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,27I,41T,68I,71D,83L,110N,116A,120S,128D,148V,169F,178T,180D,203R,208G
GQ277145	PO_277_08	Botswana			genomic DNA	patient PO sampled 277 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,27I,41T,68I,71D,83L,110N,116A,120S,128D,148V,169F,178T,180D,203R,208G
GQ277146	PO_277_09	Botswana			genomic DNA	patient PO sampled 277 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,27I,41T,68I,71D,83L,110N,116A,120S,128D,148V,169F,178T,180D,203R,208G
GQ277147	PO_277_10	Botswana			genomic DNA	patient PO sampled 277 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,27I,41T,68I,71D,83L,110N,116A,120S,128D,148V,169F,178T,180D,203R,208G
GQ277148	PP_044_01	Botswana			genomic DNA	patient PP sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91L,95H,107A,110N,115V,116A,120S,128D,148V,154K,169F,178T,183S,187D,203R,208G,225S
GQ277149	PP_044_02	Botswana			genomic DNA	patient PP sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91L,95H,110N,115V,116A,120S,128D,148V,154K,169F,178T,183G,187D,203R,208G,225S
GQ277150	PP_044_03	Botswana			genomic DNA	patient PP sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91L,95H,107A,110N,115V,116A,120S,128D,148V,154K,169F,178T,183S,187D,203R,208G,225S
GQ277151	PP_044_04	Botswana			genomic DNA	patient PP sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91L,95H,110N,115V,116A,120S,128D,148V,154K,169F,178T,183G,187D,203R,208G,225S
GQ277152	PP_044_05	Botswana			genomic DNA	patient PP sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91L,95H,107A,110N,115V,116A,120S,128D,148V,154K,169F,178T,183S,187D,203R,208G,225S
GQ277153	PP_044_06	Botswana			genomic DNA	patient PP sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91L,95H,107A,110N,115V,116A,120S,128D,148V,154K,169F,178T,183S,187D,203R,208G,225S
GQ277154	PP_044_07	Botswana			genomic DNA	patient PP sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91L,95H,107A,110N,115V,116A,120S,128D,148V,154K,169F,178T,183G,187D,203R,208G,225S
GQ277155	PP_044_08	Botswana			genomic DNA	patient PP sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,10V,27I,31G,33N,39L,41T,71D,83L,91L,95H,107A,110N,115V,116A,120S,128D,148V,154K,169F,178T,183S,187D,203R,208G,225S
GQ277156	PP_044_09	Botswana			genomic DNA	patient PP sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91L,95H,110N,115V,116A,120S,128D,148V,154K,169F,178T,183S,187D,203R,208G,225S
GQ277157	PP_044_10	Botswana			genomic DNA	patient PP sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,87Q,91L,95H,110N,115V,116A,120S,128D,148V,154K,169F,178T,183G,187D,203R,208G,225S
GQ277158	PP_100_01	Botswana			genomic DNA	patient PP sampled 100 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91L,95H,115V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277159	PP_100_02	Botswana			genomic DNA	patient PP sampled 100 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91L,95H,107A,110N,115V,116A,120S,128D,148V,154K,169F,178T,183S,187D,203R,208G,225S
GQ277160	PP_100_03	Botswana			genomic DNA	patient PP sampled 100 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91L,95H,107A,110N,115V,116A,120S,128D,148V,154K,169F,178T,183S,187D,203R,208G,225S
GQ277161	PP_100_04	Botswana			genomic DNA	patient PP sampled 100 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91L,95H,110N,115V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277162	PP_100_05	Botswana			genomic DNA	patient PP sampled 100 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91L,95H,107A,110N,115V,116A,120S,128D,148V,154K,169F,178T,183S,187D,203R,208G,225S
GQ277163	PP_100_06	Botswana			genomic DNA	patient PP sampled 100 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91L,95H,110N,115V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277164	PP_100_08	Botswana			genomic DNA	patient PP sampled 100 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91L,95H,110N,115V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277165	PP_100_09	Botswana			genomic DNA	patient PP sampled 100 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91L,95H,115V,116A,120S,128D,148V,154K,169F,178T,183G,187D,203R,208G,225S
GQ277166	PP_100_10	Botswana			genomic DNA	patient PP sampled 100 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91L,95H,115V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277167	PP_226_01	Botswana			genomic DNA	patient PP sampled 226 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91L,95H,115V,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,225S
GQ277168	PP_226_02	Botswana			genomic DNA	patient PP sampled 226 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91L,95H,115V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277169	PP_226_03	Botswana			genomic DNA	patient PP sampled 226 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91L,95H,115V,116A,120S,128D,148V,154K,169F,178T,183G,187D,203R,208G,225S
GQ277170	PP_226_04	Botswana			genomic DNA	patient PP sampled 226 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91L,95H,115V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277171	PP_226_05	Botswana			genomic DNA	patient PP sampled 226 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91L,95H,115V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277172	PP_226_06	Botswana			genomic DNA	patient PP sampled 226 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91L,95H,115V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277173	PP_226_07	Botswana			genomic DNA	patient PP sampled 226 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91L,95H,115V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277174	PP_226_08	Botswana			genomic DNA	patient PP sampled 226 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,87Q,91L,95H,110N,115V,116A,120S,128D,148V,154K,169F,178T,183S,187D,203R,208G,225S
GQ277175	PP_226_09	Botswana			genomic DNA	patient PP sampled 226 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,87Q,91L,95H,107A,110N,115V,116A,120S,128D,148V,154K,159*,169F,178T,183S,187D,203R,208G,225S
GQ277176	PP_226_10	Botswana			genomic DNA	patient PP sampled 226 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,87Q,91L,95H,110N,115V,116A,120S,128D,148V,154K,169F,178T,183G,187D,203R,208G,225S
GQ277177	PP_226_11	Botswana			genomic DNA	patient PP sampled 226 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,43S,71D,83L,91L,95H,110N,115V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277178	PP_226_12	Botswana			genomic DNA	patient PP sampled 226 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,41T,71D,83L,91L,95H,115V,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277179	QA_006_01R	Botswana			genomic RNA	patient QA sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,171V,178T,180D,191I,207T,208G
GQ277180	QA_006_03R	Botswana			genomic RNA	patient QA sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,171V,178T,180D,191I,207T,208G
GQ277181	QA_006_04R	Botswana			genomic RNA	patient QA sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,171V,178T,180D,191I,207T,208G
GQ277182	QA_006_05R	Botswana			genomic RNA	patient QA sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,171V,178T,180D,191I,207T,208G
GQ277183	QA_006_06R	Botswana			genomic RNA	patient QA sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,171V,178T,180D,191I,207T,208G
GQ277184	QA_006_07R	Botswana			genomic RNA	patient QA sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,171V,178T,180D,191I,207T,208G
GQ277185	QA_006_08R	Botswana			genomic RNA	patient QA sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,171V,178T,180D,191I,207T,208G
GQ277186	QA_006_09R	Botswana			genomic RNA	patient QA sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,171V,178T,180D,191I,207T,208G
GQ277187	QA_006_10R	Botswana			genomic RNA	patient QA sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,171V,178T,180D,191I,207T,208G
GQ277188	QA_006_11R	Botswana			genomic RNA	patient QA sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,171V,178T,180D,191I,207T,208G
GQ277189	QA_006_12R	Botswana			genomic RNA	patient QA sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,171V,178T,180D,191I,207T,208G
GQ277190	QA_181_01	Botswana			genomic DNA	patient QA sampled 181 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,116A,120S,148V,154K,169F,171V,178T,180D,191I,207T,208G
GQ277191	QA_181_02	Botswana			genomic DNA	patient QA sampled 181 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,115V,116A,120S,128D,148V,154K,169F,171V,178T,180D,191I,207T,208G
GQ277192	QA_181_03	Botswana			genomic DNA	patient QA sampled 181 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,116A,120S,148V,154K,169F,171V,178T,180D,191I,207T,208G
GQ277193	QA_181_04	Botswana			genomic DNA	patient QA sampled 181 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,171V,178T,180D,191I,207T,208G
GQ277194	QA_181_05	Botswana			genomic DNA	patient QA sampled 181 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,171V,178T,180D,191I,207T,208G
GQ277195	QA_181_06	Botswana			genomic DNA	patient QA sampled 181 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,171V,178T,180D,191I,207T,208G
GQ277196	QA_181_07	Botswana			genomic DNA	patient QA sampled 181 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,171V,178T,180D,191I,207T,208G
GQ277197	QA_181_08	Botswana			genomic DNA	patient QA sampled 181 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,171V,178T,180D,191I,207T,208G
GQ277198	QA_389_01	Botswana			genomic DNA	patient QA sampled 389 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,171V,178T,180D,191I,207T,208G
GQ277199	QA_389_04	Botswana			genomic DNA	patient QA sampled 389 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,171V,178T,180D,191I,207T,208G
GQ277200	QA_389_06	Botswana			genomic DNA	patient QA sampled 389 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,171V,178T,180D,191I,207T,208G
GQ277201	QA_389_10	Botswana			genomic DNA	patient QA sampled 389 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,171V,178T,180D,191I,207T,208G
GQ277202	QA_389_11	Botswana			genomic DNA	patient QA sampled 389 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,116A,120S,148V,154K,169F,171V,178T,180D,191I,207T,208G
GQ277203	QA_389_12	Botswana			genomic DNA	patient QA sampled 389 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,171V,178T,180D,191I,207T,208G
GQ277204	QA_389_13	Botswana			genomic DNA	patient QA sampled 389 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,171V,178T,180D,191I,207T,208G
GQ277205	QA_389_14	Botswana			genomic DNA	patient QA sampled 389 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,171V,178T,180D,191I,207T,208G
GQ277206	QA_389_15	Botswana			genomic DNA	patient QA sampled 389 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,116A,120S,148V,154K,169F,171V,178T,180D,191I,207T,208G
GQ277207	QA_389_16	Botswana			genomic DNA	patient QA sampled 389 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,171V,178T,180D,191I,207T,208G
GQ277208	QA_389_17	Botswana			genomic DNA	patient QA sampled 389 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,71D,80*,83L,91V,116A,120S,128D,148V,154K,169F,171V,178T,180D,191I,207T,208G
GQ277209	QC_080_01	Botswana			genomic DNA	patient QC sampled 080 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6M,15L,27I,41T,50T,71D,83L,86A,91A,92P,93A,116A,120G,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ277210	QC_080_02	Botswana			genomic DNA	patient QC sampled 080 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6M,15L,27I,41T,50T,71D,83L,91A,92P,93A,116A,120G,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ277211	QC_080_03	Botswana			genomic DNA	patient QC sampled 080 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6M,15L,27I,41T,50T,71D,83L,86A,91A,92P,93A,116A,120G,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ277212	QC_080_04	Botswana			genomic DNA	patient QC sampled 080 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6M,15L,27I,41T,50T,71D,83L,86A,91A,92P,93A,116A,120G,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ277213	QC_080_05	Botswana			genomic DNA	patient QC sampled 080 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6M,15L,27I,41T,50T,71D,83L,86A,91A,92P,93A,116A,120G,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ277214	QC_080_06	Botswana			genomic DNA	patient QC sampled 080 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6M,15L,27I,41T,50T,71D,83L,86A,91A,92P,93A,116A,120G,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ277215	QC_080_08	Botswana			genomic DNA	patient QC sampled 080 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6M,15L,27I,41T,50T,71D,83L,91A,92P,93A,116A,120G,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ277216	QC_080_10	Botswana			genomic DNA	patient QC sampled 080 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6M,15L,27I,41T,50T,71D,83L,86A,91A,92P,93A,116A,120G,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ277217	QC_080_11	Botswana			genomic DNA	patient QC sampled 080 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6M,15L,27I,41T,50T,71D,83L,86A,91A,92P,93A,116A,120G,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ277218	QC_080_12	Botswana			genomic DNA	patient QC sampled 080 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6M,15L,27I,41T,50T,71D,83L,86A,91A,92P,93A,116A,120G,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ277219	QC_235_01	Botswana			genomic DNA	patient QC sampled 235 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6M,15L,27I,41T,50T,71D,83L,86T,91A,92P,93A,116A,120G,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ277220	QC_235_01R	Botswana			genomic RNA	patient QC sampled 235 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6M,15L,27I,41T,50T,71D,83L,86T,91A,92P,93A,116A,120G,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ277221	QC_235_02R	Botswana			genomic RNA	patient QC sampled 235 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6M,15L,27I,41T,50T,71D,83L,86T,91A,92P,93A,116A,120G,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ277222	QC_235_03R	Botswana			genomic RNA	patient QC sampled 235 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6M,15L,27I,41T,50T,71D,83L,86T,91A,92P,93A,116A,120G,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ277223	QC_235_04	Botswana			genomic DNA	patient QC sampled 235 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6M,15L,27I,41T,50T,71D,83L,86T,91A,92P,93A,116A,120G,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ277224	QC_235_04R	Botswana			genomic RNA	patient QC sampled 235 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6M,15L,27I,41T,50T,71D,83L,86T,91A,92P,93A,116A,120G,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ277225	QC_235_05	Botswana			genomic DNA	patient QC sampled 235 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6M,15L,27I,41T,50T,71D,83L,86T,91A,92P,93A,116A,120G,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ277226	QC_235_05R	Botswana			genomic RNA	patient QC sampled 235 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6M,15L,27I,41T,50T,71D,83L,86T,91A,92P,93A,116A,120G,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ277227	QC_235_06	Botswana			genomic DNA	patient QC sampled 235 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6M,15L,27I,41T,50T,71D,83L,86T,91A,92P,93A,100K,116A,120G,124V,128D,133*,148V,154K,169F,178T,180D,187D,203R,208G
GQ277228	QC_235_06R	Botswana			genomic RNA	patient QC sampled 235 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6M,15L,27I,41T,50T,71D,83L,86T,91A,92P,93A,116A,120G,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ277229	QC_235_07	Botswana			genomic DNA	patient QC sampled 235 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6M,15L,27I,41T,50T,71D,83L,86T,91A,92P,93A,116A,120G,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ277230	QC_235_07R	Botswana			genomic RNA	patient QC sampled 235 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6M,15L,27I,41T,50T,71D,83L,86T,91A,92P,93A,116A,120G,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ277231	QC_235_08	Botswana			genomic DNA	patient QC sampled 235 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6M,15L,27I,41T,50T,71D,83L,86T,91A,92P,93A,116A,120G,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ277232	QC_235_08R	Botswana			genomic RNA	patient QC sampled 235 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6M,15L,27I,41T,50T,71D,83L,86T,91A,92P,93A,116A,120G,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ277233	QC_235_09	Botswana			genomic DNA	patient QC sampled 235 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6M,15L,27I,41T,50T,71D,83L,86T,91A,92P,93A,116A,120G,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ277234	QC_235_09R	Botswana			genomic RNA	patient QC sampled 235 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6M,15L,27I,41T,50T,71D,83L,86T,91A,92P,93A,116A,120G,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ277235	QC_235_10	Botswana			genomic DNA	patient QC sampled 235 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6M,15L,27I,41T,50T,71D,83L,86T,91A,92P,93A,116A,120G,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ277236	QC_235_10R	Botswana			genomic RNA	patient QC sampled 235 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6M,15L,27I,41T,50T,71D,83L,86T,91A,92P,93A,116A,120G,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ277237	QC_235_11	Botswana			genomic DNA	patient QC sampled 235 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6M,15L,27I,41T,50T,71D,79D,83L,86A,91A,92P,93A,116A,120G,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ277238	QC_235_11R	Botswana			genomic RNA	patient QC sampled 235 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6M,15L,27I,41T,50T,71D,83L,86T,91A,92P,93A,116A,120G,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ277239	QC_235_12R	Botswana			genomic RNA	patient QC sampled 235 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6M,15L,27I,41T,50T,71D,83L,86T,91A,92P,93A,116A,120G,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ277240	QC_415_01R	Botswana			genomic RNA	patient QC sampled 415 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6M,15L,27I,41T,50T,71D,83L,86T,91A,92P,93A,116A,120G,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ277241	QC_415_02R	Botswana			genomic RNA	patient QC sampled 415 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6M,15L,27I,41T,50T,71D,83L,86T,91A,92P,93A,116A,120G,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ277242	QC_415_03R	Botswana			genomic RNA	patient QC sampled 415 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6M,15L,27I,41T,50T,71D,83L,86T,91A,92P,93A,116A,120G,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ277243	QC_415_04R	Botswana			genomic RNA	patient QC sampled 415 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6M,15L,27I,41T,50T,71D,83L,86T,91A,92P,93A,116A,120G,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ277244	QC_415_05R	Botswana			genomic RNA	patient QC sampled 415 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6M,15L,27I,41T,50T,71D,83L,86T,91A,92P,93A,116A,120G,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ277245	QC_415_06R	Botswana			genomic RNA	patient QC sampled 415 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6M,15L,27I,41T,50T,71D,83L,86T,91A,92P,93A,116A,120G,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ277246	QC_415_07R	Botswana			genomic RNA	patient QC sampled 415 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6M,15L,27I,41T,50T,71D,83L,86T,91A,92P,93A,106E,116A,120G,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G
GQ870957	QD	Botswana		QD_199_01R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ870958	QD	Botswana		QD_199_02R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ870959	QD	Botswana		QD_199_03R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ870960	QD	Botswana		QD_199_04R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ870961	QD	Botswana		QD_199_05R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ870962	QD	Botswana		QD_199_06R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ870963	QD	Botswana		QD_199_07R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ870964	QD	Botswana		QD_199_08R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ870965	QD	Botswana		QD_199_09R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ870966	QD	Botswana		QD_199_10R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ870967	QD	Botswana		QD_199_11R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ870968	QD	Botswana		QD_199_12R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ870969	QD	Botswana		QD_199_13R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ870970	QD	Botswana		QD_199_14R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ870971	QD	Botswana		QD_199_15R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ277247	QD_079_01R	Botswana			genomic RNA	patient QD sampled 079 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ277248	QD_079_02R	Botswana			genomic RNA	patient QD sampled 079 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ277249	QD_079_03R	Botswana			genomic RNA	patient QD sampled 079 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ277250	QD_079_04R	Botswana			genomic RNA	patient QD sampled 079 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ277251	QD_079_05R	Botswana			genomic RNA	patient QD sampled 079 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ277252	QD_079_07R	Botswana			genomic RNA	patient QD sampled 079 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ277253	QD_079_08R	Botswana			genomic RNA	patient QD sampled 079 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ277254	QD_079_09R	Botswana			genomic RNA	patient QD sampled 079 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ277255	QD_079_10R	Botswana			genomic RNA	patient QD sampled 079 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,73T,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ277256	QD_079_11R	Botswana			genomic RNA	patient QD sampled 079 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ277257	QD_079_12R	Botswana			genomic RNA	patient QD sampled 079 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ277258	QD_255_01	Botswana			genomic DNA	patient QD sampled 255 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,46E,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ277259	QD_255_01R	Botswana			genomic RNA	patient QD sampled 255 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ277260	QD_255_02	Botswana			genomic DNA	patient QD sampled 255 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ277261	QD_255_02R	Botswana			genomic RNA	patient QD sampled 255 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ277262	QD_255_03	Botswana			genomic DNA	patient QD sampled 255 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ277263	QD_255_03R	Botswana			genomic RNA	patient QD sampled 255 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ277264	QD_255_04	Botswana			genomic DNA	patient QD sampled 255 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ277265	QD_255_04R	Botswana			genomic RNA	patient QD sampled 255 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ277266	QD_255_05	Botswana			genomic DNA	patient QD sampled 255 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ277267	QD_255_05R	Botswana			genomic RNA	patient QD sampled 255 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ277268	QD_255_06	Botswana			genomic DNA	patient QD sampled 255 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ277269	QD_255_06R	Botswana			genomic RNA	patient QD sampled 255 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,40S,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ277270	QD_255_07	Botswana			genomic DNA	patient QD sampled 255 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ277271	QD_255_07R	Botswana			genomic RNA	patient QD sampled 255 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ277272	QD_255_08	Botswana			genomic DNA	patient QD sampled 255 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ277273	QD_255_08R	Botswana			genomic RNA	patient QD sampled 255 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ277274	QD_255_09	Botswana			genomic DNA	patient QD sampled 255 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ277275	QD_255_09R	Botswana			genomic RNA	patient QD sampled 255 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ277276	QD_255_10	Botswana			genomic DNA	patient QD sampled 255 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ277277	QD_255_10R	Botswana			genomic RNA	patient QD sampled 255 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ277278	QD_255_11	Botswana			genomic DNA	patient QD sampled 255 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ277279	QD_255_11R	Botswana			genomic RNA	patient QD sampled 255 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ277280	QD_255_12	Botswana			genomic DNA	patient QD sampled 255 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ277281	QD_255_12R	Botswana			genomic RNA	patient QD sampled 255 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ277282	QD_420_01	Botswana			genomic DNA	patient QD sampled 420 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ277283	QD_420_02	Botswana			genomic DNA	patient QD sampled 420 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ277284	QD_420_03	Botswana			genomic DNA	patient QD sampled 420 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ277285	QD_420_04	Botswana			genomic DNA	patient QD sampled 420 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ277286	QD_420_05	Botswana			genomic DNA	patient QD sampled 420 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ277287	QD_420_06	Botswana			genomic DNA	patient QD sampled 420 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ277288	QD_420_07	Botswana			genomic DNA	patient QD sampled 420 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ277289	QD_420_08	Botswana			genomic DNA	patient QD sampled 420 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ277290	QD_420_10	Botswana			genomic DNA	patient QD sampled 420 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83T,116A,128D,148V,154K,169F,178T,181I,187D,203R,208G
GQ277291	QG_048_01	Botswana			genomic DNA	patient QG sampled 048 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,79D,83M,116A,120S,128D,148V,154K,162K,169F,177S,178T,187D,203R,208G,225S
GQ277292	QG_229_01	Botswana			genomic DNA	patient QG sampled 229 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,79D,83M,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ277293	QG_229_02	Botswana			genomic DNA	patient QG sampled 229 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,79D,83M,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ277294	QG_229_03	Botswana			genomic DNA	patient QG sampled 229 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,60E,71D,79D,80*,83M,116A,120S,128D,148V,154K,169F,177S,178T,184*,187D,203R,208G,225S,229K
GQ277295	QG_415_01	Botswana			genomic DNA	patient QG sampled 415 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,79D,83M,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ277296	QG_415_02	Botswana			genomic DNA	patient QG sampled 415 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,79D,83M,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ277297	QG_415_03	Botswana			genomic DNA	patient QG sampled 415 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,79D,83M,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,225S
GQ870972	QI	Botswana		QI_476_01R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,210S
GQ870973	QI	Botswana		QI_476_02R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,210S
GQ870974	QI	Botswana		QI_476_03R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,210S
GQ870975	QI	Botswana		QI_476_04R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,210S
GQ870976	QI	Botswana		QI_476_05R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,210S
GQ870977	QI	Botswana		QI_476_06R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,210S
GQ870978	QI	Botswana		QI_476_07R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,210S
GQ870979	QI	Botswana		QI_476_08R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,210S
GQ870980	QI	Botswana		QI_476_09R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,210S
GQ277298	QI_020_01R	Botswana			genomic RNA	patient QI sampled 020 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,210S
GQ277299	QI_020_02R	Botswana			genomic RNA	patient QI sampled 020 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,210S
GQ277300	QI_020_03R	Botswana			genomic RNA	patient QI sampled 020 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,210S
GQ277301	QI_020_04R	Botswana			genomic RNA	patient QI sampled 020 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,210S
GQ277302	QI_020_05R	Botswana			genomic RNA	patient QI sampled 020 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,210S
GQ277303	QI_020_21R	Botswana			genomic RNA	patient QI sampled 020 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,210S
GQ277304	QI_020_22R	Botswana			genomic RNA	patient QI sampled 020 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6P,27I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,210S
GQ277305	QI_020_23R	Botswana			genomic RNA	patient QI sampled 020 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,210S
GQ277306	QI_020_25R	Botswana			genomic RNA	patient QI sampled 020 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,210S
GQ277307	QI_020_27R	Botswana			genomic RNA	patient QI sampled 020 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,210S
GQ277308	QI_204_01	Botswana			genomic DNA	patient QI sampled 204 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,210S
GQ277309	QI_204_02	Botswana			genomic DNA	patient QI sampled 204 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,210S
GQ277310	QI_204_03	Botswana			genomic DNA	patient QI sampled 204 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,210S
GQ277311	QI_204_04	Botswana			genomic DNA	patient QI sampled 204 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91A,116A,120S,127R,128D,148V,154K,159G,169F,170*,177S,178T,184*,187D,203R,208G,210S
GQ277312	QI_204_05	Botswana			genomic DNA	patient QI sampled 204 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,210S
GQ277313	QI_204_06	Botswana			genomic DNA	patient QI sampled 204 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,210S
GQ277314	QI_204_07	Botswana			genomic DNA	patient QI sampled 204 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,210S
GQ277315	QI_204_08	Botswana			genomic DNA	patient QI sampled 204 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,210S
GQ277316	QI_204_09	Botswana			genomic DNA	patient QI sampled 204 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,210S
GQ277317	QI_204_10	Botswana			genomic DNA	patient QI sampled 204 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,210S
GQ277318	QI_204_11	Botswana			genomic DNA	patient QI sampled 204 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,210S
GQ277319	QI_204_12	Botswana			genomic DNA	patient QI sampled 204 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,210S
GQ277320	QI_322_01	Botswana			genomic DNA	patient QI sampled 322 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,210S
GQ277321	QI_322_02	Botswana			genomic DNA	patient QI sampled 322 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,210S
GQ277322	QI_322_03	Botswana			genomic DNA	patient QI sampled 322 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,210S
GQ277323	QI_322_04	Botswana			genomic DNA	patient QI sampled 322 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,210S
GQ277324	QI_322_05	Botswana			genomic DNA	patient QI sampled 322 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,210S
GQ277325	QI_322_06	Botswana			genomic DNA	patient QI sampled 322 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,210S
GQ277326	QI_322_07	Botswana			genomic DNA	patient QI sampled 322 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,210S
GQ277327	QI_322_08	Botswana			genomic DNA	patient QI sampled 322 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91V,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,210S
GQ277328	QI_322_09	Botswana			genomic DNA	patient QI sampled 322 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,210S
GQ277329	QI_322_10	Botswana			genomic DNA	patient QI sampled 322 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,210S
GQ277330	QI_322_11	Botswana			genomic DNA	patient QI sampled 322 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,210S
GQ277331	QI_322_12	Botswana			genomic DNA	patient QI sampled 322 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,210S
GQ277332	QI_384_01R	Botswana			genomic RNA	patient QI sampled 384 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,91A,116A,120S,128D,148V,154K,169F,177S,178T,187D,203R,208G,210S
GQ870981	QJ	Botswana		QJ_071_01R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ870982	QJ	Botswana		QJ_071_02R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ870983	QJ	Botswana		QJ_071_03R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ870984	QJ	Botswana		QJ_071_04R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ870985	QJ	Botswana		QJ_071_05R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ870986	QJ	Botswana		QJ_071_06R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ870987	QJ	Botswana		QJ_071_07R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ870988	QJ	Botswana		QJ_071_08R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ870989	QJ	Botswana		QJ_071_09R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ870990	QJ	Botswana		QJ_071_10R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ870991	QJ	Botswana		QJ_071_11R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ870992	QJ	Botswana		QJ_071_12R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ870993	QJ	Botswana		QJ_071_13R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ870994	QJ	Botswana		QJ_071_14R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ870995	QJ	Botswana		QJ_256_01R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ870996	QJ	Botswana		QJ_256_02R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ870997	QJ	Botswana		QJ_256_03R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ870998	QJ	Botswana		QJ_256_04R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ870999	QJ	Botswana		QJ_256_05R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ871000	QJ	Botswana		QJ_256_06R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ871001	QJ	Botswana		QJ_256_07R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,123S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ871002	QJ	Botswana		QJ_256_08R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,123S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ871003	QJ	Botswana		QJ_256_09R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ871004	QJ	Botswana		QJ_256_10R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,123S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ871005	QJ	Botswana		QJ_256_11R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,123S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ871006	QJ	Botswana		QJ_256_12R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,123S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ871007	QJ	Botswana		QJ_256_13R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ871008	QJ	Botswana		QJ_256_14R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ871009	QJ	Botswana		QJ_256_15R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,123S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ871010	QJ	Botswana		QJ_256_16R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,123S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ871011	QJ	Botswana		QJ_256_17R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,123S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ871012	QJ	Botswana		QJ_256_18R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,123S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ871013	QJ	Botswana		QJ_256_19R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,123S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ871014	QJ	Botswana		QJ_256_20R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ871015	QJ	Botswana		QJ_471_01R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ871016	QJ	Botswana		QJ_471_02R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ871017	QJ	Botswana		QJ_471_03R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ871018	QJ	Botswana		QJ_471_04R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ871019	QJ	Botswana		QJ_471_05R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ871020	QJ	Botswana		QJ_471_07R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ871021	QJ	Botswana		QJ_471_08R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ871022	QJ	Botswana		QJ_471_09R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ871023	QJ	Botswana		QJ_471_10R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ871024	QJ	Botswana		QJ_471_11R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ871025	QJ	Botswana		QJ_471_12R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ871026	QJ	Botswana		QJ_471_13R	genomic RNA		subtype: C	1	231	6L,14P,27I,31G,33N,71D,83L,91V,116Q,120S,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ871027	QJ	Botswana		QJ_471_14R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ871028	QJ	Botswana		QJ_471_15R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ871029	QJ	Botswana		QJ_471_16R	genomic RNA		subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ277333	QJ_008_01R	Botswana			genomic RNA	patient QJ sampled 008 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ277334	QJ_008_02R	Botswana			genomic RNA	patient QJ sampled 008 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ277335	QJ_008_03R	Botswana			genomic RNA	patient QJ sampled 008 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ277336	QJ_008_04R	Botswana			genomic RNA	patient QJ sampled 008 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ277337	QJ_198_02	Botswana			genomic DNA	patient QJ sampled 198 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ277338	QJ_198_04	Botswana			genomic DNA	patient QJ sampled 198 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ277339	QJ_198_06	Botswana			genomic DNA	patient QJ sampled 198 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ277340	QJ_198_10	Botswana			genomic DNA	patient QJ sampled 198 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ277341	QJ_198_11	Botswana			genomic DNA	patient QJ sampled 198 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,53T,71D,83L,91V,116Q,120S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ277342	QJ_198_12	Botswana			genomic DNA	patient QJ sampled 198 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ277343	QJ_198_13	Botswana			genomic DNA	patient QJ sampled 198 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ277344	QJ_198_14	Botswana			genomic DNA	patient QJ sampled 198 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ277345	QJ_198_15	Botswana			genomic DNA	patient QJ sampled 198 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ277346	QJ_198_16	Botswana			genomic DNA	patient QJ sampled 198 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ277347	QJ_198_17	Botswana			genomic DNA	patient QJ sampled 198 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ277348	QJ_198_18	Botswana			genomic DNA	patient QJ sampled 198 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ277349	QJ_344_01	Botswana			genomic DNA	patient QJ sampled 344 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ277350	QJ_344_02	Botswana			genomic DNA	patient QJ sampled 344 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ277351	QJ_344_03	Botswana			genomic DNA	patient QJ sampled 344 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ277352	QJ_344_04	Botswana			genomic DNA	patient QJ sampled 344 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ277353	QJ_344_07	Botswana			genomic DNA	patient QJ sampled 344 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ277354	QJ_344_08	Botswana			genomic DNA	patient QJ sampled 344 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,115V,116Q,120S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ277355	QJ_344_09	Botswana			genomic DNA	patient QJ sampled 344 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ277356	QJ_344_10	Botswana			genomic DNA	patient QJ sampled 344 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,97*,116Q,120S,128D,141M,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ277357	QJ_344_11	Botswana			genomic DNA	patient QJ sampled 344 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ277358	QJ_344_12	Botswana			genomic DNA	patient QJ sampled 344 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,128D,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ277359	QJ_377_01R	Botswana			genomic RNA	patient QJ sampled 377 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ277360	QJ_377_03R	Botswana			genomic RNA	patient QJ sampled 377 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,31G,33N,71D,83L,91V,116Q,120S,148V,154K,169F,178T,203R,204G,207Q,208G,225S
GQ871030	QM	Botswana		QM_415_02	genomic DNA		subtype: C	1	231	6L,41T,54S,58A,71D,83L,96I,116A,128D,148V,154K,169F,178T,187D,188S,203R,208G,225S
GQ871031	QM	Botswana		QM_415_03	genomic DNA		subtype: C	1	231	6L,20V,37K,41T,54S,58A,71D,83L,96I,116A,128D,148V,154K,169F,178T,187D,188S,203R,208G,225S
GQ871032	QM	Botswana		QM_415_06	genomic DNA		subtype: C	1	231	6L,41T,54S,58A,71D,83L,96I,116A,128D,148V,154K,169F,178T,187D,188S,203R,208G,225S
GQ871033	QM	Botswana		QM_415_07	genomic DNA		subtype: C	1	231	6L,41T,54S,58A,71D,83L,96I,116A,128D,148V,154K,169F,178T,187D,188S,203R,208G,225S
GQ871034	QM	Botswana		QM_415_08	genomic DNA		subtype: C	1	231	6L,41T,54S,58A,71D,83L,96I,116A,128D,148V,154K,169F,178T,187D,188S,203R,208G,225S
GQ871035	QM	Botswana		QM_415_10	genomic DNA		subtype: C	1	231	6L,41T,54S,58A,71D,83L,96I,116A,128D,148V,154K,169F,178T,187D,188S,203R,208G,225S
GQ871036	QM	Botswana		QM_415_11	genomic DNA		subtype: C	1	231	6L,41T,54S,58A,71D,83L,96I,116A,128D,148V,154K,169F,178T,187D,188S,203R,208G,225S
GQ277361	QM_048_01	Botswana			genomic DNA	patient QM sampled 048 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,41T,54S,58A,71D,83L,96I,116A,128D,148V,154K,169F,178T,187D,188S,203R,208G,225S
GQ277362	QM_048_02	Botswana			genomic DNA	patient QM sampled 048 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,41T,54S,58A,71D,83L,96I,116A,128D,148V,154K,169F,178T,187D,188S,203R,208G,225S
GQ277363	QM_048_05	Botswana			genomic DNA	patient QM sampled 048 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,41T,54S,58A,71D,83L,96I,116A,128D,148V,154K,169F,178T,187D,188S,203R,208G,225S
GQ277364	QM_048_06	Botswana			genomic DNA	patient QM sampled 048 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,41T,54S,58A,71D,83L,96I,116A,128D,148V,154K,169F,178T,187D,188S,203R,208G,225S
GQ277365	QM_048_21	Botswana			genomic DNA	patient QM sampled 048 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,41T,54S,58A,71D,83L,96I,116A,128D,148V,154K,169F,178T,187D,188S,203R,208G,225S
GQ277366	QM_048_22	Botswana			genomic DNA	patient QM sampled 048 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,41T,54S,58A,71D,83L,96I,116A,128D,148V,154K,169F,178T,187D,188S,203R,208G,225S
GQ277367	QM_239_02	Botswana			genomic DNA	patient QM sampled 239 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,41T,54S,58A,71D,83L,96I,116A,128D,148V,154K,169F,178T,187D,188S,203R,208G,225S
GQ277368	QM_239_04	Botswana			genomic DNA	patient QM sampled 239 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,41T,54S,58A,71D,83L,96I,116A,128D,148V,154K,169F,178T,187D,188S,203R,208G,225S
GQ277369	QM_357_02	Botswana			genomic DNA	patient QM sampled 357 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,41T,54S,58A,71D,83L,96I,116A,128D,148V,154K,169F,178T,187D,188S,203R,208G,225S
GQ277370	QM_357_03	Botswana			genomic DNA	patient QM sampled 357 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,41T,54S,58A,71D,83L,96I,116A,128D,148V,154K,169F,178T,187D,188S,203R,208G,225S
GQ277371	QM_357_04	Botswana			genomic DNA	patient QM sampled 357 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,41T,54S,58A,71D,83L,96I,116A,128D,148V,154K,169F,178T,187D,188S,203R,208G,225S
GQ277372	QM_357_07	Botswana			genomic DNA	patient QM sampled 357 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,41T,54S,58A,71D,83L,96I,116A,128D,148V,154K,169F,178T,187D,188S,203R,208G,225S
GQ277373	QM_357_08	Botswana			genomic DNA	patient QM sampled 357 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,41T,54S,58A,71D,83L,96I,116A,128D,148V,154K,169F,178T,187D,188S,203R,208G,225S
GQ277374	QM_357_10	Botswana			genomic DNA	patient QM sampled 357 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,41T,54S,58A,71D,83L,96I,116A,128D,148V,154K,169F,178T,187D,188S,203R,208G,225S
GQ871037	QP	Botswana		QP_414_01	genomic DNA		subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,110N,111H,116A,118I,120G,148V,154K,169F,178T,183G,187D,191A,203R,208G,225S
GQ871038	QP	Botswana		QP_414_02	genomic DNA		subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,110N,111H,116A,118I,120G,148V,154K,169F,178T,183G,187D,191A,203R,208G,225S
GQ871039	QP	Botswana		QP_414_03	genomic DNA		subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,110N,111H,116A,118I,120G,148V,154K,169F,178T,183G,187D,191A,203R,208G,225S
GQ871040	QP	Botswana		QP_414_04	genomic DNA		subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,110N,111H,116A,118I,120G,148V,154K,169F,178T,183G,187D,191A,203R,208G,225S
GQ871041	QP	Botswana		QP_414_06	genomic DNA		subtype: C	1	231	6L,15L,31G,33T,71D,83L,91V,110N,111H,116A,118I,120G,148V,154K,169F,178T,183G,187D,191A,203R,208G,225S
GQ871042	QP	Botswana		QP_414_07	genomic DNA		subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,110N,111H,116A,118I,120G,148V,154K,169F,178T,183G,187D,191A,203R,208G,225S
GQ871043	QP	Botswana		QP_414_08	genomic DNA		subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,110N,111H,116A,118I,120G,148V,154K,169F,178T,183G,187D,191A,203R,208G,225S
GQ871044	QP	Botswana		QP_414_09	genomic DNA		subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,110N,111H,116A,118I,120G,148V,154K,169F,178T,183G,187D,191A,203R,208G,225S
GQ871045	QP	Botswana		QP_414_10	genomic DNA		subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,110N,111H,116A,118I,120G,148V,154K,169F,178T,183G,187D,191A,203R,208G,225S
GQ871046	QP	Botswana		QP_414_11	genomic DNA		subtype: C	1	231	6L,8K,10I,15L,23*,31S,33N,71D,79K,80*,83L,89R,91V,100K,106R,110N,111H,116A,117*,118I,120G,133*,137R,148V,154K,156R,169F,178T,183G,184*,187D,191A,203R,208E,225S
GQ871047	QP	Botswana		QP_414_12	genomic DNA		subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,110N,111H,116A,118I,120G,148V,154K,169F,178T,183G,187D,191A,203R,208G,225S
GQ871048	QP	Botswana		QP_414_13	genomic DNA		subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,110N,111H,116A,118I,120G,148V,154K,169F,178T,183G,187D,191A,203R,208G,225S
GQ871049	QP	Botswana		QP_414_14	genomic DNA		subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,110N,111H,116A,118I,120G,148V,154K,169F,178T,183G,187D,191A,203R,208G,225S
GQ277375	QP_048_01	Botswana			genomic DNA	patient QP sampled 048 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,110N,111H,116A,118I,120G,148V,154K,169F,178T,183G,187D,191A,203R,208G,225S
GQ277376	QP_048_02	Botswana			genomic DNA	patient QP sampled 048 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,110N,111H,116A,118I,120G,148V,154K,169F,178T,183G,187D,191A,203R,208G,225S
GQ277377	QP_048_03	Botswana			genomic DNA	patient QP sampled 048 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,110N,111H,116A,118I,120G,148V,154K,169F,178T,183G,187D,191A,203R,208G,225S
GQ277378	QP_048_04	Botswana			genomic DNA	patient QP sampled 048 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,110N,111H,116A,118I,120G,148V,154K,169F,178T,187D,203R,208G,225S
GQ277379	QP_048_06	Botswana			genomic DNA	patient QP sampled 048 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,110N,111H,116A,118I,120G,148V,154K,169F,178T,183G,187D,191A,203R,208G,225S
GQ275380	QP_048_07	Botswana			genomic RNA	patient A sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277380	QP_048_07	Botswana			genomic DNA	patient QP sampled 048 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,110N,111H,116A,118I,120G,148V,154K,169F,178T,183G,187D,191A,203R,208G,225S
GQ275381	QP_048_08	Botswana			genomic RNA	patient A sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,131R,148V,169F,178T,180G,187D,208G
GQ277381	QP_048_08	Botswana			genomic DNA	patient QP sampled 048 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,110N,111H,116A,118I,120G,148V,154K,169F,178T,183G,187D,191A,203R,208G,225S
GQ275382	QP_048_09	Botswana			genomic RNA	patient A sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277382	QP_048_09	Botswana			genomic DNA	patient QP sampled 048 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,110N,111H,113K,116A,118I,120G,148V,154K,169F,178T,183G,187D,191A,203R,208G,225S
GQ275383	QP_048_10	Botswana			genomic RNA	patient A sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277383	QP_048_10	Botswana			genomic DNA	patient QP sampled 048 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,110N,111H,116A,118I,120G,148V,154K,169F,178T,183G,187D,191A,203R,208G,225S
GQ275384	QP_048_11	Botswana			genomic RNA	patient A sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,97S,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277384	QP_048_11	Botswana			genomic DNA	patient QP sampled 048 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,110N,111H,116A,118I,120G,148V,154K,169F,178T,183G,187D,191A,203R,208G,225S
GQ275385	QP_232_01	Botswana			genomic RNA	patient A sampled 006 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277385	QP_232_01	Botswana			genomic DNA	patient QP sampled 232 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,110N,111H,116A,118I,120G,148V,154K,169F,178T,183G,184*,187D,191A,203R,208G,225S
GQ275386	QP_232_02	Botswana			genomic DNA	patient A sampled 022 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277386	QP_232_02	Botswana			genomic DNA	patient QP sampled 232 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,110N,111H,116A,118I,120G,148V,154K,169F,178T,183G,187D,191A,203R,208G,225S
GQ275387	QP_232_03	Botswana			genomic DNA	patient A sampled 022 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277387	QP_232_03	Botswana			genomic DNA	patient QP sampled 232 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,110N,111H,116A,118I,120G,148V,154K,169F,178T,183G,187D,191A,203R,208G,225S
GQ275388	QP_232_04	Botswana			genomic DNA	patient A sampled 022 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277388	QP_232_04	Botswana			genomic DNA	patient QP sampled 232 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,110N,111H,116A,118I,120G,148V,154K,169F,178T,183G,187D,191A,203R,208G,225S
GQ275389	QP_232_05	Botswana			genomic DNA	patient A sampled 022 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277389	QP_232_05	Botswana			genomic DNA	patient QP sampled 232 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,110N,111H,116A,118I,120G,148V,154K,169F,178T,183G,187D,191A,203R,208G,225S
GQ275390	QP_232_06	Botswana			genomic DNA	patient A sampled 022 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277390	QP_232_06	Botswana			genomic DNA	patient QP sampled 232 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,110N,111H,116A,118I,120G,148V,154K,169F,178T,183G,187D,191A,203R,208G,225S
GQ275391	QP_232_07	Botswana			genomic DNA	patient A sampled 022 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277391	QP_232_07	Botswana			genomic DNA	patient QP sampled 232 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,110N,111H,116A,118I,120G,148V,154K,169F,178T,183G,187D,191A,203R,208G,225S
GQ275392	QP_232_08	Botswana			genomic DNA	patient A sampled 022 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277392	QP_232_08	Botswana			genomic DNA	patient QP sampled 232 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,110N,111H,116A,118I,120G,148V,154K,169F,178T,183G,187D,191A,203R,208G,225S
GQ275393	QP_232_09	Botswana			genomic DNA	patient A sampled 022 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277393	QP_232_09	Botswana			genomic DNA	patient QP sampled 232 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,110N,111H,116A,118I,120G,148V,154K,169F,178T,183G,187D,191A,203R,208G,225S
GQ275394	QP_232_10	Botswana			genomic DNA	patient A sampled 022 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277394	QP_232_10	Botswana			genomic DNA	patient QP sampled 232 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,110N,111H,116A,118I,120G,148V,154K,169F,178T,183G,187D,191A,203R,208G,225S
GQ275395	QP_232_11	Botswana			genomic DNA	patient A sampled 022 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277395	QP_232_11	Botswana			genomic DNA	patient QP sampled 232 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,110N,111H,116A,118I,120G,148V,154K,169F,178T,183G,187D,191A,203R,208G,225S
GQ275396	QP_353_01	Botswana			genomic RNA	patient A sampled 027 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180G,187D,208G
GQ277396	QP_353_01	Botswana			genomic DNA	patient QP sampled 353 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,110N,111H,116A,118I,120G,127R,148V,154K,169F,178T,183G,187D,191A,203R,208G,225S
GQ275397	QP_353_03	Botswana			genomic RNA	patient A sampled 027 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92L,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277397	QP_353_03	Botswana			genomic DNA	patient QP sampled 353 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,110N,111H,116A,118I,120G,148V,154K,169F,178T,183G,187D,191A,203R,208G,225S
GQ275398	QP_353_04	Botswana			genomic RNA	patient A sampled 027 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277398	QP_353_04	Botswana			genomic DNA	patient QP sampled 353 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,110N,111H,116A,118I,120G,148V,154K,169F,178T,183G,187D,191A,203R,208G,225S
GQ275399	QP_353_05	Botswana			genomic RNA	patient A sampled 027 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277399	QP_353_05	Botswana			genomic DNA	patient QP sampled 353 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,110N,111H,116A,118I,120G,148V,154K,169F,178T,183G,187D,191A,203R,208G,225S
GQ275400	QP_353_07	Botswana			genomic RNA	patient A sampled 027 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277400	QP_353_07	Botswana			genomic DNA	patient QP sampled 353 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,110N,111H,116A,118I,120G,148V,154K,169F,178T,183G,187D,191A,203R,208G,225S
GQ275401	QP_353_08	Botswana			genomic RNA	patient A sampled 027 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277401	QP_353_08	Botswana			genomic DNA	patient QP sampled 353 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,110N,111H,116A,118I,120G,148V,154K,169F,178T,183G,187D,191A,203R,208G,225S
GQ275402	QP_353_09	Botswana			genomic RNA	patient A sampled 055 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277402	QP_353_09	Botswana			genomic DNA	patient QP sampled 353 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,110N,111H,116A,118I,120G,148V,154K,169F,178T,183G,187D,191A,203R,205V,208G,225S
GQ275403	QP_353_10	Botswana			genomic RNA	patient A sampled 055 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277403	QP_353_10	Botswana			genomic DNA	patient QP sampled 353 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,110N,111H,116A,118I,120G,148V,154K,169F,178T,183G,187D,191A,203R,208G,225S
GQ871050	QR	Botswana		QR_316_01	genomic DNA		subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ871051	QR	Botswana		QR_316_02	genomic DNA		subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ871052	QR	Botswana		QR_316_03	genomic DNA		subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ871053	QR	Botswana		QR_316_04	genomic DNA		subtype: C	1	231	6L,27I,41T,71D,79K,91V,96I,116A,120S,128D,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ871054	QR	Botswana		QR_316_05	genomic DNA		subtype: C	1	231	6L,27I,41T,71D,76K,91V,96I,116A,120S,128D,143K,148V,154K,169F,178T,187D,199R,208G,210S,213K,225S
GQ871055	QR	Botswana		QR_316_06	genomic DNA		subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ871056	QR	Botswana		QR_316_08	genomic DNA		subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ871057	QR	Botswana		QR_316_09	genomic DNA		subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128N,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ871058	QR	Botswana		QR_316_10	genomic DNA		subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128D,148V,154K,169F,178T,208G,210S,225S
GQ871059	QR	Botswana		QR_316_11	genomic DNA		subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ871060	QR	Botswana		QR_316_12	genomic DNA		subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ871061	QR	Botswana		QR_316_13	genomic DNA		subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ871062	QR	Botswana		QR_316_14	genomic DNA		subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ871063	QR	Botswana		QR_316_15	genomic DNA		subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ871064	QR	Botswana		QR_485_01R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ871065	QR	Botswana		QR_485_02R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ871066	QR	Botswana		QR_485_03R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ871067	QR	Botswana		QR_485_04R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ871068	QR	Botswana		QR_485_05R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ871069	QR	Botswana		QR_485_06R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ871070	QR	Botswana		QR_485_07R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ871071	QR	Botswana		QR_485_08R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ871072	QR	Botswana		QR_485_09R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ871073	QR	Botswana		QR_485_10R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ871074	QR	Botswana		QR_485_11R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ871075	QR	Botswana		QR_485_12R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128D,129T,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ871076	QR	Botswana		QR_485_13R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ871077	QR	Botswana		QR_485_14R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ871078	QR	Botswana		QR_485_15R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ871079	QR	Botswana		QR_485_16R	genomic RNA		subtype: C	1	231	6L,27I,41T,48A,71D,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ275404	QR_007_01	Botswana			genomic RNA	patient A sampled 055 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,140R,148V,169F,178T,180D,187D,208G
GQ277404	QR_007_01	Botswana			genomic DNA	patient QR sampled 007 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ275405	QR_007_02	Botswana			genomic RNA	patient A sampled 055 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,96T,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277405	QR_007_02	Botswana			genomic DNA	patient QR sampled 007 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,127E,128N,133*,148V,154K,169F,178T,187D,199R,208G,210S,225S,229K
GQ275406	QR_007_03	Botswana			genomic RNA	patient A sampled 055 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277406	QR_007_03	Botswana			genomic DNA	patient QR sampled 007 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ275407	QR_007_05	Botswana			genomic RNA	patient A sampled 055 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277407	QR_007_05	Botswana			genomic DNA	patient QR sampled 007 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ275408	QR_007_07	Botswana			genomic RNA	patient A sampled 083 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277408	QR_007_07	Botswana			genomic DNA	patient QR sampled 007 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ275409	QR_007_08	Botswana			genomic RNA	patient A sampled 083 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277409	QR_007_08	Botswana			genomic DNA	patient QR sampled 007 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ275410	QR_007_09	Botswana			genomic RNA	patient A sampled 083 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277410	QR_007_09	Botswana			genomic DNA	patient QR sampled 007 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ275411	QR_007_10	Botswana			genomic RNA	patient A sampled 083 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277411	QR_007_10	Botswana			genomic DNA	patient QR sampled 007 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ275412	QR_007_11	Botswana			genomic RNA	patient A sampled 083 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277412	QR_007_11	Botswana			genomic DNA	patient QR sampled 007 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ275413	QR_090_01R	Botswana			genomic DNA	patient A sampled 097 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277413	QR_090_01R	Botswana			genomic RNA	patient QR sampled 090 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ275414	QR_090_02R	Botswana			genomic DNA	patient A sampled 097 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277414	QR_090_02R	Botswana			genomic RNA	patient QR sampled 090 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ275415	QR_090_03R	Botswana			genomic DNA	patient A sampled 097 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277415	QR_090_03R	Botswana			genomic RNA	patient QR sampled 090 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ275416	QR_090_04R	Botswana			genomic DNA	patient A sampled 097 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277416	QR_090_04R	Botswana			genomic RNA	patient QR sampled 090 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ275417	QR_090_05R	Botswana			genomic DNA	patient A sampled 097 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277417	QR_090_05R	Botswana			genomic RNA	patient QR sampled 090 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ275418	QR_090_06R	Botswana			genomic DNA	patient A sampled 097 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277418	QR_090_06R	Botswana			genomic RNA	patient QR sampled 090 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ275419	QR_219_01	Botswana			genomic DNA	patient A sampled 097 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277419	QR_219_01	Botswana			genomic DNA	patient QR sampled 219 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ275420	QR_219_02	Botswana			genomic DNA	patient A sampled 097 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277420	QR_219_02	Botswana			genomic DNA	patient QR sampled 219 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ275421	QR_219_03	Botswana			genomic DNA	patient A sampled 097 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277421	QR_219_03	Botswana			genomic DNA	patient QR sampled 219 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ275422	QR_219_04	Botswana			genomic DNA	patient A sampled 097 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277422	QR_219_04	Botswana			genomic DNA	patient QR sampled 219 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ275423	QR_219_05	Botswana			genomic DNA	patient A sampled 097 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277423	QR_219_05	Botswana			genomic DNA	patient QR sampled 219 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ275424	QR_219_06	Botswana			genomic DNA	patient A sampled 097 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277424	QR_219_06	Botswana			genomic DNA	patient QR sampled 219 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128N,132K,133*,148V,154K,169F,178T,187D,199R,208G,210S,213K,215I,225S
GQ275425	QR_219_07	Botswana			genomic DNA	patient A sampled 097 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277425	QR_219_07	Botswana			genomic DNA	patient QR sampled 219 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ275426	QR_219_08	Botswana			genomic DNA	patient A sampled 097 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277426	QR_219_08	Botswana			genomic DNA	patient QR sampled 219 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ275427	QR_219_09	Botswana			genomic DNA	patient A sampled 097 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277427	QR_219_09	Botswana			genomic DNA	patient QR sampled 219 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ275428	QR_219_10	Botswana			genomic RNA	patient A sampled 111 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,19A,41T,50S,71D,83L,91N,92P,116A,117*,120S,128D,148V,169F,178T,180D,187D,208G
GQ277428	QR_219_10	Botswana			genomic DNA	patient QR sampled 219 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ275429	QR_219_11	Botswana			genomic RNA	patient A sampled 111 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,198R,208G
GQ277429	QR_219_11	Botswana			genomic DNA	patient QR sampled 219 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ275430	QR_219_12	Botswana			genomic RNA	patient A sampled 111 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277430	QR_219_12	Botswana			genomic DNA	patient QR sampled 219 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,91V,98K,116A,120S,128D,133*,143K,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ275431	QR_219_13	Botswana			genomic RNA	patient A sampled 111 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277431	QR_219_13	Botswana			genomic DNA	patient QR sampled 219 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,91V,116A,120S,128D,148V,154K,169F,178T,187D,199R,208G,210S,225S
GQ871080	QS	Botswana		QS_169_01	genomic DNA		subtype: C	1	231	6L,21S,27I,41T,71D,83L,86I,91V,116A,120S,124V,128D,148V,169F,178T,180D,203R,208G
GQ871081	QS	Botswana		QS_169_02	genomic DNA		subtype: C	1	231	6L,27I,41T,71D,83L,86I,91V,116T,120S,124V,128D,148V,149I,169F,178T,180D,203R,208G
GQ871082	QS	Botswana		QS_169_03	genomic DNA		subtype: C	1	231	6L,27I,41T,70T,71D,83L,86I,91V,116T,120S,124V,128D,148V,169F,178T,180D,203R,208G
GQ871083	QS	Botswana		QS_169_04	genomic DNA		subtype: C	1	231	6L,21S,27I,41T,71D,83L,86I,91V,116A,120S,124V,128D,148V,169F,178T,180D,203R,208G
GQ871084	QS	Botswana		QS_169_06	genomic DNA		subtype: C	1	231	6L,27I,41T,71D,83L,86I,91V,116T,120S,124V,128D,148V,169F,178T,180D,203R,208G
GQ871085	QS	Botswana		QS_351_01	genomic DNA		subtype: C	1	231	6L,21S,27I,41T,71D,83L,86I,91V,116A,120S,124V,128D,148V,169F,178T,180D,203R,208G
GQ871086	QS	Botswana		QS_351_02	genomic DNA		subtype: C	1	231	6L,15M,21S,27I,41T,71D,83L,86I,91V,112H,116A,120S,124V,128D,148V,169F,178T,180D,203R,208G
GQ871087	QS	Botswana		QS_351_03	genomic DNA		subtype: C	1	231	6L,15M,21S,27I,41T,71D,83L,86I,91V,112H,116A,120S,124V,128D,148V,169F,178T,180D,203R,208G
GQ871088	QS	Botswana		QS_351_04	genomic DNA		subtype: C	1	231	6L,15M,21S,27I,41T,71D,83L,86I,91V,112H,116A,120S,124V,128D,148V,169F,178T,180D,203R,208G
GQ871089	QS	Botswana		QS_351_06	genomic DNA		subtype: C	1	231	6L,15M,21S,27I,41T,71D,83L,86I,91V,112H,116A,120S,124V,128D,148V,169F,178T,180D,203R,208G
GQ871090	QS	Botswana		QS_351_07	genomic DNA		subtype: C	1	231	6L,21I,27I,41T,71D,83L,86I,91V,116A,120S,124V,128D,148V,169F,178T,180D,203R,208G
GQ871091	QS	Botswana		QS_351_10	genomic DNA		subtype: C	1	231	6L,21S,27I,41T,71D,83L,86I,91V,116A,120S,124V,128D,148V,169F,178T,180D,203R,208G
GQ871092	QS	Botswana		QS_351_11	genomic DNA		subtype: C	1	231	6L,21S,27I,41T,71D,83L,86I,91V,115V,116A,120S,124V,128D,148V,169F,178T,180D,203R,208G
GQ871093	QS	Botswana		QS_351_14	genomic DNA		subtype: C	1	231	6L,21S,27I,41T,71D,83L,86I,91V,116A,120S,124V,128D,148V,169F,178T,180D,203R,208G
GQ871094	QS	Botswana		QS_351_15	genomic DNA		subtype: C	1	231	6L,15M,21S,27I,41T,71D,83L,86I,91V,112H,116A,120S,124V,128D,148V,169F,178T,180D,203R,208G
GQ871095	QS	Botswana		QS_351_16	genomic DNA		subtype: C	1	231	6L,15M,21S,27I,41T,71D,83L,86I,91V,112H,116A,120S,124V,128D,148V,169F,178T,180D,203R,208G
GQ275432	QS_044_01	Botswana			genomic RNA	patient A sampled 111 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,97G,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277432	QS_044_01	Botswana			genomic DNA	patient QS sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,86I,91V,116T,120S,124V,128D,148V,169F,178T,180D,203R,208G
GQ275433	QS_044_02	Botswana			genomic RNA	patient A sampled 111 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277433	QS_044_02	Botswana			genomic DNA	patient QS sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,86I,91V,116T,120S,124V,128D,148V,169F,178T,180D,203R,208G
GQ275434	QS_044_03	Botswana			genomic RNA	patient A sampled 147 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,54A,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,206E,208G
GQ277434	QS_044_03	Botswana			genomic DNA	patient QS sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,86I,91V,116T,120S,124V,128D,148V,169F,178T,180D,203R,208G
GQ275435	QS_044_04	Botswana			genomic RNA	patient A sampled 147 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277435	QS_044_04	Botswana			genomic DNA	patient QS sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,86I,91V,116T,120S,124V,128D,148V,169F,178T,180D,203R,208G
GQ275436	QS_044_05	Botswana			genomic RNA	patient A sampled 147 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277436	QS_044_05	Botswana			genomic DNA	patient QS sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,86I,91V,116T,120S,124V,128D,148V,169F,178T,180D,203R,208G
GQ275437	QS_044_08	Botswana			genomic RNA	patient A sampled 147 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277437	QS_044_08	Botswana			genomic DNA	patient QS sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,86I,91V,116T,120S,124V,128D,148V,169F,178T,180D,203R,208G
GQ275438	QS_044_09	Botswana			genomic RNA	patient A sampled 147 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277438	QS_044_09	Botswana			genomic DNA	patient QS sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,86I,91V,116T,120S,124V,128D,148V,169F,178T,180D,203R,208G
GQ275439	QS_044_10	Botswana			genomic DNA	patient A sampled 266 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,39R,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277439	QS_044_10	Botswana			genomic DNA	patient QS sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,86I,91V,116T,120S,124V,128D,148V,169F,178T,180D,203R,208G
GQ275440	QS_232_01	Botswana			genomic DNA	patient A sampled 266 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277440	QS_232_01	Botswana			genomic DNA	patient QS sampled 232 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,21S,27I,41T,71D,83L,86I,91V,116A,120S,124V,128D,148V,169F,178T,180D,203R,208G
GQ275441	QS_232_02	Botswana			genomic DNA	patient A sampled 266 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277441	QS_232_02	Botswana			genomic DNA	patient QS sampled 232 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,86I,91V,116T,120S,124V,128D,148V,169F,178T,180D,203R,208G
GQ275442	QS_232_03	Botswana			genomic DNA	patient A sampled 266 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277442	QS_232_03	Botswana			genomic DNA	patient QS sampled 232 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,21S,27I,41T,71D,83L,86I,91V,116A,120S,124V,128D,148V,169F,178T,180D,203R,208G
GQ275443	QS_292_02	Botswana			genomic DNA	patient A sampled 266 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277443	QS_292_02	Botswana			genomic DNA	patient QS sampled 292 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,21S,27I,41T,71D,83L,86I,91V,116N,120S,124V,128D,148V,169F,178T,180D,203R,208G
GQ275444	QS_292_03	Botswana			genomic DNA	patient A sampled 266 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277444	QS_292_03	Botswana			genomic DNA	patient QS sampled 292 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,21S,23*,27I,41T,71D,80*,83L,86I,91V,100K,116A,120S,124V,128D,133*,148V,169F,178T,180D,203R,208E
GQ275445	QS_292_04	Botswana			genomic DNA	patient A sampled 356 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,184*,187D,208G,220R
GQ277445	QS_292_04	Botswana			genomic DNA	patient QS sampled 292 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,21S,23*,27I,41T,71D,80*,83L,86I,116N,117*,120S,124V,128D,137R,148V,169F,178T,180D,203R,208E
GQ275446	QS_292_05	Botswana			genomic DNA	patient A sampled 356 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277446	QS_292_05	Botswana			genomic DNA	patient QS sampled 292 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,21S,27I,41T,71D,83L,86I,116N,120S,124V,128D,148V,169F,178T,180D,203R,208G
GQ275447	QS_292_06	Botswana			genomic DNA	patient A sampled 356 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277447	QS_292_06	Botswana			genomic DNA	patient QS sampled 292 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,21S,27I,41T,71D,83L,86I,91V,116A,120S,124V,128D,148V,169F,178T,180D,203R,208G
GQ275448	QS_292_07	Botswana			genomic DNA	patient A sampled 356 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6P,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277448	QS_292_07	Botswana			genomic DNA	patient QS sampled 292 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,86I,91V,116T,120S,124V,128D,148V,169F,178T,180D,203R,208G
GQ871096	QT	Botswana		QT_137_01R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ871097	QT	Botswana		QT_137_02R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ871098	QT	Botswana		QT_137_03R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ871099	QT	Botswana		QT_137_04R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ871100	QT	Botswana		QT_137_05R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ871101	QT	Botswana		QT_137_06R	genomic RNA		subtype: C	1	231	6L,27I,35A,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,153M,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ871102	QT	Botswana		QT_137_07R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ871103	QT	Botswana		QT_137_08R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,215I,225S
GQ871104	QT	Botswana		QT_137_09R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ871105	QT	Botswana		QT_137_10R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ871106	QT	Botswana		QT_137_11R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ871107	QT	Botswana		QT_289_01R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ871108	QT	Botswana		QT_289_02R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ871109	QT	Botswana		QT_289_03R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ871110	QT	Botswana		QT_289_04R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ871111	QT	Botswana		QT_289_05R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ871112	QT	Botswana		QT_289_06R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ871113	QT	Botswana		QT_289_07R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ871114	QT	Botswana		QT_289_08R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,143K,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ871115	QT	Botswana		QT_289_09R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169L,178T,180D,187D,200I,203R,204G,208G,225S
GQ871116	QT	Botswana		QT_289_10R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ871117	QT	Botswana		QT_289_11R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ871118	QT	Botswana		QT_289_12R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ871119	QT	Botswana		QT_289_13R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ871120	QT	Botswana		QT_289_14R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ871121	QT	Botswana		QT_289_15R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ871122	QT	Botswana		QT_289_16R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ871123	QT	Botswana		QT_289_17R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ871124	QT	Botswana		QT_289_18R	genomic RNA		subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ275449	QT_044_01R	Botswana			genomic DNA	patient A sampled 356 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277449	QT_044_01R	Botswana			genomic RNA	patient QT sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ275450	QT_044_02R	Botswana			genomic DNA	patient A sampled 356 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277450	QT_044_02R	Botswana			genomic RNA	patient QT sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ275451	QT_044_04R	Botswana			genomic DNA	patient A sampled 356 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277451	QT_044_04R	Botswana			genomic RNA	patient QT sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ275452	QT_044_05R	Botswana			genomic DNA	patient A sampled 356 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6H,14P,17A,41T,50S,71D,83L,91N,92P,116A,120S,128D,148V,169F,178T,180D,187D,208G
GQ277452	QT_044_05R	Botswana			genomic RNA	patient QT sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ275453	QT_044_06R	Botswana			genomic DNA	patient B sampled 010 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277453	QT_044_06R	Botswana			genomic RNA	patient QT sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ275454	QT_044_07R	Botswana			genomic DNA	patient B sampled 010 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277454	QT_044_07R	Botswana			genomic RNA	patient QT sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ275455	QT_044_08R	Botswana			genomic DNA	patient B sampled 010 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277455	QT_044_08R	Botswana			genomic RNA	patient QT sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ275456	QT_044_09R	Botswana			genomic DNA	patient B sampled 010 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277456	QT_044_09R	Botswana			genomic RNA	patient QT sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ275457	QT_044_10R	Botswana			genomic DNA	patient B sampled 010 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277457	QT_044_10R	Botswana			genomic RNA	patient QT sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ275458	QT_044_11R	Botswana			genomic DNA	patient B sampled 010 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277458	QT_044_11R	Botswana			genomic RNA	patient QT sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ275459	QT_044_12R	Botswana			genomic DNA	patient B sampled 010 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277459	QT_044_12R	Botswana			genomic RNA	patient QT sampled 044 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ275460	QT_228_01	Botswana			genomic DNA	patient B sampled 010 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277460	QT_228_01	Botswana			genomic DNA	patient QT sampled 228 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ275461	QT_228_02	Botswana			genomic DNA	patient B sampled 010 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277461	QT_228_02	Botswana			genomic DNA	patient QT sampled 228 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ275462	QT_228_03	Botswana			genomic DNA	patient B sampled 018 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277462	QT_228_03	Botswana			genomic DNA	patient QT sampled 228 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ275463	QT_228_04	Botswana			genomic DNA	patient B sampled 018 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277463	QT_228_04	Botswana			genomic DNA	patient QT sampled 228 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ275464	QT_228_05	Botswana			genomic DNA	patient B sampled 074 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277464	QT_228_05	Botswana			genomic DNA	patient QT sampled 228 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ275465	QT_228_06	Botswana			genomic RNA	patient B sampled 074 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277465	QT_228_06	Botswana			genomic DNA	patient QT sampled 228 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ275466	QT_228_07	Botswana			genomic RNA	patient B sampled 074 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277466	QT_228_07	Botswana			genomic DNA	patient QT sampled 228 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ275467	QT_228_08	Botswana			genomic RNA	patient B sampled 074 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277467	QT_228_08	Botswana			genomic DNA	patient QT sampled 228 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ275468	QT_228_09	Botswana			genomic RNA	patient B sampled 074 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277468	QT_228_09	Botswana			genomic DNA	patient QT sampled 228 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ275469	QT_228_10	Botswana			genomic RNA	patient B sampled 074 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277469	QT_228_10	Botswana			genomic DNA	patient QT sampled 228 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ275470	QT_228_11	Botswana			genomic RNA	patient B sampled 074 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277470	QT_228_11	Botswana			genomic DNA	patient QT sampled 228 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ275471	QT_228_12	Botswana			genomic RNA	patient B sampled 074 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277471	QT_228_12	Botswana			genomic DNA	patient QT sampled 228 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ275472	QT_228_13	Botswana			genomic RNA	patient B sampled 074 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277472	QT_228_13	Botswana			genomic DNA	patient QT sampled 228 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ275473	QT_349_01R	Botswana			genomic RNA	patient B sampled 074 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277473	QT_349_01R	Botswana			genomic RNA	patient QT sampled 349 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ275474	QT_349_02R	Botswana			genomic RNA	patient B sampled 074 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277474	QT_349_02R	Botswana			genomic RNA	patient QT sampled 349 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ275475	QT_349_03R	Botswana			genomic RNA	patient B sampled 074 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277475	QT_349_03R	Botswana			genomic RNA	patient QT sampled 349 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ275476	QT_349_04R	Botswana			genomic RNA	patient B sampled 074 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277476	QT_349_04R	Botswana			genomic RNA	patient QT sampled 349 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ275477	QT_349_07R	Botswana			genomic RNA	patient B sampled 074 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277477	QT_349_07R	Botswana			genomic RNA	patient QT sampled 349 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ275478	QT_349_21R	Botswana			genomic RNA	patient B sampled 074 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277478	QT_349_21R	Botswana			genomic RNA	patient QT sampled 349 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,68L,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ275479	QT_349_23R	Botswana			genomic RNA	patient B sampled 074 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277479	QT_349_23R	Botswana			genomic RNA	patient QT sampled 349 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ275480	QT_349_24R	Botswana			genomic RNA	patient B sampled 074 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277480	QT_349_24R	Botswana			genomic RNA	patient QT sampled 349 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ275481	QT_349_25R	Botswana			genomic RNA	patient B sampled 074 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277481	QT_349_25R	Botswana			genomic RNA	patient QT sampled 349 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	1S,6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ275482	QT_349_26R	Botswana			genomic RNA	patient B sampled 074 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277482	QT_349_26R	Botswana			genomic RNA	patient QT sampled 349 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ275483	QT_349_27R	Botswana			genomic RNA	patient B sampled 074 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277483	QT_349_27R	Botswana			genomic RNA	patient QT sampled 349 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,71D,83L,87P,91V,96I,98D,116T,120S,128D,136M,148V,154K,169F,178T,180D,187D,200I,203R,204G,208G,225S
GQ871125	QU	Botswana		QU_114_01R	genomic RNA		subtype: C	1	231	6L,15L,16A,27I,41T,71D,83L,87Q,91V,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,225S
GQ871126	QU	Botswana		QU_114_02R	genomic RNA		subtype: C	1	231	6L,15L,16A,27I,41T,71D,83L,87Q,91V,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,225S
GQ871127	QU	Botswana		QU_114_03R	genomic RNA		subtype: C	1	231	6L,15L,16A,27I,41T,71D,83L,87Q,91V,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,225S
GQ871128	QU	Botswana		QU_114_04R	genomic RNA		subtype: C	1	231	6L,15L,16A,27I,41T,71D,83L,87Q,91V,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,225S
GQ871129	QU	Botswana		QU_114_05R	genomic RNA		subtype: C	1	231	6L,15L,16A,27I,41T,71D,83L,87Q,91V,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,225S
GQ871130	QU	Botswana		QU_114_06R	genomic RNA		subtype: C	1	231	6L,15L,16A,27I,41T,71D,83L,87Q,91V,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,225S
GQ871131	QU	Botswana		QU_114_07R	genomic RNA		subtype: C	1	231	6L,15L,16A,27I,41T,71D,83L,87Q,91V,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,225S
GQ871132	QU	Botswana		QU_114_08R	genomic RNA		subtype: C	1	231	6L,15L,16A,27I,41T,71D,83L,87Q,91V,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,225S
GQ871133	QU	Botswana		QU_114_09R	genomic RNA		subtype: C	1	231	6L,15L,16A,27I,41T,71D,83L,87Q,91V,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,225S
GQ871134	QU	Botswana		QU_114_10R	genomic RNA		subtype: C	1	231	6L,15L,16A,27I,41T,71D,83L,87Q,91V,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,225S
GQ871135	QU	Botswana		QU_114_11R	genomic RNA		subtype: C	1	231	6L,15L,16A,27I,41T,71D,83L,87Q,91V,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,225S
GQ871136	QU	Botswana		QU_114_12R	genomic RNA		subtype: C	1	231	6L,15L,16A,27I,41T,71D,83L,87Q,91V,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,225S
GQ871137	QU	Botswana		QU_114_13R	genomic RNA		subtype: C	1	231	6L,15L,16A,27I,41T,71D,83L,87Q,91V,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,225S
GQ871138	QU	Botswana		QU_114_14R	genomic RNA		subtype: C	1	231	6L,15L,16A,27I,41T,71D,83L,87Q,91V,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,225S
GQ275484	QU_084_01R	Botswana			genomic RNA	patient B sampled 074 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277484	QU_084_01R	Botswana			genomic RNA	patient QU sampled 084 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,16A,27I,41T,71D,83L,87Q,91V,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,225S
GQ275485	QU_084_02R	Botswana			genomic DNA	patient B sampled 103 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,110N,112G,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277485	QU_084_02R	Botswana			genomic RNA	patient QU sampled 084 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,16A,27I,41T,71D,83L,87Q,91V,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,225S
GQ275486	QU_084_03R	Botswana			genomic DNA	patient B sampled 103 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,31G,33N,71D,83L,91V,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277486	QU_084_03R	Botswana			genomic RNA	patient QU sampled 084 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,16A,27I,41T,71D,83L,87Q,91V,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,225S
GQ275487	QU_084_04R	Botswana			genomic DNA	patient B sampled 103 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277487	QU_084_04R	Botswana			genomic RNA	patient QU sampled 084 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,16A,27I,41T,71D,83L,87Q,91V,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,225S
GQ275488	QU_084_05R	Botswana			genomic DNA	patient B sampled 103 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277488	QU_084_05R	Botswana			genomic RNA	patient QU sampled 084 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,16A,27I,41T,71D,83L,87Q,91V,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,225S
GQ275489	QU_084_06R	Botswana			genomic DNA	patient B sampled 103 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277489	QU_084_06R	Botswana			genomic RNA	patient QU sampled 084 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,16A,27I,41T,71D,83L,87Q,91V,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,225S
GQ275490	QU_084_07R	Botswana			genomic DNA	patient B sampled 103 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277490	QU_084_07R	Botswana			genomic RNA	patient QU sampled 084 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,16A,27I,41T,71D,83L,87Q,91V,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,225S
GQ275491	QU_084_08R	Botswana			genomic DNA	patient B sampled 103 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,110N,112G,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277491	QU_084_08R	Botswana			genomic RNA	patient QU sampled 084 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,16A,27I,41T,71D,83L,87Q,91V,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,225S
GQ275492	QU_084_09R	Botswana			genomic DNA	patient B sampled 103 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277492	QU_084_09R	Botswana			genomic RNA	patient QU sampled 084 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,16A,27I,41T,71D,83L,87Q,91V,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,225S
GQ275493	QU_084_10R	Botswana			genomic DNA	patient B sampled 103 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,31G,33N,71D,83L,91V,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277493	QU_084_10R	Botswana			genomic RNA	patient QU sampled 084 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,16A,27I,41T,61E,71N,83L,87Q,91V,97K,98K,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,225S
GQ275494	QU_084_11R	Botswana			genomic DNA	patient B sampled 103 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,27I,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277494	QU_084_11R	Botswana			genomic RNA	patient QU sampled 084 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,16A,27I,41T,71D,83L,87Q,91V,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,225S
GQ275495	QU_174_01R	Botswana			genomic DNA	patient B sampled 103 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277495	QU_174_01R	Botswana			genomic RNA	patient QU sampled 174 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,16A,27I,41T,71D,83L,87Q,91V,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,225S
GQ275496	QU_174_02R	Botswana			genomic DNA	patient B sampled 103 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277496	QU_174_02R	Botswana			genomic RNA	patient QU sampled 174 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,16A,27I,41T,71D,83L,87Q,91V,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,225S
GQ275497	QU_174_03R	Botswana			genomic DNA	patient B sampled 103 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277497	QU_174_03R	Botswana			genomic RNA	patient QU sampled 174 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,16A,27I,41T,71D,83L,87Q,91V,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,225S
GQ275498	QU_174_05R	Botswana			genomic DNA	patient B sampled 103 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277498	QU_174_05R	Botswana			genomic RNA	patient QU sampled 174 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,16A,27I,41T,71D,83L,87Q,91V,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,225S
GQ275499	QU_174_06R	Botswana			genomic DNA	patient B sampled 103 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277499	QU_174_06R	Botswana			genomic RNA	patient QU sampled 174 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,16A,27I,41T,71D,83L,87Q,91V,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,225S
GQ275500	QU_174_07R	Botswana			genomic DNA	patient B sampled 103 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277500	QU_174_07R	Botswana			genomic RNA	patient QU sampled 174 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,16A,27I,41T,71D,83L,87Q,91V,116A,120S,128D,148V,154K,169F,178T,185I,187D,203R,208G,225S
GQ275501	QU_174_08R	Botswana			genomic DNA	patient B sampled 164 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277501	QU_174_08R	Botswana			genomic RNA	patient QU sampled 174 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,16A,27I,41T,71D,83L,87Q,91V,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,225S
GQ275502	QU_174_09R	Botswana			genomic DNA	patient B sampled 164 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277502	QU_174_09R	Botswana			genomic RNA	patient QU sampled 174 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,16A,27I,41T,71D,83L,87Q,91V,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,225S
GQ275503	QU_266_01	Botswana			genomic DNA	patient B sampled 164 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277503	QU_266_01	Botswana			genomic DNA	patient QU sampled 266 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,16A,27I,41T,71D,83L,87Q,91V,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,225S
GQ275504	QU_266_02	Botswana			genomic DNA	patient B sampled 164 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,31G,33N,71D,83L,91V,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277504	QU_266_02	Botswana			genomic DNA	patient QU sampled 266 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,16A,27I,41T,71D,83L,87Q,91V,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,225S
GQ275505	QU_266_03	Botswana			genomic DNA	patient B sampled 164 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277505	QU_266_03	Botswana			genomic DNA	patient QU sampled 266 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,16A,27I,41T,71D,83L,87Q,91V,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,225S
GQ275506	QU_266_04	Botswana			genomic DNA	patient B sampled 164 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277506	QU_266_04	Botswana			genomic DNA	patient QU sampled 266 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,16A,27I,41T,71D,83L,87Q,91V,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,225S
GQ275507	QU_266_05	Botswana			genomic DNA	patient B sampled 164 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277507	QU_266_05	Botswana			genomic DNA	patient QU sampled 266 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,16A,27I,41T,71D,83L,87Q,91V,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,225S
GQ275508	QU_266_06	Botswana			genomic DNA	patient B sampled 164 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277508	QU_266_06	Botswana			genomic DNA	patient QU sampled 266 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,16A,27I,41T,71D,83L,87Q,91V,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,225S
GQ275509	QU_266_07	Botswana			genomic DNA	patient B sampled 164 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,31G,33N,71D,83L,91V,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277509	QU_266_07	Botswana			genomic DNA	patient QU sampled 266 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,16A,27I,41T,71D,83L,87Q,91V,97K,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,214I,215I,225S
GQ275510	QU_266_08	Botswana			genomic DNA	patient B sampled 164 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,31G,33N,71D,83L,91V,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277510	QU_266_08	Botswana			genomic DNA	patient QU sampled 266 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,16A,27I,41T,71D,83L,87Q,91V,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,225S
GQ275511	QU_266_10	Botswana			genomic DNA	patient B sampled 164 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277511	QU_266_10	Botswana			genomic DNA	patient QU sampled 266 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,16A,27I,41T,71D,83L,87Q,91V,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,225S
GQ275512	QU_266_12	Botswana			genomic DNA	patient B sampled 164 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,132K,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277512	QU_266_12	Botswana			genomic DNA	patient QU sampled 266 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,16A,27I,41T,71D,83L,87Q,91V,116A,120S,128D,148V,154K,169F,178T,187D,203R,208G,225S
GQ375107	RA	Botswana	07-Nov-2008	RA_328_01R	genomic RNA		sampled approximately 328 days afterseroconversion;subtype: C	1	231	6L,15L,27I,41T,50T,71D,83L,110N,115V,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ375108	RA	Botswana	07-Nov-2008	RA_328_02R	genomic RNA		sampled approximately 328 days afterseroconversion;subtype: C	1	231	6L,14P,27I,41T,50T,71D,83L,110N,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ375109	RA	Botswana	07-Nov-2008	RA_328_03R	genomic RNA		sampled approximately 328 days afterseroconversion;subtype: C	1	231	6L,14P,27I,41T,50T,71D,83L,110N,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ375110	RA	Botswana	07-Nov-2008	RA_328_04R	genomic RNA		sampled approximately 328 days afterseroconversion;subtype: C	1	231	6L,14P,27I,41T,50T,71D,83L,110N,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ375111	RA	Botswana	07-Nov-2008	RA_328_05R	genomic RNA		sampled approximately 328 days afterseroconversion;subtype: C	1	231	6L,14P,17A,27I,41T,50T,71D,83L,110N,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ375112	RA	Botswana	07-Nov-2008	RA_328_06R	genomic RNA		sampled approximately 328 days afterseroconversion;subtype: C	1	231	6L,14P,17A,27I,41T,50T,71D,83L,110N,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ375113	RA	Botswana	07-Nov-2008	RA_328_07R	genomic RNA		sampled approximately 328 days afterseroconversion;subtype: C	1	231	6L,27I,41T,50T,71D,83L,110N,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ375114	RA	Botswana	07-Nov-2008	RA_328_08R	genomic RNA		sampled approximately 328 days afterseroconversion;subtype: C	1	231	6L,14P,27I,41T,50T,71D,83L,110N,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ375115	RA	Botswana	07-Nov-2008	RA_328_09R	genomic RNA		sampled approximately 328 days afterseroconversion;subtype: C	1	231	6L,15L,27I,41T,50T,71D,83L,115V,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ375116	RA	Botswana	07-Nov-2008	RA_328_10R	genomic RNA		sampled approximately 328 days afterseroconversion;subtype: C	1	231	6L,15L,27I,41T,50T,71D,83L,112H,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ375117	RA	Botswana	07-Nov-2008	RA_328_11R	genomic RNA		sampled approximately 328 days afterseroconversion;subtype: C	1	231	6L,14P,27I,41T,50T,71D,83L,110N,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ375118	RA	Botswana	07-Nov-2008	RA_328_12R	genomic RNA		sampled approximately 328 days afterseroconversion;subtype: C	1	231	6L,14P,27I,41T,50T,71D,83L,110N,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ375119	RA	Botswana	07-Nov-2008	RA_328_13R	genomic RNA		sampled approximately 328 days afterseroconversion;subtype: C	1	231	6L,15L,27I,41T,50T,71D,83L,115V,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ375120	RA	Botswana	07-Nov-2008	RA_328_14R	genomic RNA		sampled approximately 328 days afterseroconversion;subtype: C	1	231	6L,14P,27I,41T,50T,71D,83L,110N,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ375121	RA	Botswana	07-Nov-2008	RA_328_15R	genomic RNA		sampled approximately 328 days afterseroconversion;subtype: C	1	231	6L,14P,17A,27I,41T,50T,71D,83L,110N,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ375122	RA	Botswana	07-Nov-2008	RA_328_16R	genomic RNA		sampled approximately 328 days afterseroconversion;subtype: C	1	231	6L,15L,27I,41T,50T,71D,83L,110N,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ375123	RA	Botswana	07-Nov-2008	RA_328_17R	genomic RNA		sampled approximately 328 days afterseroconversion;subtype: C	1	231	6L,15L,27I,41T,50T,71D,83L,115V,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ375124	RA	Botswana	07-Nov-2008	RA_328_18R	genomic RNA		sampled approximately 328 days afterseroconversion;subtype: C	1	231	6L,15L,27I,41T,50T,71D,83L,110N,116A,120G,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ375125	RA	Botswana	07-Nov-2008	RA_328_19R	genomic RNA		sampled approximately 328 days afterseroconversion;subtype: C	1	231	6L,14P,27I,41T,50T,71D,83L,110N,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ375126	RA	Botswana	07-Nov-2008	RA_328_20R	genomic RNA		sampled approximately 328 days afterseroconversion;subtype: C	1	231	6L,14P,27I,41T,50T,71D,83L,110N,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ375127	RA	Botswana	07-Nov-2008	RA_328_21R	genomic RNA		sampled approximately 328 days afterseroconversion;subtype: C	1	231	6L,14P,27I,41T,50T,71D,83L,110N,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ375128	RA	Botswana	07-Nov-2008	RA_328_22R	genomic RNA		sampled approximately 328 days afterseroconversion;subtype: C	1	231	6L,14P,16T,27I,41T,50T,71D,83L,110N,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ871139	RA	Botswana		RA_389_01R	genomic RNA		subtype: C	1	231	6L,14P,17A,27I,41T,44L,50T,71D,83L,110N,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ871140	RA	Botswana		RA_389_02R	genomic RNA		subtype: C	1	231	6L,14P,17A,27I,41T,50T,71D,83L,110N,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ871141	RA	Botswana		RA_389_03R	genomic RNA		subtype: C	1	231	6L,14P,17A,27I,41T,50T,71D,83L,110N,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ871142	RA	Botswana		RA_389_04R	genomic RNA		subtype: C	1	231	6L,14P,17A,27I,41T,50T,71D,83L,110N,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ871143	RA	Botswana		RA_389_05R	genomic RNA		subtype: C	1	231	6L,14P,17A,27I,41T,50T,71D,83L,110N,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ871144	RA	Botswana		RA_389_06R	genomic RNA		subtype: C	1	231	6L,14P,17A,27I,41T,50T,71D,83L,110N,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ871145	RA	Botswana		RA_389_07R	genomic RNA		subtype: C	1	231	6L,14P,17A,27I,41T,50T,71D,83L,110N,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ871146	RA	Botswana		RA_389_08R	genomic RNA		subtype: C	1	231	6L,14P,17A,27I,41T,50T,71D,83L,110N,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ871147	RA	Botswana		RA_389_09R	genomic RNA		subtype: C	1	231	6L,14P,17A,27I,41T,50T,71D,83L,110N,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ871148	RA	Botswana		RA_389_10R	genomic RNA		subtype: C	1	231	6L,14P,17A,27I,41T,50T,71D,83L,110N,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ871149	RA	Botswana		RA_389_11R	genomic RNA		subtype: C	1	231	6L,14P,17A,27I,41T,50T,71D,83L,110N,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ871150	RA	Botswana		RA_389_12R	genomic RNA		subtype: C	1	231	6L,14P,16T,27I,41T,50T,71D,83L,110N,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ871151	RA	Botswana		RA_389_13R	genomic RNA		subtype: C	1	231	6L,14P,17A,27I,41T,50T,71D,83L,110N,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ871152	RA	Botswana		RA_389_14R	genomic RNA		subtype: C	1	231	6L,14P,17A,27I,41T,50T,71D,83L,110N,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ871153	RA	Botswana		RA_389_15R	genomic RNA		subtype: C	1	231	6L,14P,17A,27I,41T,50T,71D,83L,110N,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ871154	RA	Botswana		RA_422_01R	genomic RNA		subtype: C	1	231	6L,14P,17A,27I,41T,50T,71D,83L,110N,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ871155	RA	Botswana		RA_422_02R	genomic RNA		subtype: C	1	231	6L,14P,17A,27I,41T,50T,71D,83L,96L,110N,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ871156	RA	Botswana		RA_422_03R	genomic RNA		subtype: C	1	231	6L,14P,17A,27I,41T,50T,71D,83L,110N,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ871157	RA	Botswana		RA_422_04R	genomic RNA		subtype: C	1	231	6L,14P,17A,27I,41T,50T,71D,83L,87Q,110N,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ871158	RA	Botswana		RA_422_05R	genomic RNA		subtype: C	1	231	6L,14P,17A,27I,41T,50T,71D,83L,110N,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ871159	RA	Botswana		RA_422_06R	genomic RNA		subtype: C	1	231	6L,14P,17A,27I,41T,50T,71D,83L,110N,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ871160	RA	Botswana		RA_422_07R	genomic RNA		subtype: C	1	231	6L,14P,17A,27I,41T,50T,71D,83L,110N,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ871161	RA	Botswana		RA_422_08R	genomic RNA		subtype: C	1	231	6L,14P,17A,27I,41T,50T,71D,83L,110N,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ871162	RA	Botswana		RA_422_09R	genomic RNA		subtype: C	1	231	6L,14P,27I,41T,50T,71D,83L,110N,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ871163	RA	Botswana		RA_422_10R	genomic RNA		subtype: C	1	231	6L,14P,17A,27I,41T,50T,71D,83L,110N,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ871164	RA	Botswana		RA_422_11R	genomic RNA		subtype: C	1	231	6L,14P,17A,27I,41T,50T,71D,83L,110N,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ871165	RA	Botswana		RA_422_12R	genomic RNA		subtype: C	1	231	6L,14P,17A,27I,41T,50T,71D,83L,110N,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ871166	RA	Botswana		RA_422_13R	genomic RNA		subtype: C	1	231	6L,14P,17A,27I,41T,50T,71D,83L,110N,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ871167	RA	Botswana		RA_422_14R	genomic RNA		subtype: C	1	231	6L,14P,17A,27I,41T,50T,71D,83L,110N,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ871168	RA	Botswana		RA_422_15R	genomic RNA		subtype: C	1	231	6L,14P,17A,27I,41T,50T,71D,83L,110N,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ871169	RA	Botswana		RA_422_16R	genomic RNA		subtype: C	1	231	6L,14P,17A,27I,41T,50T,71D,83L,110N,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ871170	RA	Botswana		RA_422_17R	genomic RNA		subtype: C	1	231	6L,14P,17A,27I,41T,50T,71D,83L,96R,110N,116A,120S,124V,128D,148V,154K,168L,169F,178T,180D,187D,203R,208G,225S
GQ275513	RA_054_01	Botswana			genomic DNA	patient B sampled 164 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,31G,33N,71D,83L,91V,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277513	RA_054_01	Botswana			genomic DNA	patient RA sampled 054 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,50T,71D,83L,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275514	RA_054_02	Botswana			genomic DNA	patient B sampled 164 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277514	RA_054_02	Botswana			genomic DNA	patient RA sampled 054 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,50T,71D,83L,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275515	RA_054_04	Botswana			genomic DNA	patient B sampled 223 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,31G,33N,71D,83L,91V,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277515	RA_054_04	Botswana			genomic DNA	patient RA sampled 054 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,50T,71D,83L,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275516	RA_054_05	Botswana			genomic DNA	patient B sampled 223 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,112A,116A,120S,128D,148V,154K,167Q,169F,178T,180D,184*,187D,203R,208G,225S
GQ277516	RA_054_05	Botswana			genomic DNA	patient RA sampled 054 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,50T,71D,83L,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275517	RA_054_06	Botswana			genomic DNA	patient B sampled 223 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277517	RA_054_06	Botswana			genomic DNA	patient RA sampled 054 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,50T,71D,83L,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275518	RA_054_08	Botswana			genomic DNA	patient B sampled 223 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,110N,112A,116A,120S,128D,148V,154K,167Q,169F,178T,180D,187D,203R,208G,225S
GQ277518	RA_054_08	Botswana			genomic DNA	patient RA sampled 054 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14V,27I,41T,50T,71D,83L,115V,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275519	RA_054_09	Botswana			genomic DNA	patient B sampled 223 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277519	RA_054_09	Botswana			genomic DNA	patient RA sampled 054 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,50T,71D,83L,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275520	RA_054_10	Botswana			genomic DNA	patient B sampled 223 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277520	RA_054_10	Botswana			genomic DNA	patient RA sampled 054 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,50T,71D,83L,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275521	RA_054_11	Botswana			genomic DNA	patient B sampled 223 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,31G,33N,71D,83L,91V,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277521	RA_054_11	Botswana			genomic DNA	patient RA sampled 054 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,50T,71D,83L,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275522	RA_054_12	Botswana			genomic DNA	patient B sampled 223 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,31G,33N,71D,83L,91V,112A,116A,120S,128D,148V,154K,169F,175D,178T,180D,187D,203R,208G,225S
GQ277522	RA_054_12	Botswana			genomic DNA	patient RA sampled 054 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,50T,71D,83L,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275523	RA_142_01	Botswana			genomic DNA	patient B sampled 223 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,31G,33N,71D,83L,91V,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277523	RA_142_01	Botswana			genomic DNA	patient RA sampled 142 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,50T,71D,83L,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275524	RA_142_02	Botswana			genomic DNA	patient B sampled 223 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14S,15L,31G,33N,71D,83L,91V,112A,116A,120S,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ277524	RA_142_02	Botswana			genomic DNA	patient RA sampled 142 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,50T,71D,83L,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275525	RA_142_03	Botswana			genomic DNA	patient C sampled 004 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ277525	RA_142_03	Botswana			genomic DNA	patient RA sampled 142 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,50T,71D,83L,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275526	RA_142_04	Botswana			genomic RNA	patient C sampled 004 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ277526	RA_142_04	Botswana			genomic DNA	patient RA sampled 142 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,50T,71D,83L,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275527	RA_142_05	Botswana			genomic DNA	patient C sampled 004 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ277527	RA_142_05	Botswana			genomic DNA	patient RA sampled 142 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,50T,71D,83L,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275528	RA_142_06	Botswana			genomic RNA	patient C sampled 004 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ277528	RA_142_06	Botswana			genomic DNA	patient RA sampled 142 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,50T,71D,83L,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275529	RA_142_07	Botswana			genomic DNA	patient C sampled 004 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ277529	RA_142_07	Botswana			genomic DNA	patient RA sampled 142 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,50T,71D,83L,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275530	RA_142_08	Botswana			genomic RNA	patient C sampled 004 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ277530	RA_142_08	Botswana			genomic DNA	patient RA sampled 142 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,50T,71D,83L,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275531	RA_142_09	Botswana			genomic DNA	patient C sampled 004 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ277531	RA_142_09	Botswana			genomic DNA	patient RA sampled 142 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,50T,71D,83L,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275532	RA_142_10	Botswana			genomic RNA	patient C sampled 004 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ277532	RA_142_10	Botswana			genomic DNA	patient RA sampled 142 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,50T,71D,83L,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275533	RA_142_11	Botswana			genomic DNA	patient C sampled 004 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ277533	RA_142_11	Botswana			genomic DNA	patient RA sampled 142 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,50T,71D,83L,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275534	RA_142_12	Botswana			genomic RNA	patient C sampled 004 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ277534	RA_142_12	Botswana			genomic DNA	patient RA sampled 142 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,50T,71D,83L,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275535	RA_240_01	Botswana			genomic DNA	patient C sampled 004 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ277535	RA_240_01	Botswana			genomic DNA	patient RA sampled 240 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,41T,50T,71D,83L,115V,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275536	RA_240_02	Botswana			genomic RNA	patient C sampled 004 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ277536	RA_240_02	Botswana			genomic DNA	patient RA sampled 240 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,27I,41T,50T,71D,83L,110N,115V,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275537	RA_240_03	Botswana			genomic DNA	patient C sampled 004 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ277537	RA_240_03	Botswana			genomic DNA	patient RA sampled 240 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,50T,71D,83L,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275538	RA_240_04	Botswana			genomic RNA	patient C sampled 004 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120G,128D,148V,154K,169F,187D,203R,208G,210S
GQ277538	RA_240_04	Botswana			genomic DNA	patient RA sampled 240 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,50T,71D,83L,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275539	RA_240_05	Botswana			genomic DNA	patient C sampled 004 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ277539	RA_240_05	Botswana			genomic DNA	patient RA sampled 240 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,27I,41T,50T,71D,83L,110N,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275540	RA_240_06	Botswana			genomic DNA	patient C sampled 004 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ277540	RA_240_06	Botswana			genomic DNA	patient RA sampled 240 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,14P,27I,41T,50T,63P,71D,83L,110N,116A,120S,124V,128D,148V,154K,169F,178T,180D,183H,187D,191I,203R,208G,210A,225S
GQ275541	RA_240_07	Botswana			genomic DNA	patient C sampled 004 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ277541	RA_240_07	Botswana			genomic DNA	patient RA sampled 240 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,50T,71D,83L,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ275542	RA_240_08	Botswana			genomic DNA	patient C sampled 004 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ277542	RA_240_08	Botswana			genomic DNA	patient RA sampled 240 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,27I,41T,50T,71D,83L,116A,120S,124V,128D,148V,154K,169F,178T,180D,187D,203R,208G,225S
GQ871171	RB	Botswana		RB_332_01R	genomic RNA		subtype: C	1	231	27I,41T,71D,75D,83M,91V,96I,116T,120S,128D,136M,148V,169F,178T,187D,203R,208G,210S
GQ871172	RB	Botswana		RB_332_02R	genomic RNA		subtype: C	1	231	27I,41T,71D,75D,83M,91V,96I,111F,116T,120S,128D,136M,148V,169F,178T,187D,203R,208G,210S
GQ871173	RB	Botswana		RB_332_03R	genomic RNA		subtype: C	1	231	27I,41T,71D,75D,83M,91V,96I,116T,120S,128D,136M,148V,169F,178T,187D,203R,208G,210S
GQ871174	RB	Botswana		RB_332_04R	genomic RNA		subtype: C	1	231	27I,41T,71D,75D,83M,91V,96I,116T,120S,128D,136M,148V,169F,178T,187D,203R,208G,210S
GQ871175	RB	Botswana		RB_332_05R	genomic RNA		subtype: C	1	231	27I,41T,71D,75D,83M,91V,96I,116T,120S,128D,136M,148V,169F,178T,187D,203R,208G,210S
GQ871176	RB	Botswana		RB_332_06R	genomic RNA		subtype: C	1	231	27I,41T,71D,75D,83M,91V,96I,116T,120S,128D,136M,148V,169F,178T,187D,203R,208G,210S
GQ871177	RB	Botswana		RB_332_07R	genomic RNA		subtype: C	1	231	27I,41T,71D,75D,83M,91V,96I,116T,120S,128D,136M,148V,169F,178T,187D,203R,208G,210S,229K
GQ871178	RB	Botswana		RB_332_08R	genomic RNA		subtype: C	1	231	27I,41T,71D,75D,83M,91V,96I,116T,120S,128D,136M,148V,169F,178T,187D,203R,208G,210S
GQ871179	RB	Botswana		RB_332_09R	genomic RNA		subtype: C	1	231	27I,41T,71D,75D,83M,91V,96I,116T,120S,128D,136M,148V,163N,169F,178T,187D,203R,208G,210S
GQ871180	RB	Botswana		RB_332_11R	genomic RNA		subtype: C	1	231	27I,41T,71D,75D,83M,87Q,91V,96I,116T,120S,128D,136M,148V,169F,178T,187D,203R,208G,210S,229K
GQ871181	RB	Botswana		RB_332_12R	genomic RNA		subtype: C	1	231	27I,41T,71D,75D,83M,91V,96I,116T,120S,128D,136M,148V,169F,178T,187D,203R,208G,210S
GQ871182	RB	Botswana		RB_332_13R	genomic RNA		subtype: C	1	231	27I,41T,71D,75D,83M,91V,96I,116T,120S,128D,136M,148V,169F,178T,187D,203R,208G,210S
GQ871183	RB	Botswana		RB_332_14R	genomic RNA		subtype: C	1	231	27I,41T,71D,75D,83M,91V,96I,116T,120S,128D,136M,148V,169F,178T,187D,203R,208G,210S
GQ275543	RB_052_01	Botswana			genomic DNA	patient C sampled 004 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ277543	RB_052_01	Botswana			genomic DNA	patient RB sampled 052 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	27I,41T,71D,75D,83M,91V,96I,116T,120S,128D,136M,137E,148V,169F,178T,187D,203R,208G,210S,225S,229K
GQ275544	RB_052_03	Botswana			genomic DNA	patient C sampled 004 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ277544	RB_052_03	Botswana			genomic DNA	patient RB sampled 052 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	27I,41T,71D,75D,83M,91V,96I,116T,120S,128D,136M,148V,169F,178T,187D,203R,208G,210S,225S
GQ275545	RB_052_04	Botswana			genomic DNA	patient C sampled 004 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ277545	RB_052_04	Botswana			genomic DNA	patient RB sampled 052 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	27I,41T,71D,75D,83M,91V,96I,116T,120S,128D,136M,148V,169F,178T,187D,203R,208G,210S,225S
GQ275546	RB_052_05	Botswana			genomic DNA	patient C sampled 004 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ277546	RB_052_05	Botswana			genomic DNA	patient RB sampled 052 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	27I,41T,71D,75D,83M,91V,96I,116T,120S,128D,136M,148V,169F,178T,187D,203R,208G,210S,225S
GQ275547	RB_052_21	Botswana			genomic DNA	patient C sampled 004 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ277547	RB_052_21	Botswana			genomic DNA	patient RB sampled 052 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	27I,41T,71D,75D,83M,91V,96I,116T,120S,128D,136M,148V,169F,178T,187D,203R,208G,210S,225S
GQ275548	RB_052_22	Botswana			genomic RNA	patient C sampled 004 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ277548	RB_052_22	Botswana			genomic DNA	patient RB sampled 052 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	27I,41T,71D,75D,83M,91V,96I,116T,120S,128D,136M,148V,169F,178T,187D,203R,208G,210S,225S
GQ275549	RB_052_23	Botswana			genomic DNA	patient C sampled 004 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ277549	RB_052_23	Botswana			genomic DNA	patient RB sampled 052 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	27I,41T,71D,75D,83M,91V,96I,116T,117*,120S,128D,136M,148V,169F,178T,187D,203R,208E,210S,225S,229K
GQ275550	RB_142_01	Botswana			genomic RNA	patient C sampled 004 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ277550	RB_142_01	Botswana			genomic DNA	patient RB sampled 142 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	27I,41T,71D,75D,83M,91V,96I,116T,120S,128D,136M,148V,169F,178T,187D,203R,208G,210S
GQ275551	RB_142_02	Botswana			genomic DNA	patient C sampled 004 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ277551	RB_142_02	Botswana			genomic DNA	patient RB sampled 142 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	27I,41T,71D,75D,83M,91V,96I,116T,120S,128D,136M,148V,169F,178T,187D,203R,208G,210S
GQ275552	RB_142_03	Botswana			genomic RNA	patient C sampled 004 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ277552	RB_142_03	Botswana			genomic DNA	patient RB sampled 142 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	27I,41T,71D,75D,83M,91V,96I,116T,120S,128D,136M,148V,169F,178T,187D,203R,208G,210S,225S,229K
GQ275553	RB_142_04	Botswana			genomic DNA	patient C sampled 004 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ277553	RB_142_04	Botswana			genomic DNA	patient RB sampled 142 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	27I,41T,71D,75D,83M,91V,96I,116T,120S,128D,136M,148V,169F,178T,187D,203R,208G,210S,225S
GQ275554	RB_142_05	Botswana			genomic RNA	patient C sampled 004 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ277554	RB_142_05	Botswana			genomic DNA	patient RB sampled 142 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	23*,27I,41T,71D,75D,83M,91V,96I,116T,120S,128D,136M,148V,169F,178T,187D,203R,208G,210S,229K
GQ275555	RB_142_06	Botswana			genomic DNA	patient C sampled 004 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ277555	RB_142_06	Botswana			genomic DNA	patient RB sampled 142 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	27I,41T,71D,75D,83M,91V,96I,116T,120S,128D,136M,148V,169F,178T,187D,203R,208G,210S
GQ275556	RB_142_07	Botswana			genomic DNA	patient C sampled 004 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ277556	RB_142_07	Botswana			genomic DNA	patient RB sampled 142 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	27I,41T,71D,75D,83M,91V,96I,116T,120S,128D,136M,148V,169F,178T,187D,203R,208G,210S
GQ275557	RB_142_08	Botswana			genomic DNA	patient C sampled 004 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ277557	RB_142_08	Botswana			genomic DNA	patient RB sampled 142 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	27I,41T,71D,75D,83M,91V,96I,116T,120S,128D,136M,148V,169F,178T,187D,203R,208G,210S,225S,229K
GQ275558	RB_142_09	Botswana			genomic DNA	patient C sampled 004 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ277558	RB_142_09	Botswana			genomic DNA	patient RB sampled 142 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	27I,41T,71D,75D,83M,91V,96I,116T,120S,128D,136M,148V,169F,178T,187D,203R,208G,210S,225S,229K
GQ275559	RB_240_01R	Botswana			genomic DNA	patient C sampled 004 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ277559	RB_240_01R	Botswana			genomic RNA	patient RB sampled 240 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	27I,41T,71D,75D,83M,91V,96I,116T,120S,128D,136M,148V,169F,178T,187D,203R,208G,210S
GQ275560	RB_240_02R	Botswana			genomic DNA	patient C sampled 004 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S,212K
GQ277560	RB_240_02R	Botswana			genomic RNA	patient RB sampled 240 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	27I,41T,71D,75D,83M,91V,96I,116T,120S,128D,136M,148V,169F,178T,187D,203R,208G,210S
GQ275561	RB_240_03R	Botswana			genomic DNA	patient C sampled 095 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ277561	RB_240_03R	Botswana			genomic RNA	patient RB sampled 240 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	27I,41T,71D,75D,83M,91V,96I,116T,120S,128D,136M,148V,169F,178T,187D,203R,208G,210S
GQ275562	RB_240_04R	Botswana			genomic DNA	patient C sampled 095 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ277562	RB_240_04R	Botswana			genomic RNA	patient RB sampled 240 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	27I,41T,71D,75D,83M,91V,96I,116T,120S,128D,136M,148V,169F,178T,187D,203R,208G,210S
GQ275563	RB_240_05R	Botswana			genomic DNA	patient C sampled 095 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ277563	RB_240_05R	Botswana			genomic RNA	patient RB sampled 240 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	27I,41T,71D,75D,83M,91V,96I,116T,120S,128D,136M,148V,169F,178T,187D,203R,208G,210S
GQ275564	RB_240_06R	Botswana			genomic DNA	patient C sampled 095 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ277564	RB_240_06R	Botswana			genomic RNA	patient RB sampled 240 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	27I,41T,71D,75D,83M,91V,96I,116T,120S,128D,136M,148V,169F,178T,187D,203R,208G,210S,229K
GQ275565	RB_240_07R	Botswana			genomic DNA	patient C sampled 095 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,201M,203R,208G,210S
GQ277565	RB_240_07R	Botswana			genomic RNA	patient RB sampled 240 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	27I,41T,71D,75D,83M,91V,96I,116T,120S,128D,136M,148V,169F,178T,187D,203R,208G,210S,229K
GQ275566	RB_240_08R	Botswana			genomic DNA	patient C sampled 095 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ277566	RB_240_08R	Botswana			genomic RNA	patient RB sampled 240 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	27I,41T,71D,75D,83M,91V,96I,116T,120S,128D,136M,148V,169F,178T,187D,203R,208G,210S
GQ275567	RB_240_09R	Botswana			genomic DNA	patient C sampled 095 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ277567	RB_240_09R	Botswana			genomic RNA	patient RB sampled 240 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	27I,41T,71D,75D,83M,91V,96I,116T,120S,128D,136M,148V,169F,178T,187D,203R,208G,210S
GQ275568	RB_240_10R	Botswana			genomic DNA	patient C sampled 095 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ277568	RB_240_10R	Botswana			genomic RNA	patient RB sampled 240 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	27I,41T,71D,75D,83M,91V,96I,116T,120S,128D,136M,148V,169F,178T,187D,203R,208G,210S
GQ275569	RB_240_11R	Botswana			genomic DNA	patient C sampled 095 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	6L,15L,27I,47C,71D,83L,110N,116A,120S,128D,148V,154K,169F,187D,203R,208G,210S
GQ277569	RB_240_11R	Botswana			genomic RNA	patient RB sampled 240 days fromestimated seroconversion	part of Tshedimoso study;subtype: C	1	231	27I,41T,71D,75D,83M,91V,96I,116T,120S,128D,136M,148V,169F,178T,187D,203R,208G,210S